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Abstract 
General anesthetics are widely used in clinical and scientific contexts, but their molecular 
mechanisms, and how these mechanisms give rise to the state of anesthesia, are poorly 
understood. We investigated the influence of the volatile anesthetic isoflurane on 
serotonin (5-hydroxytryptamine; 5-HT) and γ-aminobutyric acid (GABA) synthesizing 
raphé neurons. These cell types have been proposed as central chemoreceptors, cells that 
sense changes in arterial CO2/pH and stimulate respiratory output to regain homeostasis. 
We tested the hypotheses that isoflurane inhibits 5-HT neuron baseline firing, enhances 
GABA neuron baseline firing, and disrupts the chemosensitivity of both neuron types. 
We performed extracellular recordings in the medullary raphé using the unanesthetized in 
situ perfused brainstem preparation. Subsets of neurons were labeled with biotinamide 
using the juxtacellular labeling method and immunohistochemically identified by 
neurotransmitter phenotype. Results indicated that isoflurane inhibited action potential 
discharge in 5-HT neurons. Isoflurane inhibited action potential discharge in a subset of 
CO2-inhibited putative GABA neurons and enhanced action potential discharge in a 
different subset of these neurons. Isoflurane disrupted the chemosensitivity of both 5-HT 
and GABA neurons. Disruption of 5-HT and GABA neuron chemosensitivity by 
isoflurane may contribute to the blunted hypercapnic ventilatory response that is a 
secondary effect of general anesthesia.   
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Chapter 1 
Introduction 
 
1.1  Introduction to general anesthetics 
General anesthesia was first publically demonstrated with diethyl ether in 1846, and soon 
after, many different anesthetics, including nitrous oxide, chloroform, ethylene, 
cyclopropane, trichloroethylene, and divinyl ether, were popularly used in clinical 
practice. Some of these anesthetics were later discontinued due to issues with toxicity, 
flammability, and compromising side effects, and new agents such as halothane, 
isoflurane, enflurane, sevoflurane, and desflurane were developed. The wide variety of 
anesthetics used today are classified into two major groups: 1) intravenous anesthetics, 
such as propofol, etomidate, and ketamine; and 2) inhalational anesthetics, which include 
volatile anesthetics such as isoflurane, enflurane, halothane, sevoflurane, and desflurane, 
and gaseous inhaled anesthetics, such as cyclopropane, nitrous oxide, and xenon (Evers et 
al., 2006). The present study will distinguish between these different types of anesthetics 
by referring to the two major classes as: 1) intravenous anesthetics; and 2) volatile or 
inhalational anesthetics. This introduction will primarily focus on volatile inhalational 
anesthetics, as the present study was conducted using the volatile anesthetic isoflurane.   
 
General anesthetics depress the central nervous system to a sufficient degree to allow for 
surgical or other noxious procedures. This central nervous system depression, generally 
referred to as the state of anesthesia, can be described as a collection of changes in 
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behavior and perception, which include amnesia, immobility in response to noxious 
stimuli, attenuation of autonomic responses to noxious stimuli, analgesia, and hypnosis 
(Evers et al., 2006). The precise pattern of behavioral change is different for each 
anesthetic agent, which has made it difficult to define general anesthesia as a precise 
behavioral state. Clinically, general anesthesia is understood as the state in which 
perception and reflex motor responses to stimuli, particularly painful stimuli, are 
sufficiently inhibited to allow for noxious procedures.  
 
In addition to producing the general state of anesthesia, all general anesthetics exert 
significant secondary effects on organ systems and suppress homeostatic reflexes, and as 
a result, these drugs have a low therapeutic index. Given their relatively narrow margin of 
safety, anesthetics must be administered with careful consideration of their secondary 
effects and pharmacokinetic properties. Furthermore, these agent-specific properties must 
be evaluated in the context of the patient’s age, medical condition, medication use, and 
surgical procedure.  
 
The key point of administering anesthetics is to reach and then maintain the appropriate 
level of anesthesia, as an excess of anesthesia can cause injury and may even prove fatal. 
Every anesthetic agent produces the cardinal clinical features of immobility, hypnosis, 
analgesia, and amnesia, but these clinical signs of general anesthesia can be unreliable in 
assessing the level of anesthesia because the degree and pattern of each effect is different 
for each anesthetic agent. This issue was addressed in 1965 when Eger et al. introduced 
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the concept of anesthetic equipotency, which defines the minimum alveolar concentration 
(MAC) of anesthetic preventing movement in response to surgical stimulation in 50 % of 
subjects (Eger et al., 1965). MAC values measuring the potency of inhalational 
anesthetics in terms of the response to noxious stimulation have been determined for all 
anesthetics that are used clinically (Evers et al., 2006). These MAC values allow for 
measurement of an endpoint representing the clinical goal of immobility. Additional 
MAC values have also been developed that measure different endpoints, such as MAC 
awake, which defines the concentration of anesthetic that prevents response to verbal 
commands in 50 % of subjects, as well as MAC for suppression of memory. In summary, 
MAC values afford the ability to measure anesthetic potency, which is of critical 
importance when administering anesthetics, particularly in light of the low therapeutic 
index and significant secondary effects of these drugs.  
 
MAC values allow for measurement of endpoints representing clinical goals that are 
common to all anesthetics, but the pharmacokinetics that mediate the changes in behavior 
and perception necessary to reach those endpoints are specific to each anesthetic. The 
solubility properties of inhalational anesthetics are fundamental to their kinetics. 
Typically, solubility is represented by the blood/gas partition coefficient, which indicates 
the ratio of the concentration of the two phases, blood and gas, when partial pressures are 
in equilibrium. All inhalational anesthetics are selectively soluble in fatty tissues, and due 
to this lipid affinity, the solubility in tissue is different than the solubility in blood (Evers 
et al., 2006). The solubility in the blood and tissue contributes to the uptake, distribution, 
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and elimination of anesthetics. In humans, the uptake of anesthetics depends on the ratio 
between the alveolar and inspired concentration (FA/FI), which represents the 
equilibrium state between body tissues and inspired concentration (Torri, 2010). The rate 
of rise of FA/FI depends on numerous factors, such as the blood/gas partition coefficient, 
alveolar ventilation, cardiac output, blood flow, and tissue capacity. The elimination of 
anesthetics can be defined by the decrease in alveolar concentration relative to the 
alveolar concentration determined at the end of anesthesia (FA/FAo). The lower the 
anesthetic solubility, the shorter the recovery time (Torri, 2010). The kinetics of uptake 
and elimination are specific to each anesthetic agent, and these processes are important 
for clinicians to understand when administering different anesthetic drugs to ensure safe 
induction and recovery from anesthesia. 
 
The present study used the volatile anesthetic isoflurane, which is commonly used in both 
clinical and scientific practice. Isoflurane is relatively difficult to synthesize and purify, 
so its development in 1965 followed that of its isomer, enflurane (Eger, 1981). Many of 
the physical properties of isoflurane and enflurane are similar, and both drugs are 
currently approved for use by the Food and Drug Administration. Isoflurane is a methyl 
ethyl ether compound that is highly halogenated with five flourines and one chlorine, 
which renders the compound nonflammable over clinically useful concentrations. 
Isoflurane potency, as measured by MAC-immobility, is 1.15 % in 100 % oxygen (Eger, 
1981). The blood/gas partition coefficient of 1.4 is relatively low, which indicates that 
isoflurane is poorly soluble in blood. As with all inhalational anesthetics, the low blood 
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solubility of isoflurane is coupled with a greater affinity for lipid tissues. Despite the 
relatively high tissue solubility of isoflurane, the extremely low blood solubility allows 
for a faster elimination time compared to other potent inhaled anesthetics. This rapid 
elimination is a significant advantage of isoflurane because it allows mental function to 
return to normal and the circulatory, respiratory, and neuromuscular depression to 
quickly reverse, and it also decreases the possibility of liver or kidney toxicity. As with 
all general anesthetics, isoflurane does exert significant secondary effects on organ 
systems, including decreased systemic arterial blood pressure, suppressed ventilation, and 
depressed neuromuscular transmission.  
 
1.2 Secondary effects of general anesthetics 
In addition to their depressive effects on the central nervous system, all general 
anesthetics suppress homeostatic reflexes and exert secondary effects on organ systems. 
The predominate effect of inhalational anesthetics is a decrease in systemic arterial blood 
pressure due to vasodilation, myocardial depression, suppressed baroreceptor control, and 
a general decrease in sympathetic tone (Evers et al., 2006). The magnitude of this 
response is variable among different anesthetics, but all cause hemodynamic effects to 
some degree, and this secondary effect is crucial to consider in the context of the surgical 
procedure and patient’s medical condition, particularly for trauma victims who already 
have severely depleted intravascular volume. Hypothermia is another critical secondary 
effect of anesthesia, in which patients develop a colder body temperature (<36 °C) during 
surgery (Evers et al., 2006). All anesthetics lower the core temperature point at which 
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thermoregulatory vasoconstriction is activated, which compromises the body’s normal 
defense against heat loss and causes hypothermia. Also, the metabolic rate decreases 
during anesthesia, which reduces heat generation and contributes to the hypothermic 
condition. Postoperative side effects, such as nausea and vomiting, continue to be 
problematic side effects of general anesthetics during the recovery period.  
 
Respiratory depression is a particularly important point of concern during general 
anesthesia. Virtually all anesthetics cause significant changes in the control of breathing, 
which involves both chemical and behavioral control systems. Chemical control of 
breathing depends on the chemical composition of arterial blood (pH, PO2, PCO2) or 
interstitial fluid in the brainstem (pH, PCO2), whereas behavioral control adjusts 
breathing in response to changes in state such as sleep, arousal, speech, exercise, and pain 
(Dahan and Teppema, 2003). Inhalational anesthetics, particularly volatile halogenated 
agents such as halothane and isoflurane, affect both chemical and behavioral control 
systems, and thus, they exert some of the most drastic effects on respiration.  
 
All inhalational agents depress ventilation by reducing tidal volume, and the 
accompanying increase in respiratory rate does not compensate for reduced alveolar 
ventilation because it primarily results in increased dead space ventilation (Torri, 2010). 
This reduced alveolar ventilation causes PaCO2 to increase. Under normal conditions, the 
change in the chemical composition of the blood and interstitial fluid would trigger a 
ventilatory response, but inhalational anesthetics disrupt the normal homeostatic response 
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to hypercapnic (increased CO2) and/or hypoxic (decreased O2) conditions. This blunted 
ventilatory response to hypercapnia and hypoxia involves anesthetic action at peripheral 
sites of respiratory control in the carotid bodies and central respiratory control networks 
in the central nervous system. Furthermore, inhalational anesthetics reduce the reflexes 
that maintain airways, including gag and cough reflexes (Evers et al., 2006). Due to these 
serious secondary effects, ventilation generally must be controlled or assisted during 
surgery to prevent apnea or periodic breathing.  
 
1.3 Theories of general anesthetic mechanisms of action  
Although general anesthetics are widely used in medical practice and scientific contexts, 
the mechanism of action of anesthetics is poorly understood. Anesthesia is used to block 
perception of and motor reflex responses to painful stimuli, and since the functional unit 
of perception and motor reflexes are neurons, it has long been assumed that anesthetics 
act by modulating neuronal activity. Numerous theories have been proposed to describe 
the mechanisms by which anesthetics modulate neural activity. In the mid 1800s, 
chloroform, ether, and nitrous oxide, three structurally diverse inhalational anesthetics, 
were widely used to produce the state of anesthesia. The fact that structurally unrelated 
compounds could produce the same behavioral effects of immobility, hypnosis, 
analgesia, and amnesia led to the first theory of anesthetic action, termed the unitary 
theory. Proposed by Claude Bernard in the 1870s, the unitary theory of anesthetic action 
postulated that anesthetics acted non-specifically through a common mechanism in the 
central nervous system (Leake, 1971). Approximately 30 years later, Meyer and Overton 
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observed a strong correlation between anesthetic potency and solubility in olive oil, and 
they supplemented the unitary theory with the Meyer-Overton rule, which proposed that 
volatile anesthetics act by nonspecifically perturbing lipid cell membranes (Miller, 1969). 
The unitary theory and Meyer-Overton rule dominated general thinking until the late 20th 
century, when the consensus began to shift toward the concept of anesthetics acting on 
specific protein targets (Franks and Lieb, 1978; Franks and Lieb, 1984). The current 
literature supports an agent-specific, multiple-mechanism theory of anesthetic action, in 
which anesthetics act on multiple molecular targets in different anatomical sites to 
produce the complex changes in behavior and perception that characterize the state of 
anesthesia (Campagna et al., 2003; Grasshoff et al., 2005; Torri, 2010).  
 
Currently, ion channels are considered the most likely target of anesthetics (Campagna et 
al., 2003; Rudolph and Antkowiak, 2004). Ion channels mediate action potential 
conductance, resting membrane potential, and neurotransmitter release, all of which are 
fundamental aspects of neural activity and signaling; thus, these channels should be 
central to changes in behavior and consciousness, such as those observed in the state of 
anesthesia (Mashour et al., 2005). The field is now focused on relating molecular actions 
of anesthetics, most notably on ion channels, to behavioral states of anesthesia.  
 
The majority of research on molecular mechanisms has focused on postsynaptic 
anesthetic action on the chloride channels gated by inhibitory GABAA receptors [receptor 
subtype for the inhibitory neurotransmitter γ-aminobutyric acid (GABA)]. These GABAA 
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receptors are sensitive at clinical concentrations to a wide array of different anesthetics, 
including both intravenous and inhalational agents. It has been widely shown that 
anesthetics potentiate inhibitory currents through GABAA receptors and increase the 
sensitivity of these receptors to GABA, which inhibits postsynaptic neuronal excitability 
(Evers et al., 2006). The mechanism is proposed to involve direct binding of anesthetics 
to specific binding sites on GABAA receptors, since point mutations have been shown to 
eliminate anesthetic effects on the associated ion channels (Rudolph and Antkowiak, 
2004), but interestingly, none of the general anesthetics compete with GABA for its 
binding site. The only anesthetics that do not affect GABAA receptors are ketamine, 
nitrous oxide, cyclopropane, and xenon, which instead inhibit the N-methyl-D-aspartate 
(NMDA) receptor that mediates excitatory glutamatergic neurotransmission (Evers et al., 
2006). Anesthetic action on GABAA receptors has long been considered to play the 
primary role in producing the overall central nervous system depression characteristic of 
general anesthesia.  
 
Despite the long-standing predominance of research on postsynaptic anesthetic action, a 
growing body of literature describes presynaptic sites of anesthetic action as critical 
components of anesthetic mechanisms (Griffiths and Norman, 1993; Pocock and 
Richards, 1993). Presynaptic sites are primarily implicated by studies indicating that 
anesthetics affect neurotransmitter release (Evers et al., 2006). Neurotransmitter release 
can be inhibited by direct anesthetic interaction with the neurotransmitter release 
machinery (Xie et al., 2013), or by inhibition of the action potential leading to 
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neurotransmitter release. For example, anesthetic action on sodium (Na+) channels has 
been shown to inhibit action potential dependent neurotransmitter release (Hemmings, 
2009; Herold and Hemmings, 2012). Additionally, anesthetics binding to two-pore 
domain potassium (K+) channels can inhibit neurotransmitter release by hyperpolarizing 
neurons (Patel et al., 1999), which leads to decreased action potential dependent calcium 
(Ca2+) influx and neurotransmitter release.  
 
1.4 Working hypothesis describing central depression in anesthesia 
The overarching effect of anesthetics is depressed central nervous system activity. Within 
the widely accepted agent-specific, multiple-mechanism theory of anesthetic action, the 
governing hypothesis is that the central depression results from enhanced inhibitory 
activity and depressed excitatory activity. There are multiple ways to achieve both 
enhanced inhibitory and depressed excitatory transmission. For example, inhibition may 
be enhanced by increasing the release of inhibitory neurotransmitters, potentiating the 
response of postsynaptic receptors, or by augmenting postsynaptic neuronal excitability 
by direct modulation of the membrane potential. Excitation may be depressed by 
blocking action potential propagation, enhancing presynaptic inhibition, or inhibiting the 
response mediated by postsynaptic receptors. The enhanced inhibitory transmission is 
thought to primarily involve anesthetic action on GABAA and glycine receptors, and the 
depressed excitatory transmission has been shown to involve action on glutamate, 
nicotinic acetylcholine, and serotonin receptors (Franks and Lieb, 1994; Campagna et al., 
2003; Torri, 2010). As stated, a growing number of studies suggest that presynaptic 
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modulation of neurotransmitter release by anesthetics may also contribute to the 
enhanced inhibitory and depressed excitatory neurotransmission that is hypothesized to 
cause overall central nervous system depression. Mechanisms of anesthetic action have 
been explored in virtually all areas of the brain, and all areas exhibit this pattern of 
enhanced inhibitory activity and depressed excitatory activity for a net result of central 
nervous system depression during anesthesia.  
 
1.5 Target populations in the medullary raphé of the brainstem 
The research presented in this thesis focuses on the influence of the volatile anesthetic 
isoflurane on neurons in the medullary raphé region of the rat brainstem. We targeted 
neurons of two distinct phenotypes: 1) serotonin (5-hydroxytryptamine; 5-HT) 
synthesizing neurons and 2) γ-aminobutyric acid (GABA) synthesizing neurons. These 
two cell types are proposed central respiratory chemoreceptors, which are neurons that 
sense changes in arterial CO2/pH and respond by stimulating the respiratory network 
responses that are necessary to regain homeostasis. Carbon dioxide is soluble in the 
blood, and thus, CO2 levels are linked to pH through the equation CO2 + H2O → H+ + 
CO3– (Richerson, 2004). To give a broad overview of central chemoreception, under 
conditions of increased CO2, the pH of the blood decreases. Respiratory chemoreceptors 
in the brain sense this condition of hypercapnia/acidosis and stimulate respiratory 
networks to signal an increase in respiratory output. This neural signaling results in 
increased breath frequency and amplitude, which allows the organism to offload the 
excess CO2 and return the pH of the blood to homeostatic conditions. The margin of 
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change in blood pH, as governed by the amount of blood protons (H+), that can be 
tolerated is extremely small; an increase in blood protons as little as 0.1 µM is fatal 
(Richerson, 2004). Thus, central respiratory chemoreceptors that monitor arterial blood 
CO2/pH and stimulate respiratory output are critical to survival.  
 
Both serotonergic and GABAergic systems have been implicated in facilitation of the 
homeostatic response to hypercapnia/acidosis (Richerson, 2004). CO2-stimulated 5-HT 
and CO2-inhibited GABA neurons have been shown to be intrinsically chemosensitive in 
the medullary raphé in vitro (Richerson et al., 2001). Research using the unanesthetized 
rat in situ perfused decerebrate brainstem preparations suggests these raphé neurons also 
function as central chemosensors in the intact animal (Corcoran et al., 2008; Iceman et 
al., 2010; Corcoran et al., 2013; Iceman et al., 2013). We propose the “push – pull” 
model of central chemosensitivity, in which 5-HT and GABA raphé neurons provide 
excitatory and inhibitory drive, respectively, to the respiratory central pattern generator, 
which represents a network of neurons that control the rate and relative timing of 
respiratory muscle contraction, and to motor neuron pools, which control breath 
amplitude (Fig. 1.1). Hypercapnia has been shown to stimulate the excitatory 
serotonergic pathway and inhibit the inhibitory GABAergic pathway in vitro and in situ 
(Richerson et al., 2001; Corcoran et al., 2008; Iceman et al., 2010; Corcoran et al., 2013; 
Iceman et al., 2013). By the “push – pull” model, hypercapnic conditions cause 5-HT 
neurons to stimulate respiratory output directly by increasing excitatory drive to the 
respiratory central pattern generator and motor neuron pools, and GABA neurons to 
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stimulate respiratory output through disinhibition by decreasing inhibitory drive to the 
respiratory control network.  
 
Studying the effect of isoflurane on both 5-HT and GABA neurons allowed us to 
examine how anesthetics effect cells involved in excitatory and inhibitory 
neurotransmission, respectively, which allowed us to place our results in context of the 
working hypothesis that central depression results in enhanced inhibitory and depressed 
excitatory activity. Targeting these specific neuron types also allowed us to observe the 
effect of isoflurane on neurons that are known to be involved in respiratory control 
networks and to study how isoflurane affects the chemosensitive properties of these 
neurons. Investigating the influence of isoflurane on neurons involved in central 
chemosensitivity may offer insight into the mechanisms underlying the blunted 
ventilatory response that is a well-known secondary effect of general anesthesia (Evers et 
al., 2006). The remainder of this introduction will provide general background on the two 
cell populations of 5-HT and GABA raphé neurons, discuss the specific aims and 
experimental approach for this research, and briefly review major findings.  
 
1.6 Introduction to the 5-HT system 
Central mechanisms for integrating stimuli and modulating control system responses are 
essential for maintaining homeostasis. The serotonergic system, an interconnected 
network of neurons that communicate via the amine neurotransmitter serotonin (5-
hydroxytryptamine; 5-HT), has been proposed as one such central mechanism that 
!14!
integrates and modulates a wide range of homeostatic functions. These serotonergic cell 
bodies are located in the midbrain and caudal regions and project to virtually all areas of 
the central nervous system, allowing for their critical involvement in maintaining 
homeostatic processes across the motor, somatosensory, and limbic systems (Jacobs and 
Azmitia, 1992; Lovick, 1997; Hornung, 2003; Kinney et al., 2009).  
 
5-HT neurons are divided into two distinct groups based on their distinct anatomical 
locations, connectivity, and functions: 1) the rostral group of the midbrain and pons; and 
2) the caudal group of the medulla (Fig. 1.2 adapted from Kinney et al., 2009). The 
rostral group (ascending serotonergic network), including the pontine raphé, dorsal raphé, 
and median raphé, project to the forebrain and mediate arousal, cognition, anxiety, and 
cerebral blood flow (Jacobs and Azmitia, 1992). These neural circuits have been 
implicated in numerous neuropsychiatric and neurological disorders. The caudal group 
(descending serotonergic network), including raphé obscurus, raphé pallidus, and raphé 
magnus in the midline and the parapyramidal region on the ventrolateral medullary 
surface (VLMS), project to the lower brainstem and spinal cord and mediate autonomic 
output, respiratory, cardiovascular, and motor control, and nociception (Richerson, 2004). 
The widespread involvement of both ascending and descending serotonergic networks in 
diverse neural circuits leads to their hallmark characteristic as integrators, modulators, 
and critical regulators of essential homeostatic processes. 
 
 
! 15!
1.7 Pathology associated with raphé 5-HT neurons 
As serotonin is critical to the modulation and integration of diverse homeostatic 
functions, failure of the serotonergic system to function normally can have severe 
implications. Sudden Infant Death syndrome (SIDS) is defined as the unexpected death 
of an infant less than one year of age that is usually correlated with sleeping and cannot 
be explained after autopsy, death scene investigation, and review of clinical history. SIDS 
is thought to be due to a defective brainstem-mediated protective response to homeostatic 
stress during sleep in a critical period of life (Kinney et al., 2009). This failed protective 
response is described by a “Triple Risk Model,” which involves three risk factors: 1) 
intrinsic factors that cause an underlying brainstem abnormality; 2) a critical 
developmental period during which rapid changes in cardiorespiratory control and 
sleep/wake cycles occur; and 3) exogenous stressors that cause hypoxia (decreased O2), 
hypercapnia (increased CO2), and asphyxia (combined hypoxia and hypercapnia), such as 
over-bundling and the prone sleep position (Fig. 1.3). Convergence of these three risk 
factors leads to the failed protective response, in which SIDS infants cannot adjust to 
lethal, asphyxia-producing circumstances that normal infants would survive (Kinney et 
al., 2009).   
 
Pathologic findings identify an intrinsic risk factor for SIDS to be abnormalities in the 
development of the medullary serotonergic system (Panigrahy et al., 2000; Kinney et al., 
2003; Paterson et al., 2006). Compared to controls, SIDS cases exhibit abnormal 
medullary 5-HT pathology characterized by decreased 5-HT1A receptor-binding sites in 
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the medulla, increased 5-HT cell number and density, immature cell morphology, and 
reduced binding to the 5-HT transporter. These results are consistent with abnormal 5-HT 
firing, synthesis, release, and clearance (Paterson et al., 2006). An example of SIDS 
pathology resulting in increased 5-HT cell density and decreased 5-HT1A receptor-
binding sites is shown in Figure 1.4 (adapted from Paterson et al., 2006). Abnormalities 
in the 5-HT system may translate into unexpected infant death because the 5-HT system 
is required to maintain multiple homeostatic functions that are crucial to autoresuscitation 
and survival, including cardiorespiratory reflexes, temperature regulation, arousal, and 
breathing.  
 
1.8 Role of medullary raphé 5-HT neurons in central respiratory control 
Arguably the most critical homeostatic function mediated by 5-HT neurons that is 
relevant to SIDS pathology is cardiorespiratory homeostasis. Medullary raphé 5-HT 
neurons have been studied extensively for their predominant role in the control and 
modulation of breathing. A wide array of anatomic evidence indicates that 5-HT neurons 
are located in respiratory networks. Serotonin-immunoreactive nerve terminals, arising 
from 5-HT neurons in the medullary raphé and ventrolateral medulla, are found in all 
major respiratory nuclei, including the phrenic motor nucleus, hypoglossal nucleus, 
retrotrapezoid nucleus, pre-Bötzinger complex (pre-BötC), nucleus ambiguus, and 
nucleus tractus solitarius (Pilowsky et al., 1990; Voss et al., 1990; Jacobs and Azmitia, 
1992; Ptak et al., 2009). These respiratory nuclei also contain nerve terminals that are 
immunoreactive for substance P (SP) and thyrotropin-releasing hormone (TRH), 
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neuropeptides that colocalize in medullary raphé 5-HT neurons (Holtman et al., 1984; 
Holtman, 1988). Receptors for raphé neurotransmitters and neuropeptides are also found 
present in the major respiratory nuclei (Richerson, 2004). Additionally, medullary raphé 
5-HT neurons receive reciprocal projections from some major respiratory nuclei, such as 
the pre-BötC neurons responsible for inspiratory rhythm generation (Ptak et al., 2009). 
This anatomical evidence indicates that medullary raphé 5-HT neurons are embedded 
within the central respiratory network.  
 
Given the anatomical evidence indicating that 5-HT neurons are embedded within 
respiratory networks, much research is aimed toward defining the functional role of 5-HT 
neurons in respiratory circuits. Activation of receptors in the major respiratory nuclei via 
exongenous application of 5-HT, SP, and TRH has been widely shown to stimulate 
breathing, both in vitro and in vivo (Richerson, 2004). The contribution of endogenous 5-
HT and raphé neuropeptides to respiratory circuits, however, was a long-held source of 
controversy, with contradictory conclusions that 5-HT inhibits, excites, or has no effect 
on breathing (Hodges and Richerson, 2010), until recently, experiments from Ptak et al. 
(2009) provided clear evidence that endogenous 5-HT provides a necessary tonic, 
excitatory drive to respiratory circuits. These experiments in neonatal rat medullary slices 
in vitro, as well as in the arterially perfused brainstem – spinal cord preparations in situ, 
demonstrated that simultaneous release of 5-HT and SP, activating 5-HT2A/2C, 5-HT4, or 
NK-1 receptors, is required to maintain inspiratory motor output. The study showed that 
some raphé obscurus 5-HT neurons project to the pre-Bötzinger complex and hypoglossal 
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motor nucleus, and stimulating raphé obscurus activity results in increased motor output 
due to excitation of pre-BötC and motor neurons. The study also showed that 5-HT can 
cause some pre-BötC neurons to display intrinsic bursting activity, which suggests an 
additional role for 5-HT in rhythm generation. Additional studies in knockout mice 
indicated that genetic elimination of 5-HT neurons disrupts respiratory rhythm in vivo 
and leads to high postnatal mortality in neonates (Hodges et al., 2009). Collectively, these 
data allow for the conclusion that 5-HT neurons function within respiratory circuits to 
stimulate breathing.  
 
1.9 Identity of 5-HT neurons as central chemoreceptors is controversial 
Although it is clear that 5-HT neurons stimulate respiratory output, their identity as 
central chemoreceptors has not been conclusively demonstrated. As stated previously, 
central chemoreceptors are neurons that sense changes in arterial CO2/pH and respond by 
stimulating the respiratory network responses that are necessary to regain homeostasis. 
Under normal circumstances, central chemoreceptors detect small changes (1 to 2 
mmHg) in arterial PCO2 and elicit changes in breathing frequency and amplitude to 
maintain blood PCO2 at a steady state (40 mmHg). Under situations of stress, such as 
asphyxia-producing circumstances, central chemoreceptors detect abnormally high levels 
of arterial PCO2 (on the order of tens of mmHg) and elicit relatively large changes in 
breathing (Guyenet et al., 2010).  
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To be conclusively identified as a central respiratory chemoreceptor, cells must meet two 
essential criteria: 1) express intrinsic chemosensitivity to physiologically relevant 
changes in arterial pH/CO2; and 2) exert specific effects on respiration, as in, they must 
respond to an increase in CO2 by increasing respiratory output (Richerson et al., 2005). 
Firstly, demonstrating that chemosensitivity is an intrinsic mechanism is practically 
difficult. The cell must be physically separated from all other cells to eliminate 
modulatory effects, but this approach may eliminate connections that are integral to the 
cell’s ability to express intrinsic chemosensitivity. Pharmacological blockade of synaptic 
transmission is another method for cell isolation, but these methods are less complete, 
since the typical method of applying glutamate or GABA receptor antagonists to 
eliminate excitatory or inhibitory modulatory effects, respectively, does not block other 
forms of neurotransmission, and decreasing calcium does not block non-vesicular 
transmission. The difficulty of isolating a potential central respiratory chemoreceptor 
impedes conclusive determination of intrinsic chemosensitivity. Secondly, defining the 
mechanism by which a potential central respiratory chemoreceptor exerts specific effects 
on respiratory output has also proved difficult, since many different proteins, ion 
channels, and neurons are pH-sensitive to some degree. The cellular mechanisms 
underlying the vital homeostatic process of central chemoreception, and the identity of 
neurons that function as respiratory chemoreceptors, is still much debated (Guyenet et al., 
2005; Richerson et al., 2005; Nattie and Li, 2009; Guyenet et al., 2013).  
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It is generally accepted that central chemoreception involves multiple different sites and 
mechanisms (Nattie and Li, 2009). The current literature proposes two main candidates as 
potential central respiratory chemoreceptors: glutamatergic neurons in the retrotrapezoid 
nucleus (RTN) (Mulkey et al., 2004; Guyenet et al., 2008; Guyenet and Mulkey, 2010) 
and serotonergic neurons in the medullary raphé (Richerson et al., 2001; Richerson, 
2004; Hodges and Richerson, 2010; Corcoran et al., 2013; Iceman et al., 2013). 
Noradrenergic, orexinergic, and histaminergic neurons of the locus coeruleus, all of 
which have wake-promoting capabilities, have also been proposed as potential central 
chemoreceptors (Guyenet et al., 2010). Some research also supports a role of glial cells, 
specifically astrocytes, which exhibit pH-induced ATP release that stimulates the 
proposed chemoreceptive RTN neurons (Gourine et al., 2010).  
 
Medullary raphé 5-HT neurons are proposed as potential central respiratory 
chemoreceptors. These cells do have some properties that are consistent with central 
chemoreceptors. In terms of anatomical location, 5-HT neurons are closely associated 
with the basal artery and its major branches, which is an ideal location for monitoring 
arterial blood pH/CO2 (Fig. 1.5 adapted from Bradley et al., 2002). As previously 
discussed, there is a dense concentration of 5-HT immunoreactive nerve terminals in 
major respiratory nuclei, such as the pre-BötC and hypoglossal motor nucleus, and 
stimulating raphé obscurus activity results in increased motor output due to excitation of 
pre-BötC and motor neurons (Ptak et al., 2009). Although it is well established that 5-HT 
neurons are embedded in respiratory networks and function to stimulate breathing, their 
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identity as central chemoreceptors remains a source of controversy because of 
contradictory evidence regarding the response of 5-HT neurons to hypercapnia. 
Serotonergic neurons in the medullary raphé nuclei have been identified as 
chemosensitive in vitro and in situ (Richerson et al., 2001; Corcoran et al., 2013; Iceman 
et al., 2013). A representative serotonergic neuron that was stimulated by CO2 in vitro is 
shown in Figure 1.6 (adapted from Wang et al., 2001). Although CO2-stimulated 5-HT 
neurons are identified in vitro and in situ, some electrophysiological studies on 
anesthetized rats in vivo do not find 5-HT neurons to be chemosensitive. Mulkey et al. 
(2004) reported that 5-HT neurons in the VLMS do not respond to inhalation of 10 % 
CO2 in halothane anesthetized rats in vivo. Corroborating these findings, DePuy et al. 
(2011) found that 5-HT neurons in raphé obscurus do not respond to inhalation of 10 % 
CO2 in isoflurane anesthetized rats in vivo. However, in vivo studies on awake, 
unanesthetized, freely-moving cats found that a subset of 5-HT neurons in the medulla 
and midbrain increase firing in response to inhalation of as little as 3 % CO2 (Veasey et 
al., 1995; Veasey et al., 1997). Due to these contradictory findings regarding the response 
of 5-HT neurons to hypercapnia in vivo, the identity of 5-HT neurons as central 
chemoreceptors has been a long-standing source of controversy.  
 
Previously, we hypothesized that use of anesthetics during neuronal recording was the 
primary reason for the lack of chemosensitive raphé neuronal subtypes identified in 
anesthetized rat in vivo preparations. In collaboration with in culture and in vivo studies 
from the Richerson laboratory at the University of Iowa, we established that the 
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anesthetic isoflurane disrupts the chemosensitivity of 5-HT neurons in situ (Johansen et 
al., 2012; Massey et al., 2013). Our observations of the severe artifact introduced by 
anesthesia may explain why in vivo experiments on anesthetized rats do not find 5-HT 
neurons to be chemosensitive (Mulkey et al., 2004; DePuy et al., 2011). I contributed to 
the data collection and manuscript preparation for this project, and our manuscript has 
been submitted for publication and is included in the appendix of this thesis. Building on 
this study of how isoflurane affects the chemosensitivity of 5-HT neurons, we targeted 
how isoflurane affects action potential discharge in 5-HT neurons, and these data are 
presented in the second chapter of this thesis. 
 
1.10  Role of medullary raphé GABA neurons in central respiratory control 
Having established the effect of isoflurane on the basal activity and chemosensitivity of 
5-HT neurons, the proposed excitatory chemosensors in our “push – pull” model, we then 
focused on defining how isoflurane affects GABA neurons, which are the inhibitory 
chemosensors in our model (Fig. 1.1). Studies in vitro have identified GABAergic 
neurons in the medullary raphé that are inhibited by hypercapnia (Wang et al., 1998; 
Zhang et al., 2003; Richerson et al., 2005). These neurons are proposed to disinhibit 
respiratory output during hypercapnia (Wang et al., 2001; Richerson, 2004), which 
supports the function of GABA neurons in central respiratory control that we proposed in 
our “push – pull” model. Research in the arterially perfused rat brainstem in situ 
preparation provides additional evidence for medullary raphé GABA neurons that 
function as central chemosensors (Corcoran et al., 2008; Iceman et al., 2010). Studies in 
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vivo also indicate that GABA mechanisms are involved in homeostatic responses to 
hypercapnia (Gourine and Spyer, 2001; Liu et al., 2003; Kuribayashi et al., 2008). 
Collectively, these studies serve as strong evidence that central chemosensitivity involves 
input from GABA neurons. Investigating how isoflurane affects the chemosensitivity of 
neurons that are known to contribute to central chemosensitivity may afford important 
insight into the neuronal mechanisms that give rise to the decreased ventilatory 
hypercapnic response that is a well-known secondary effect of general anesthesia.  
 
In addition to the potential to contribute to our understanding of the mechanisms 
governing respiratory depression during anesthesia, studying the effect of isoflurane on 
action potential discharge in GABA neurons is an important research focus because 
although the GABA system has been a major focus of research on anesthetic 
mechanisms, the majority of research targets postsynaptic anesthetic action on GABAA 
receptors, and little is known about how anesthetics affect GABA neurons themselves. 
Select studies have targeted how anesthetics affect neurotransmitter release from GABA 
neurons, which represents presynaptic anesthetic action, but evidence on how anesthetics 
affect GABA release is controversial. Both inhibition and enhancement of 
neurotransmitter release of GABA in response to anesthetic has been reported. For 
example, in the CA1 region of rat hippocampal slices, general anesthetics were shown to 
cause an increase in inhibitory postsynaptic current (IPSC) frequency, which was 
attributed to a presynaptic mechanism (Pittson et al., 2004), but in a different study, 
volatile anesthetics were shown to decrease action potential dependent GABA release in 
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synaptic boutons isolated from rat hippocampal CA1 neurons (Ogawa et al., 2011). Our 
study monitoring action potential discharge, and by extension, action potential dependent 
neurotransmitter release, in medullary raphé CO2-inhibited putative GABA neurons may 
lend insight into how anesthetics affect neurotransmitter release of GABA. These data 
will contribute to literature that describes presynaptic sites of anesthetic action.  
 
As a general note, this thesis will typically refer to medullary raphé GABA neurons as 
“CO2-inhibited putative GABA neurons.” Unlike 5-HT neurons, which have a 
characteristic firing pattern and can by confirmed as 5-HT neurons by the Mason 
algorithm (Mason, 1997), medullary raphé GABA neurons display a wide variety of 
firing patterns, and there is not a mathematical algorithm that can identify a neuron as 
GABAergic. Thus, we rely on the juxtacellular labeling method in combination with 
immunohistochemistry to identify recorded neurons by neurotransmitter phenotype. 
Although we are limited by our inability to conclusively identify all CO2-inhibited 
neurons as GABAergic, due to the fact that the juxtacellular labeling method is, by 
nature, a low-yield process, our identification of CO2-inhibited cells as GABA-
synthesizing neurons is supported by prior in vitro and in situ studies that document a 
population of GABA neurons that are inhibited by hypercapnia (Corcoran et al., 2008; 
Iceman et al., 2010). We do not propose that all GABA neurons in the medullary raphé 
are CO2-inhibited, but we have yet to document a CO2-inhibited neuron that was 
identified as a non-GABA neuron. Thus, we will typically refer to this population of 
neurons as CO2-inhibited putative GABA neurons.  
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1.11 Specific aims 
I aimed to identify how isoflurane affects the basal activity of 5-HT neurons in the 
medullary raphé. We tested the hypothesis that isoflurane inhibits baseline firing of 
medullary raphé 5-HT neurons in situ. Documenting how isoflurane affects 5-HT action 
potential discharge has three important applications: 1) to contribute to our understanding 
of anesthetic mechanisms involving 5-HT neurons; 2) lend important insight into 
interpretation of results from in vivo studies conducted in animals maintained under 
anesthesia and aid in future experimental design involving anesthesia; and 3) add to the 
growing body of literature describing presynaptic mechanisms of anesthetic action. This 
research is reported in the second chapter in this thesis.  
 
I also aimed to identify how isoflurane affects the basal activity and chemosensitivity of 
CO2-inhibited putative GABA neurons in the medullary raphé. We tested the hypothesis 
that isoflurane enhances action potential discharge of medullary raphé CO2-inhibited 
GABA neurons and disrupts their chemosensitivity in situ. Investigating how anesthetics 
affect the action potential discharge and chemosensitivity of medullary raphé CO2-
inhibited putative GABA neurons has three important applications: 1) to contribute to our 
understanding of anesthetic mechanisms involving GABA neurons, which may lend 
insight into molecular mechanisms that give rise to the state of anesthesia; 2) add to the 
growing body of literature describing presynaptic mechanisms of anesthetic action, which 
is a particularly germane contribution to the field, as the vast majority of prior research 
focuses on postsynaptic anesthetic action on GABAA receptors; and 3) offer insight into 
!26!
the central mechanisms that contribute to the depressed ventilatory response to 
hypercapnia during anesthesia. This research is reported in the third chapter in this thesis.  
 
1.12 Experimental approach  
I addressed the following questions: 1) how does isoflurane affect the action potential 
discharge of medullary raphé 5-HT neurons in situ; and 2) how does isoflurane affect the 
action potential discharge and chemosensitivity of medullary raphé GABA neurons in 
situ. To record action potentials in 5-HT and GABA neurons, I performed extracellular 
recordings on single neurons in the rat brainstem and monitored how action potential 
discharge changed during isoflurane treatment. I labeled a subset of these neurons with 
biotinamide using the juxtacellular labeling method (Pinault, 1996; Winkler et al., 2006). 
By this method, I applied a current stimulus that was ejected through the electrode until 
the cell was entrained to fire simultaneously with the applied stimulus. Injected current, 
ejection of biotinamide, and cellular firing entrainment caused uptake of the biotinamide 
marker by the recorded cell. Brainstems were then removed for further processing, and I 
performed immunohistochemistry to identify the labeled neuron by neurotransmitter 
phenotype.  
 
For all experiments, I used the in situ brainstem preparation as originally described 
(Paton, 1996) and in general usage in our laboratory (Corcoran et al., 2013; Iceman et al., 
2013). A simplified diagram of this preparation is shown in Figure 1.7. A complete 
description of the methods used to generate this preparation is provided in the appendix. 
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Briefly, the preparation is bisected sub-diaphragmatically, decerebrated rostral to the 
superior colliculi, and the descending aorta is isolated to allow for arterial perfusion with 
artificial cerebral spinal fluid. Following removal of the surrounding bone and 
musculature, the surface of the brainstem is exposed to allow for neuronal recording. This 
preparation demonstrates eupnea-like respiratory activity, which indicates that the 
medulla is adequately oxygenated to preserve the normal activity of brainstem respiratory 
neural networks (Paton, 1996). We have previously shown that this preparation allows for 
successful use of electrophysiological recording, juxtacellular labeling, and 
immunohistochemistry techniques (Iceman et al., 2013).  
 
1.13 Major findings 
Here we present the first evidence that isoflurane inhibits the baseline firing of caudal 
raphé 5-HT neurons in the descending 5-HT system. Isoflurane routinely inhibited the 
baseline firing of 5-HT neurons or caused firing to cease completely. These results were 
consistent for all tested concentrations of isoflurane (1, 1.5, and 2 %), and the degree of 
inhibition increased as the concentration of isoflurane in extracellular solution increased. 
We found a significant difference between neuronal responses to 1 and 2 % isoflurane, 
which indicated dose responsiveness of 5-HT neurons to isoflurane within a clinically 
relevant range. 1 % isoflurane approximated 1.15 MAC, the minimum alveolar 
concentration for isoflurane (Eger, 1981). This concentration was confirmed by gas 
chromatography – mass spectrometry analysis. This analysis allowed us to confirm that 
our results from experiments in situ are relevant to evaluating results from in vivo 
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experiments on anesthetized animals, which typically are anesthetized within the range of 
1 to 2 % inhaled anesthetic. Furthermore, confirming that the concentration of isoflurane 
received by the preparation was equivalent to 1.15 MAC allowed us to ensure that our 
results documenting the influence of isoflurane on 5-HT neurons are clinically relevant. 
 
Here we present the first evidence documenting heterogeneity in the response of 
medullary raphé CO2-inhibited putative GABA neurons to isoflurane. We found that 
CO2-inhibited cells respond to isoflurane in one of two distinct ways: action potential 
discharge of these cells either significantly decreased, to the point of ceasing in the 
majority of cases, or dramatically increased in response to 1 % isoflurane. Comparing the 
baseline firing characteristics of cells that were inhibited to cells that were stimulated by 
isoflurane, we found a significant difference in baseline firing rates, in which isoflurane-
stimulated neurons fired slowly at baseline (mean firing frequency: 0.50 ± 0.38 Hz) 
compared to isoflurane-inhibited neurons (mean firing frequency: 2.72 ± 0.70 Hz). Our 
results indicate a heterogeneous population of medullary raphé CO2-inhibited putative 
GABA neurons represented by at least two distinct groups, which differ in their response 
to isoflurane and baseline firing frequency: 1) “slow-firing” CO2-inhibited putative 
GABA neurons that are stimulated by isoflurane; and 2) “fast-firing” CO2-inhibited 
putative GABA neurons that are inhibited by isoflurane. 
 
In terms of the influence of isoflurane on chemosensitivity, we found that isoflurane 
disrupts chemosensitivity in 5-HT neurons, and these data are presented in the attached 
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manuscript (Massey et al., 2013). Here, we show that isoflurane disrupts 
chemosensitivity in the population of “slow-firing” isoflurane-stimulated CO2-inhibited 
putative GABA neurons. Chemosensitive responses could not be resolved in the 
population of “fast-firing” isoflurane-inhibited CO2-inhibited putative GABA neurons 
because these neurons ceased firing with isoflurane. We observed that the chemosensitive 
properties of both CO2-stimulated 5-HT and CO2-inhibited GABA neurons in the 
medullary raphé were disrupted by isoflurane.  
 
Collectively, this research will contribute to our understanding of how anesthetics affect 
action potential discharge in medullary raphé neurons, which may offer insight into 
mechanisms of general anesthesia. Documenting how anesthetics affect the 
chemosensitivity of medullary raphé neurons that are known to be involved in respiratory 
circuits may help define molecular mechanisms underlying the decreased ventilatory 
response to hypercapnia that is characteristic of general anesthesia. Furthermore, this 
research indicating that medullary raphé neurons are profoundly affected by anesthetics, 
both in terms of their baseline firing and chemosensitive properties, will aid in 
interpretation of results from in vivo studies on anesthetized rodents and may inform 
future design of experiments that require anesthesia for conducting neuronal recordings. 
Finally, these data will add to the growing body of literature describing presynaptic 
mechanisms of anesthetic action by documenting how action potential discharge in 
medullary raphé 5-HT and GABA neurons is affected by isoflurane.  
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Figure 1.1. "Push - pull" model of central chemosensitivity. We propose the 
“push – pull” model of central chemosensitivity, in which raphé 5-HT and GABA 
neurons provide excitatory and inhibitory drive, respectively, to the central pattern 
generator (CPG), a network of neurons that control the rate and relative timing of 
respiratory muscle contraction, and to motor neuron pools, which control breath 
amplitude. By this model, increased CO2 stimulates 5-HT neuron firing and 
release of the excitatory neurotransmitter serotonin, which stimulates activity in 
the CPG and motor neurons and leads to increased respiratory output. Increased 
CO2 inhibits GABA neuron firing and release of the inhibitory neurotransmitter 
GABA, which decreases the inhibitory input to 5-HT neurons, the CPG, and 
motor neuron pools, leading to increased respiratory output through disinhibition. 
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Figure 2
(a) Sagittal view of whole human brain upon which the site of the 5-hydroxytryptamine (5-HT) neuronal cell
bodies (red circles) and their projections (red lines) are superimposed. Serotonergic neurons are located in the
brainstem in either the rostral or the caudal domain, each of which has different projections and functions.
In the rostral domain, 5-HT neurons are present in the rostral pons and midbrain and project rostrally to the
cerebral cortex, thalamus, hypothalamus, hippocampus, and basal ganglia to help modulate cognition and
mood, among other functions. In the caudal domain, 5-HT neurons are located primarily in the medulla and
project caudally to other brainstem regions, cerebellum, and spinal cord; this domain, known as the
medullary 5-HT system, is postulated to integrate and modulate homeostatic function relative to the
individual’s state. Interconnections exist between 5-HT neurons in the rostral and caudal domains but are
poorly characterized. (b) Cross-sectional diagrams of the medullary 5-HT system at representative rostral-
and midlevels. Panel b based upon the human brainstem atlas of Olszewski & Baxter (188). The nuclei shown
in red are the site of 5-HT cell bodies, positioned in the midline raphe´, extra-raphe´, and ventral surface. The
nucleus of the solitary tract (NTS) and the hypoglossal nucleus (HG) (blue), along with the principal inferior
olive (PIO) (tan), are a major target site of 5-HT projections within the medulla. Abbreviations: ARC,
arcuate nucleus; IRZ, intermediate reticular zone; nGC, nucleus gigantocellularis; nPGCL, nucleus
paragigantocellularis; ROB, raphe´ obscurus; RPA, raphe´ pallidus.
(Figure 2). It helps mediate arousal, cognition,
mood, motor activity, and cerebral blood flow
(86) and has been implicated in cognitive
problems and/or derangements in autism (87),
depression (88), and fetal alcohol syndrome
(89). The medullary 5-HT system projects dif-
fusely to other brainstem sites, the cerebellum,
and the spinal cord (Figure 2) and is critical for
respiratory and autonomic output (Figure 3).
This 5-HT caudal system may be involved in
other disorders of respiratory and autonomic
function than SIDS, e.g., Rett syndrome (90).
Anatomically, the medullary 5-HT system
comprises the 5-HT neuronal cell bodies in
the medulla that are located in the raphe´,
extra-raphe´ (medial and lateral reticular for-
mation), and ventral surface (arcuate nucleus)
(Figure 2). The inhibitory or excitatory ef-
fect of 5-HT is determined largely by the pre-
and postsynaptic receptor subtypes. At least
17 5-HT receptor subtypes are currently rec-
ognized and are organized into 7 groups (5-
HT1–5-HT7) based upon genetic and pharma-
cologic features, and all but one (5-HT3) act as
neuromodulators through G proteins and
second-messenger systems (91). Serotonergic
receptors are located both synaptically and ex-
trasynaptically with 5-HT1A receptors in the
highest abundance as autoreceptors on the
soma and dendrites of 5-HT neurons; 5-HT
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Figure 1.2. Serotonergic cell bodies and their projections (adapted from Kinney 
et al., 2009). Sagittal view of the human brain showing the sites of serotonergic cell 
bodies (red circles) and their projections (red lines). 5-HT neurons in the rostral 
domain are located in the rostral pons and midbrain, and these cells project to the 
cerebral cortex, thalamus, ypothalamus, hippoc mpus, and basal g nglia. 5-HT 
neurons in the cau al domain are locat d in the m dulla. These cells pr ject to other 
brainstem regions, the cerebellum, and the spinal cord. 
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Figure 1.3. The "Triple Risk Model" describing three risk factors that are 
proposed to contribute to Sudden Infant Death Syndrome (SIDS). SIDS is 
thought to be due to a failed brainstem-mediated protective response to 
homeostatic stress during sleep in a critical period of life. The occurrence of SIDS 
is thought to involve the convergence of three risk factors: 1) intrinsic 
vulnerability caused by brainstem abnormality; 2) a critical development period 
when changes in cardiorespiratory control and sleep/wake cycles occur; and 3) 
exogenous stressors that cause hypoxia, hypercapnia, and asphyxia.
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natively, 5-HT synthesis, release, or both
may be dysfunctional in the 5-HT neu-
rons (which are overabundant in com-
pensation), resulting in a deficiency of
extracellular 5-HT. The level of avail-
able 5-HT in themedullae of SIDS cases
has yet to be determined, and the mo-
lecular and cellular regulatory mecha-
nisms between neuron count and re-
ceptor and transporter expression are
incompletely understood. It is diffi-
cult, therefore, to predict with any cer-
tainty which, if either, of these pro-
posed conditions exist in SIDS.
Determination ofmedullary 5-HT level
in SIDS and the elucidation of the path-
ways andmechanisms regulating the ex-
pression of the 5-HT markers analyzed
in this study will therefore be neces-
sary before the nature and pathogen-
esis of themedullary 5-HT dysfunction
in SIDS can be determined. The in-
creased number of 5-HT neurons, the
greater proportion of neurons of
“simple” (ie, granular)morphology, and
the decreased number of neurons of
“complex” (ie, multipolar) morphol-
ogy in SIDS cases compared with con-
trols, however, supports the concept of
an underlying developmental disorder
involving abnormal regulation of 5-HT
neuron count and delayed neuronal dif-
ferentiation and maturation. This idea
is supported by the relative reduction in
5-HTT expression observed in the me-
dullae of SIDS cases. The 5-HTT is ex-
pressed predominantly in peri-
synaptic sites on5-HTneuron terminals.
Reduced 5-HTT expressionmay be due
to reduced expression of 5-HTT pro-
tein at 5-HT neuron terminals, a re-
duced number of 5-HT terminals and
synapses, or both, consistent with ab-
normal or delayed 5-HT synapse forma-
tion and neuron development. Of note,
5-HT neuron migration appears to be
relatively unaffected in SIDS cases, aswe
observed5-HTneurons in the same ana-
tomical positions in the component nu-
clei of the medullary 5-HT system as in
the controls.
In this study, we described known
risk factors for SIDS either as “abnor-
mality” risk factors or as “stressors” in
an effort to distinguish between the 2
types of risks we propose are involved
in the pathogenesis of SIDS. Eighty-
seven percent of the SIDS cases in this
study were observed to be both at risk
from having medullary 5-HT abnor-
malities and exposed to an exogenous
stressor at the time of death. These data
support the triple risk model.8 The
prone or side sleeping position, face-
down sleeping, and bed sharing are rec-
ognized as important risk factors or
stressors for SIDS.5,39We identified that
77%of the SIDS cases in this study slept
prone or on their side, shared a bed, or
both, indicating that these sleep prac-
tices remainmajor risk factors for SIDS.
We found that abnormalities of 5-HT
markers, specifically in 5-HT1A recep-
Figure 1. Medullary 5-HT Neuron Count in a SIDS Case and a Control
SIDS Case Control Case
MID-MEDULLA MID-MEDULLA
Midline Raphé Extraraphé Ventral Surface
Distribution of mid-medullary serotonergic (5-hydroxytryptamine [5-HT]) neurons in an infant dying from
sudden infant death syndrome (SIDS case) and an infant with acute death from a cause other than SIDS
(control), plotted using Neurolucida version 6.02.2 (Microbrightfield Inc, Williston, Vt).There are qualita-
tively more 5-HT neurons in the plot from the SIDS case, particularly in the midline raphe´ nucleus, than in
the control.
Figure 2. 5-HT1A Receptor Binding Density in a SIDS Case and a Control
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Illustrative autoradiogram displayingmean 3H-8-OH-DPAT (3H8-hydroxy-2-[di-N-propylamino]-tetralin) bind-
ing to 5-hydroxytryptamine 1A (5-HT1A) receptors in a tissue section at the mid-medulla level from an infant
dying from sudden infant death syndrome (SIDS case) and an infant with acute death from a cause other than
SIDS (control). The density of 5-HT1A receptor binding sites, including in the raphe´ obscurus (arrowheads), is
visually lower in the SIDS case compared with the control. The “halo” observable around the outside of the
image from the SIDS case represents binding to 5-HT1A receptors in tissue from the cerebellum that was arti-
factually collected during sectioning of the medulla.
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down sleeping, and bed sharing are rec-
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both, indicating that these sleep prac-
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Illustrative autoradiogram displayingmean 3H-8-OH-DPAT (3H8-hydroxy-2-[di-N-propylamino]-tetralin) bind-
ing to 5-hydroxytryptamine 1A (5-HT1A) receptors in a tissue section at the mid-medulla level from an infant
dying from sudden infant death syndrome (SIDS case) and an infant with acute death from a cause other than
SIDS (control). The density of 5-HT1A receptor binding sites, including in the raphe´ obscurus (arrowheads), is
visually lower in the SIDS case compared with the control. The “halo” observable around the outside of the
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Figure 1.4. 5-HT neuron count and 5-HT1A receptor binding sites in a SIDS 
case compared to a control case (adapted from Paterson et al., 2006). Top 
panel: Distribution  5-HT n urons  an infant dying from Sudden Infant Death 
Syndrome (SIDS case) and an infant with acute death from a non-SIDS cause 
(control case). The SIDS case has an increased number of 5-HT neurons, 
particularly in the midline, compared to the control. Bottom panel: Autoradiogram 
indicating mean 3H-8-OH-DPAT (labeled probe) binding to 5-HT1A receptors in a 
mid-medulla tissue section from an infant dying from SIDS and an infant with 
acute death from a non SIDS cause. Density of 5-HT1A receptor binding sites, 
particularly in raphé obscurus (arrowheads), is lower in the SIDS case compared 
to the control. 
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We have previously shown that serotonergic neurons of the
medulla are strongly stimulated by an increase in CO2, suggesting
that they are central respiratory chemoreceptors. Here we used
confocal imaging and electron microscopy to show that neurons
immunoreactive for tryptophan hydroxylase (TpOH) are tight-
ly apposed to large arteries in the rat medulla. We used patch-
clamp recordings from brain slices to confirm that neurons with
this anatomical specialization are chemosensitive. Serotonergic
neurons are ideally situated for sensing arterial blood CO2, and
may help maintain pH homeostasis via wide-ranging effects on
brain function. The results reported here support a recent pro-
posal that sudden infant death syndrome (SIDS) results from a
developmental abnormality of medullary serotonergic neurons1.
Serotonin is produced in the brain by a small collection of neu-
rons located mainly in the brainstem raphe nuclei, which project
to virtually every region of the CNS2. A subset of these seroton-
ergic neurons located within the medulla are involved in respira-
tory and autonomic control3,4, and have recently been identified
as putative central chemoreceptors5. These neurons are unusual-
ly sensitive to small changes in pH (which indirectly reflects CO2
concentration), responding in vitro with a threefold increase in
firing rate to a decrease in pH from 7.4 to 7.2 (ref. 6). A role for
the raphe nuclei in central chemoreception is supported by pre-
vious in vivo experiments using c-fos staining in response to hyper-
capnia (an excess of CO2 in the blood)
7, measurement of
ventilation during focally induced acidosis8 and recording of fir-
ing rate during CO2 inhalation
9.
The rat medulla is supplied with blood primarily from large
branches of the basilar artery that penetrate the parenchyma in
the midline and in the ventrolateral medulla (VLM). We exam-
ined the relationship between these large arteries and trypto-
phan hydroxylase–immunoreactive (TpOH-IR) neurons using
confocal imaging. (For experimental details, see Supplemen-
tary Methods online; the Yale Animal Care and Use Commit-
tee approved all experiments.) The highest concentration of
TpOH-IR neurons was on the ventral surface dorsal to the basi-
lar artery and deeper within the parenchyma in a narrow band
adjacent to large midline penetrating arteries (Fig. 1a). These
penetrating arteries, intermingled with TpOH-IR neuron soma-
ta and processes, formed an extensive sheet in the mid-sagittal
plane and extended throughout much of the rostro-caudal
extent of the medulla (Fig. 1b). This midline region was unique
within the medulla, in that it contained large arteries and was
almost devoid of veins. This unusual vascular anatomy likely
results in a situation whereby local CO2 concentration closely
reflects arterial CO2 concentration, before it has been influenced
by local tissue metabolism—an ideal location for monitoring
the effectiveness of lung ventilation.
There was also a smaller subset of TpOH-IR neurons near the
pial surface of the VLM (Fig. 1c). The highest density of TpOH-IR
neurons in the VLM was in the rostral and caudal medulla, which
also contained the highest density of surface arteries (Fig. 1d; note
that the VLM also contained veins). These two regions of the VLM
are classically associated with central respiratory chemoreception.
They roughly correspond to the rostral and caudal chemosensi-
tive zones (or ‘areas of Mitchell and Loeschcke’, respectively), in
cats10,11. We propose that serotonergic neurons on the VLM sur-
face mediate chemoreception in these two regions. Although clas-
sical experiments did not report finding chemoreceptors in the
midline (where we found the most TpOH-IR neurons), this
region was usually avoided during in vivo experiments to pre-
vent bleeding from the basilar artery.
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Fig. 1. Serotonergic medullary neurons were concentrated near the basilar
artery and its largest branches. Shown are confocal images of arteries filled
with fluorescein-tagged albumin (red), and serotonergic neurons stained
with anti-TpOH antibody (green). (a–b) TpOH-IR neurons (top), arteries
(bottom), composite (middle) seen in (a) a transverse section at the level of
the rostral inferior olive and (b) a mid-sagittal section (rostral side to the
right). (c) Transverse section of the rostral VLM. (d) Ventral surface of the
medulla en bloc; filled vessels include arteries and some veins. Scale bars,
200 µm in (a–c), 1.5 mm in (d). Ba, basilar artery; P, pyramidal tracts.
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Figure 1.5. 5-HT neurons are closely associated with major arteries in the 
medullary raphé (adapted from Bradley et al., 2002). Confocal images of 
arteries filled with fluorescein-tagged albumin (red) and serotonergic neurons 
stained with anti-tryptophan hydroxylase (anti-TpOH) antibody (green). 
Colocalization of fluorescent markers (yellow) indicates that 5-HT neurons are 
highly concentrated along major arteries. a) Transverse section showing TpOH-
immunoreactive neurons (top panel), arteries (bottom panel), and colocalization 
(middle panel). b) Mid-sagittal section (rostral side at right). c) Transverse section 
of the rostral ventrolateral medulla. d) Ventral surface of the medulla (filled 
vessels include arteries and some veins). Scale bars = 200 µm in (a-c) and 1.5 mm 
in (d). Ba, basilar artery; P, pyramidal tracts. 
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All acidosis-stimulated raphe neurons were immunoreactive
for TpOH
It was next determined whether stimulation by acidosis
was specific for serotonergic neurons in this culture prepa-
ration. For this set of experiments, an antibody against
TpOH was used instead of an antibody against serotonin,
because serotonin can be taken up by nonserotonergic neu-
rons (Lebrand et al. 1996), which could potentially lead to
false-positive results.
After determining the effect of changes in CO2 on firing rate
of raphe neurons using current-clamp recordings, cells were
processed for immunohistochemistry against TpOH. All aci-
dosis-stimulated neurons tested (n5 22) were immunoreactive
for TpOH (TpOH-IR). Examples are shown of two neurons
that were stimulated by hypercapnic acidosis (Fig. 3, A and C).
As an illustration of the methods used for quantification of
chemosensitivity, the first neuron (Fig. 3A) had a mean firing
rate at 5% PCO2 of 0.41 Hz, and this increased to 1.45 Hz at
9% PCO2, an increase to 354% of control. The extracellular pH
changed an average of 0.19 pH units during the four transi-
tions, and the CI for this neuron was 395%. Consistent with
previous results, both neurons had a larger multipolar soma.
Both of these neurons were strongly immunopositive for TpOH
(Fig. 3, B and D).
Consistent with previous results (Wang et al. 1998), acido-
sis-stimulated neurons in this study had a high degree of
chemosensitivity. On average, acidosis-stimulated neurons
(n 5 22 TpOH-IR neurons) increased their firing rate to 240 6
93% of control in response to an increase in PCO2 from 5 to
9% (P , 0.0001) and decreased their firing rate to 40 6 38%
of control in response to a decrease in PCO2 from 5 to 3% (P,
0.0005). The mean firing rate for these neurons was 0.97 6
0.55 Hz at 5% PCO2, 2.01 6 0.83 Hz at 9% PCO2, and 0.51 6
0.65 Hz at 3% PCO2 (differences significant between 5 and
9%, P , 0.0001, and between 5 and 3%, P , 0.05). The mean
CI was 327 6 185% (P , 0.0001).
The majority of serotonergic medullary raphe neurons in this
culture system were chemosensitive. From a total of 30 record-
ings from TpOH-IR medullary raphe neurons, 73% (22 of 30)
met the criteria for stimulation by acidosis. Of the eight
TpOH-IR neurons that did not meet the criteria for chemosen-
sitivity, five had an increase in firing rate in response to
acidosis that was either subthreshold or occurred less than four
times. Two of these five TpOH-IR neurons had been in culture
for,20 days, an age at which the full chemosensitive response
may not have developed (Wang and Richerson 1999).
All acidosis-inhibited neurons were immunonegative
for TpOH
Using the same approach, it was next determined whether
acidosis-inhibited neurons were serotonergic. The effect of
changes in CO2 on the firing rate of two acidosis-inhibited
neurons is shown (Fig. 4, A and C). The degree of chemo-
sensitivity of acidosis-inhibited neurons was as large as that
of acidosis-stimulated neurons but was opposite in sign. For
those acidosis-inhibited neurons in which the mean baseline
firing rate was maintained between 0.2 and 2 Hz (n 5 12),
an increase in PCO2 from 5 to 9% resulted in a decrease in
firing rate to 25 6 23% of control (P , 0.0001). A decrease
in PCO2 from 5 to 3% resulted in an increase in firing rate
to 170 6 94% of control (P , 0.05). The mean firing rate for
these neurons was 0.81 6 0.45 Hz at 5% PCO2, 0.26 6 0.31
Hz at 9% PCO2, and 1.34 6 1.11 Hz at 3% PCO2 (statistical
significance between 5 and 9%, P , 0.005, and between 5
and 3%, NS).
Typical of acidosis-inhibited neurons (Wang et al. 1998),
both neurons shown (Fig. 4) had a smaller fusiform soma. In
FIG. 2. Acidosis-stimulated medullary raphe neurons were immunoreactive
for serotonin. A: membrane potential of an acidosis-stimulated medullary raphe
neuron, with highly regular firing pattern typical of serotonergic neurons. B:
the firing rate of the same neuron increased in response to an increase in CO2
and decreased in response to a decrease in CO2. Bottom trace is the pH of the
bath solution measured at the inflow to the chamber. C: immunohistochemistry
using antibody against serotonin from the same neuron shown in A and B (2).
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All acidosis-stimulated raphe neurons were imm noreactive
for TpOH
It was next determined whether stimulation by acidosis
was specific for serotonergic neurons in this culture prepa-
ration. For this set of experiments, an antibody against
TpOH was used instead of an antibody against serotonin,
because serotonin can be taken up by nonserotonergic neu-
rons (Lebrand et al. 1996), which could potentially lead to
false-positive results.
After determining the effect of changes in CO2 on firing rate
of raphe neurons using current-clamp recordings, cells were
processed for immunohistochemistry against TpOH. All aci-
dosis-stimulated neurons tested (n5 22) were immunoreactive
for TpOH (TpOH-IR). Examples are shown of two neurons
that were stimulated by hypercapnic acidosis (Fig. 3, A and C).
As an illustration of the methods used for quantification of
chemosensitivity, the first neuron (Fig. 3A) had a mean firing
rate at 5% PCO2 of 0.41 Hz, and this increased to 1.45 Hz at
9% PCO2, an increase to 354% of control. The extracellular pH
changed an average of 0.19 pH units during the four transi-
tions, and the CI for this neuron was 395%. Consistent with
previous results, both neurons had a larger multipolar soma.
Both of these neurons were strongly immunopositive for TpOH
(Fig. 3, B and D).
Consistent with previous results (Wang et al. 1998), acido-
sis-stimulated neurons in this study had a high degree of
chemosensitivity. On average, acidosis-stimulated neurons
(n 5 22 TpOH-IR neurons) increased their firing rate to 240 6
93% of control in response to an increase in PCO2 from 5 to
9% (P , 0.0001) and decreased their firing rate to 40 6 38%
of control in response to a decrease in PCO2 from 5 to 3% (P,
0.0005). The mean firing rate for these neurons was 0.97 6
0.55 Hz at 5% PCO2, 2.01 6 0.83 Hz at 9% PCO2, and 0.51 6
0.65 Hz at 3% PCO2 (differences significant between 5 and
9%, P , 0.0001, and between 5 and 3%, P , 0.05). The mean
CI was 327 6 185% (P , 0.0001).
The majority of serotonergic medullary raphe neurons in this
culture system were chemosensitive. From a total of 30 record-
ings from TpOH-IR medullary raphe neurons, 73% (22 of 30)
met the criteria for stimulation by acidosis. Of the eight
TpOH-IR neurons that did not meet the criteria for chemosen-
sitivity, five had an increase in firing rate in response to
acidosis that was either subthreshold or occurred less than four
times. Two of these five TpOH-IR neurons had been in culture
for,20 days, an age at which the full chemosensitive response
may not have developed (Wang and Richerson 1999).
All acidosis-inhibited neurons were immunonegative
for TpOH
Using the same approach, it was next determined whether
acidosis-inhibited neurons were serotonergic. The effect of
changes in CO2 on the firing rate of two acidosis-inhibited
neurons is shown (Fig. 4, A and C). The degree of chemo-
sensitivity of acidosis-inhibited neurons was as large as that
of acidosis-stimulated neurons but was opposite in sign. For
those acidosis-inhibited neurons in which the mean baseline
firing rate was maintained between 0.2 and 2 Hz (n 5 12),
an increase in PCO2 from 5 to 9% resulted in a decrease in
firing rate to 25 6 23% of control (P , 0.0001). A decrease
in PCO2 from 5 to 3% resulted in an increase in firing rate
to 170 6 94% of control (P , 0.05). The mean firing rate for
these neurons was 0.81 6 0.45 Hz at 5% PCO2, 0.26 6 0.31
Hz at 9% PCO2, and 1.34 6 1.11 Hz at 3% PCO2 (statistical
significance between 5 and 9%, P , 0.005, and between 5
and 3%, NS).
Typical of acidosis-inhibited neurons (Wang et al. 1998),
both neurons shown (Fig. 4) had a smaller fusiform soma. In
FIG. 2. Acidosis-sti ulated medullary raph neurons were immunoreactive
for serotonin. A: membrane potential of an acidosis-stimulated medullary raphe
neuron, with highly regular firing pattern typical of serotonergic neurons. B:
the firing rate of the same neuron increased in response to an increase in CO2
and decreased in response to a decrease in CO2. Bottom trace is the pH of the
bath solution measured at the inflow to the chamber. C: immunohistochemistry
using antibody against serotonin from the same neuron shown in A and B (2).
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Figure 1.6. Acidosis-stimulated neurons in the medullary raphé are 
serotonergic (adapted from Wang et al., 2001). Left panel: The firing rate of a 
single medullary raphé neuron increased in response to increased CO2/decreased 
pH and decreased in response to decreased CO2/increased pH. The increase in 
firing rate response was both reversible and repeatable. Right p nel: 
Immunohistochemistry using an antibody for serotonin indicated the neuron 
(arrow head) was serotonergic. 
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Figure 1.7. Diagram of the in situ perfused brainstem preparation. Shown is a 
bisected, decerebrated rat in prone position in the recording chamber. Perfusate 
solution was pumped through a heat exchanger and bubble trap, entered the 
preparation through the descending aorta, and was recirculated. Levels of O2 and 
CO2 were controlled by a gas mixer bubbling gas directly into the perfusate 
reservoir. A recording electrode was placed in the midline of the brainstem, and 
action potentials were amplified and monitored by computer output. The 
juxtacellular labeling method was employed using a stimulator to inject current 
through the recording electrode. A complete description of methods is given in the 
appendix. Credit for drawing to Bryan Mosher, Harris laboratory, University of 
Alaska Fairbanks. 
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Chapter 2 
Isoflurane dose-dependently inhibits medullary raphé 5-HT neurons in situ1 
 
2.1   Abstract 
The ascending and descending serotonin (5-HT) networks are critically involved in the 
motor, somatosensory, and limbic systems and as such, serotonergic neurons are the 
subject of much research in a wide range of fields. The majority of in vivo 
electrophysiological studies of 5-HT neurons are conducted in animals maintained under 
anesthesia, and yet little is known about how anesthetics affect 5-HT neuron function. 
Here we used electrophysiology in the unanesthetized in situ perfused brainstem to 
determine how the volatile anesthetic isoflurane affects medullary raphé 5-HT neurons. 
We tested the hypothesis that medullary raphé 5-HT neurons are inhibited by isoflurane. 
We examined changes in 5-HT neuron baseline firing with 1, 1.5, and 2 % isoflurane, and 
we confirmed isoflurane concentrations by gas chromatography – mass spectrometry 
analysis. Results indicate that isoflurane inhibits 5-HT neurons, and this inhibition is 
dose-dependent. These findings will aid in interpretation of reports from in vivo studies of 
the 5-HT system conducted under anesthesia and may provide insight into how 5-HT 
neurons are involved in general anesthesia mechanisms.   
 
 !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
1 Johansen SL, Iceman KE, Iceman CR, Richerson GB, and Harris MB. 2014. Isoflurane 
dose-dependently inhibits medullary raphé 5-HT neurons in situ. In preparation for 
submission in the British Journal of Anesthesiology. 
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2.2   Introduction 
The serotonergic system is an interconnected network of neurons that communicate via 
the amine neurotransmitter serotonin (5-hydroxytrptamine; 5-HT).  Evolutionarily one of 
the oldest amine systems, these serotonergic cell bodies are located in the midbrain and 
caudal regions and project to virtually all areas of the central nervous system, allowing 
for their critical involvement in maintaining homeostatic processes across the motor, 
somatosensory, and limbic systems (Jacobs and Azmitia, 1992; Lovick, 1997; Hornung, 
2003; Kinney et al., 2009). 5-HT neurons are divided into two populations based on their 
distinct anatomical location, connectivity, and function: the rostral group of the midbrain 
and pons and the caudal group of the medulla. The rostral 5-HT neurons (ascending 
serotonergic network), including the pontine raphé, dorsal raphé, and median raphé, 
project to the forebrain to mediate arousal, cognition, anxiety, and cerebral blood flow, 
and these neural circuits have been implicated in numerous neuropsychiatric and 
neurological disorders (Jacobs and Azmitia, 1992). The caudal 5-HT neurons (descending 
serotonergic network), including raphé obscurus, raphé pallidus, and raphé magnus in the 
midline and the parapyramidal region on the ventrolateral medullary surface (VLMS), 
project to the lower brainstem and spinal cord and mediate autonomic output, respiratory 
control, cardiovascular control, motor control, and nociception (Richerson, 2004). The 
widespread involvement of both ascending and descending serotonergic networks in 
diverse neural circuits leads to their hallmark characteristic as integrators, modulators, 
and critical regulators of essential homeostatic processes.  
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The majority of in vivo electrophysiological studies on the ascending and descending 5-
HT networks in rodents are conducted in animals maintained under anesthesia, and yet 
little is known about how anesthetics affect 5-HT neuron activity. Maintaining animals 
under general anesthesia has research advantages that are not easily achieved in non-
anesthetized preparations. From a technical standpoint, it is much easier to record from 
anesthetized than non-anesthetized animals. Some electrophysiological recordings of 5-
HT neurons have been conducted in head-restrained but otherwise freely moving cats 
(Fornal et al., 1996; Veasey et al., 1997; Bjorvatn et al., 1998; Martin-Cora et al., 2005); 
however, chronically instrumenting these animals and achieving stable recordings while 
animals are moving remains a significant obstacle for successful data collection. 
Furthermore, anesthesia allows researchers to avoid changes in the behavioral state of the 
animal that could affect neuronal recordings. 5-HT neuronal firing spontaneously 
changes across the sleep-wake cycle (Bjorvatn et al., 1998), as do levels of 
neurotransmitters that regulate 5-HT neurons (Sakai and Crochet, 2000), and it would be 
difficult to distinguish behavioral-induced changes in 5-HT neuronal firing from 
experimental results. Additionally, drug treatments that affect movement, cognition, or 
anxiety level could change the behavioral state of the animal and effect neuronal 
recordings. Anesthesia allows for prolonged surgery with more stable 
electrophysiological recordings and avoids changes in behavioral arousal and cognitive 
state that could affect neuronal activity.  
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The research advantages of working under anesthesia are clear; however, before 
anesthesia can be used to facilitate 5-HT neuronal recordings in animals, it is necessary to 
define how these anesthetics affect 5-HT neuron function. Prior studies on anesthetics 
and 5-HT neurons have primarily focused on how 5-HT neurons contribute to the state of 
anesthesia. The ligand-gated 5-HT3 receptor, which is highly sensitive to modulation by 
volatile anesthetics (Franks and Lieb, 1994; Campagna et al., 2003; Mashour et al., 
2005), is postulated to contribute to producing general anesthesia (Jenkins et al., 1996) 
and may also contribute to postoperative side effects (Haigh et al., 1993). Previous 
reports documenting that inhalational anesthetics block the effect of the neurotransmitter 
serotonin on 5-HT2A and/or 5-HT2C receptors, receptor subtypes known to be involved in 
anti-nociception in the spinal cord (Bardin et al., 2000), suggest that 5-HT neurons 
contribute to analgesia and immobility during anesthesia (Minami et al., 1997; Zhang et 
al., 2003; Nagatani et al., 2011). Serotonin release in the frontal cortex decreases during 
isoflurane anesthesia, similar to slow-wave sleep, which suggests a role for 5-HT neurons 
in hypnosis during anesthesia (Mukaida et al., 2007). These prior studies indicate that 
anesthetic modulation of serotonergic transmission contributes to the behavioral effects 
of general anesthesia. 
 
Although it has been clearly demonstrated that anesthetics modulate serotonergic 
transmission, most notably through postsynaptic action on 5-HT receptors, surprisingly 
few studies target the presynaptic effects of anesthetics on 5-HT neurons themselves. 
McCardle and Gartside (2012) studied the influence of a range of anesthetics on dorsal 
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raphé 5-HT neuron activity in vitro. However, this study did not investigate how 5-HT 
neuron firing is affected by the commonly used volatile anesthetic isoflurane, a 
halogenated ether compound that, due to its low blood solubility leading to faster 
elimination time compared to many other general anesthetics, is widely used in both 
clinical and scientific contexts (Campagna et al., 2003). Additionally, the effects of 
general anesthetics on caudal 5-HT neurons in the medullary raphé and VLMS have not 
been systematically investigated. Thus, the effect of anesthesia on 5-HT neuron function 
is not wholly defined.  
 
Importantly, studying the effects of anesthetics on 5-HT neurons themselves contributes 
to the growing body of literature that suggests that presynaptic mechanisms are critical 
sites of anesthetic action. Until recently, the majority of research on anesthetic 
mechanisms has focused on postsynaptic sites of anesthetic action, notably on GABAA 
receptors, but presynaptic effects on transmitter release are also identified (Griffiths and 
Norman, 1993; Pocock and Richards, 1993). Current evidence suggests that volatile 
anesthetics exert presynaptic effects on voltage-gated Na+ channels (Herold and 
Hemmings, 2012), two-pore-domain background K+ channels (Bayliss and Barrett 2008), 
and voltage-gated Ca2+ channels (Orestes and Todorovic, 2010), all of which could affect 
5-HT neuron activity under anesthesia. The presynaptic effect of anesthetics, specifically 
on 5-HT neuron function, remains a pertinent question.  
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We have previously shown that the anesthetic isoflurane disrupts the pH/CO2 
chemosensitivity of a subset of medullary raphé 5-HT neurons that are proposed to 
function as central chemoreceptors in respiratory control (Johansen et al., 2012; Massey 
et al., 2013). In the present study, we characterized the effect of isoflurane on baseline 
firing of medullary raphé 5-HT neurons using the arterially perfused in situ brainstem 
preparation. We tested the hypothesis that isoflurane inhibits baseline firing of medullary 
raphé 5-HT neurons in situ. We demonstrated the influence of isoflurane on 5-HT neuron 
firing rate and evaluated the dose-dependence of isoflurane-induced 5-HT neuron 
inhibition within a clinically relevant range (1, 1.5, and 2 %), in which 1 % isoflurane 
approximates 1.15 MAC (minimum alveolar concentration that prevents response to 
noxious stimulation in 50 % of subjects; Eger, 1981). We confirmed the dose 
concentration by gas chromatography – mass spectrometry analysis. Our present aim is to 
further define the effect of isoflurane on 5-HT neuron activity. Our findings will aid in 
interpretation of results from in vivo studies that use anesthesia, contribute to the growing 
body of literature describing presynaptic mechanisms of anesthetic action, and may 
provide insight into how 5-HT neurons are involved in mechanisms of general anesthesia.  
 
2.3   Methods 
Experimental animals and preparations: Animal care and experimental procedures 
followed guidelines set by the National Institutes of Health Office of Laboratory Animal 
Welfare and the United States Department of Agriculture Animal Welfare Act. All 
experiments were done in accordance with the guidelines of the “Guide for the Care and 
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Use of Laboratory Animals'' of the National Institutes of Health and were approved by 
the University of Alaska Fairbanks Institutional Animal Care and Use Committee. 
Juvenile male rats (50 – 150 g; Sprague-Dawley strain; Simonson Laboratories) were 
used to generate the perfused in situ brainstem preparation as previously described 
(Paton, 1996; Corcoran et al., 2013; Iceman et al., 2013). Briefly, animals were 
administered an intraperitoneal heparin sodium injection (0.5 mL, 1000 USP; Sagent 
Pharmaceuticals) to prevent formation of blood clots during surgery. Deep anesthesia was 
induced using isoflurane and assessed by cessation of spontaneous breathing and absence 
of a withdrawal response to firm toe pinch. Anesthesia was discontinued as preparations 
were bisected sub-diaphragmatically and decerebrated rostral to the superior colliculi, 
and subsequent procedures were conducted in the absence of anesthesia. Preparations 
were immersed in chilled artificial cerebral spinal fluid (aCSF) for the remainder of the 
dissection, which was conducted to isolate the descending aorta.  
 
Each preparation was placed in the recording chamber in a prone position. The 
descending aorta was cannulated retrogradely with a double-lumen catheter, and 
preparations were perfused with a solution at a temperature of 31 °C. The perfusate 
solution contained the following (in mM): 1.0 MgSO4, 125 NaH2PO4, 4.0 KCl, 24 
NaHCO3, 115 NaCl, 10 D-Glucose, 2.0 CaCl2, and 0.18 Ficoll. Baseline conditions, when 
the perfusate was equilibrated with 95 % O2 – 5 % CO2 (PCO2 33 mmHg; pH=7.4), 
approximated normocapnic plasma in vivo. Levels of O2 and CO2 in the perfusate were 
controlled by equilibrating a perfusate reservoir with gas mixtures produced by a 
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precision gas mixer (CWE GSM-3) and verified by a CO2 analyzer (Applied 
Electrochemistry CD-3A). Following cannulation, perfusion pressure was gradually 
increased to 40-60 mmHg by regulating the speed of a peristaltic perfusion pump. The 
first 50 mL of perfusate that passed through the preparation was discarded to eliminate 
blood, and the remaining 450 mL of perfusate was recirculated. The neuro-muscular 
blocker gallamine triethidodide (60 mg/L, Sigma-Aldrich) was added to the perfusate to 
eliminate movement. The occipital bone, surrounding musculature, and cerebellum were 
removed to expose the dorsal surface of the brainstem.  
 
Extracellular recording and experimental treatments: Extracellular recordings of 
medullary raphé (r. magnus, r. obscurus, r. pallidus) neurons were made using pulled-
glass capillary electrodes (15–20 MΩ) filled with biotinamide hydrobromide (5 % in 0.5 
M sodium acetate, Life Technologies). The electrode was positioned along the brainstem 
midline (≤ 0.1 mm lateral) 0 to 3 mm rostral of obex and advanced through the brain 
tissue in 2 µm increments using a fine stepping motor (Burleigh Instruments Inchworm). 
Extracellular recordings were made with an intracellular amplifier (Axon Instruments 
Multiclamp 700B) in current clamp mode, with a high pass filter at 300 Hz and low pass 
filter at 1 kHz bessel with an high impedance headstage (Axon CV7B, Molecular 
Devices). Action potentials were digitized using Spike 2 (Cambridge Electronic Design 
Power 1401) and LabChart (AD Instruments) software and stored as computer data files. 
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Neuronal recordings were initiated under baseline conditions (95 % O2 – 5 % CO2; PCO2 
33 mmHg; pH=7.4). As stated, these conditions approximate normocapnic plasma in 
vivo; however, due to the lack of hemoglobin, the solution hyperoxia (PO2 ~ 600 mmHg) 
was necessary to maintain O2 content sufficient to meet tissue metabolic demands, and 
this unavoidable hyperoxia was constant under all conditions. The normocapnic condition 
was followed by a hypercapnic challenge (91 % O2 – 9 % CO2; PCO2 60 mmHg; pH 7.2; 
5 min) to approximate conditions similar to those in plasma during a 4 % increase in 
inspired CO2. The preparation was then returned to normocapnic conditions for an 
additional 5 min. The 5-min exposure was demonstrated to be sufficient for brain tissue 
equilibration with the 91 % O2 – 9 % CO2 gas levels in the perfusate (Wilson et al., 
2001).   
 
Spontaneously active neurons were identified electrophysiologically and classified 
according to changes in firing frequency elicited by elevation of arterial CO2 
concentrations during hypercapnic challenges (increase, decrease, and no change in 
baseline firing frequency). Both chemosensitive and insensitive neurons were 
administered isoflurane bubbled into the perfusate for 10 min (1, 1.5, or 2 % isoflurane in 
95 % O2 – 5 % CO2; percent isoflurane refers to volume percent). For chemosensitive 
neurons, the 5-min hypercapnic challenge was repeated in the presence of isoflurane (1, 
1.5, or 2 % isoflurane; 91 % O2 – 9 % CO2). For insensitive neurons, hypercapnic 
challenges were not repeated. Upon return to baseline conditions (0 % isoflurane; 95 % 
O2 – 5 % CO2), the neuron was allowed to recover toward its baseline firing frequency. 
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Recovery times ranged from 10-30 min, depending on the individual neuronal 
characteristics and assays performed.   
 
Juxtacellular labeling: Subsets of recorded neurons were individually filled with 
biotinamide using the juxtacellular labeling method (Pinault, 1996; Winkler et al., 2006). 
Extracellular recordings were conducted in current clamp mode (Axon Multiclamp 700B) 
to allow current to be injected through the electrode while action potentials were 
monitored. Positive current pulses were applied through the electrode (400-ms duration) 
and gradually increased from 0-15 mV (0.5 mV steps; Grass Stimulator S44B) until the 
cell was entrained to fire simultaneously with the applied stimulus.  Injected current, 
ejection of biotinamide, and cellular firing entrainment caused uptake of the biotinamide 
marker by the recorded cell. Entrainment was maintained for at least 30 s. After 
termination of entrainment, the biotinamide was allowed to disperse for 30 min. Rats 
were then perfused through the descending aorta with fixative [4 % paraformaldehyde 
(PFA) in 0.1 M phosphate buffer saline (PBS); pH 7.4; Sigma-Aldrich]. Brainstems were 
then removed and stored in fixative prior to sectioning. Coronal sections (60 µm) were 
cut through the medulla (Vibratome 1000Plus), and sections were processed free-floating.  
 
Immunohistochemistry: Coronal tissue sections were blocked and permeabilized in 
blocking buffer [Blocking buffer: 5 % normal goat serum (NGS in 0.1 % sodium axide; 
Caltag Spec. No. L10000, Lot: 384935A) and 0.3 % Triton X-100 in 0.1 M PBS] for 1 hr 
at 22 °C. Sections were incubated with a streptavidin-Alexa 546 conjugate (Life 
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Technologies #S-11225; 1:500 dilution in PBS with 5 % NGS) for 2 hr at 22 °C to reveal 
biotinamide introduced into single neurons by juxtacellular labeling. To identify 
serotonergic cells, we used an antibody for the 5-HT-synthesizing enzyme tryptophan 
hydroxylase (TpOH). Sections were incubated overnight at 4 °C with mouse monoclonal 
anti-TpOH (Sigma-Aldrich #T0678; 1:1000 dilution in blocking buffer). Following 
incubation for 1 hr at 22 °C, sections were incubated for 2 hr at 22 °C in a secondary goat 
anti-mouse Alexa 488 antibody (Life Technologies #A-11029; 1:500 dilution in 0.1 M 
PBS with 5 % NGS) to label TpOH-immunoreactive cells. Sections were air-dried for 30 
min, mounted with Vectashield (Vector Labs), and coverslipped. Low-magnification 
(10x) images were used to determine the location of biotinamide-labeled cells in relation 
to anatomical landmarks. Local biotinamide and 5-HT fluorescence identified 
colocalization of serotonergic markers in biotinamide-labeled neurons. Fluorophores 
were individually excited and emission spectra were collected separately to minimize 
interference using a Zeiss LSM510 confocal microscope: biotinamide-labeled neuron, 
Alexa 546, 543 nm laser, filter BP 560-615; anti-TpOH, Alexa 488, 488 nm laser, filter 
BP505-530. Images were constructed as 40x projections of z-stacks.  
 
Gas chromatography – mass spectrometry: All gas chromatography – mass spectrometry 
(GC – MS) analyses were performed on an Agilent Technologies 7890A GC System and 
5975C mass selective detector with Triple Axis Detector. Helium carrier gas was used at 
a constant flow rate of 20 mL min−1. A sample of 250 µL was injected into a DB-1 ms 
capillary column (45 m x 0.25 mm, film thickness 0.25 µm) at a split ratio of 50:1. The 
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system oven temperature was initially maintained at 30 °C for 6 min, and then increased 
at a rate of 10 °C min−1 from 30 to 120 °C. MS acquisition was performed in full scan 
mode in the 40 to 200 amu mass ranges. Mass conditions were as follows: ionization 
voltage, 69.9 eV; ion source temperature, 230 °C; detector voltage, 1.6 kV.  
 
A saturated solution of isoflurane was prepared by adding aliquots of isoflurane to 
perfusate solution and stirring in an airtight container for 3 hr (15 mM; Scheller et al., 
1997). Different concentrations were prepared by diluting the saturated solution in 
perfusate (1:2, 1:4, 1:8, 1:16, 1:32, and 1:64) and 250 µL of headspace gas from each 
dilution was injected directly onto the GC – MS. The mean peak area for each dilution, 
corresponding to the number of isoflurane molecules in solution, was used to generate a 
standard curve for isoflurane. The standard curve was fit to a linear regression line 
(SigmaPlot).  
 
Samples of perfusate were taken from the aortic cannula, to best approximate the sample 
received by experimental preparations, at each minute during a 10-min 1 % isoflurane 
exposure. Additional samples were taken at 11 and 15 min to confirm that isoflurane 
concentrations were stable throughout the period of recording. GC – MS analysis of these 
samples yielded a value for mean peak area, corresponding to the number of isoflurane 
molecules in solution. The concentration of isoflurane in solution at each minute of the 
drug exposure was calculated from the standard curve equation. These calculated 
concentrations were used to confirm that at 10 min, the time point when all neuronal 
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responses to isoflurane were recorded, the concentration of isoflurane in the perfusate 
was equivalent to 1 volume percent.  
 
Data analysis: We discriminated extracellularly recorded individual unit activity using 
computer spike sorting software (Spike Histogram, AD Instruments). Stable 1-2 min 
periods of individual unit firing were analyzed before and during hypercapnic challenge 
to provide a mean value for unit firing frequency (spikes/s) and interspike interval (ms). 
Subset analysis was used to classify neurons as chemo-stimulated or chemo-inhibited 
where relative frequencies changed by greater than 20 %, and chemo-insensitive where 
relative frequencies changed by less than 20 % (Wang et al., 2001). We have previously 
reported the influence of isoflurane on hypercapnic responses in chemo-stimulated 5-HT 
neurons (Johansen et al., 2012; Massey et al., 2013). The present data set includes only 
chemo-insensitive neurons.  
 
Cells were initially screened for being serotonergic by a real-time assessment of firing 
frequency and regularity. Neurons with firing frequencies between approximately 0.5 and 
3 Hz that fired regularly, without sustained pauses or bursts in firing, were regarded as 
putative serotonergic neurons during experimental recording. Putative serotonergic cells 
were confirmed as such with the following algorithm, in which the mean interspike 
interval (!, in ms) and standard deviation of the intervals (sd, in ms) are considered 
independent variables: Y(!,sd) = 146 – ! + 0.98sd (Mason, 1997). If the value of this 
function is less than zero [Y(!,sd) < 0], then the cell was confirmed serotonergic, and if 
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the value of the function is greater than zero [Y(!,sd) > 0], then the cell was considered 
non-serotonergic. All putative 5-HT neurons that were identified by real-time assessment 
of firing pattern and regularity for recording were confirmed serotonergic cells by the 
algorithm.  
 
All putative 5-HT neurons (n=38) were administered a single dose of isoflurane [1 % 
(n=18); 1.5 % (n=10); or 2 % (n=10)]. For each dose, the mean firing frequency at 
baseline (0 % isoflurane) and mean firing frequency in the last minute of isoflurane 
exposure (1, 1.5, or 2 % isoflurane) were compared using a paired t-test. Baseline firing 
frequencies for each of the three groups (1, 1.5, and 2 % isoflurane) were compared by 
one-way ANOVA to confirm that mean firing frequencies under baseline conditions were 
not significantly different from each other. To assess the existence of a dose response, 
percent change from baseline during isoflurane exposure was compared between 
isoflurane treatment groups using a one-way ANOVA. Post-hoc tests used Holm-Sidak 
pairwise comparison (SigmaPlot). Throughout the text, values are expressed as means ± 
standard error of the mean. The criteria for statistical significance was P < 0.05, and 
instances of P < 0.01 and P < 0.001 are also noted. 
 
2.4   Results 
Isoflurane inhibits firing of medullary raphé 5-HT neurons. Single unit extracellular 
recordings performed on medullary raphé putative 5-HT neurons before, during, and after 
isoflurane treatment indicated that isoflurane inhibited the action potential discharge of 
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these neurons. Putative 5-HT neurons were characterized by firing frequency and 
regularity (Mason, 1997). Subsets of these neurons were filled with biotinamide and 
confirmed serotonergic neurons by colocalization of markers of serotonin synthesis 
[presence of tryptophan hydroxylase (TpOH)] in the biotinamide-labeled neuron. A 
representative cell is shown in Figure 2.1. Putative 5-HT neurons exhibited a baseline 
firing frequency within the range 0.1 to 2.01 Hz and a firing pattern consistent with 
serotonergic neuron characteristics, including a large spike width, long after-
hyperpolarization, and regular firing without any sustained pauses or bursts in firing. 
Putative 5-HT neurons either decreased or ceased firing during isoflurane treatment and 
returned to baseline upon washout. Following recovery, a subset of these neurons was 
entrained to fire simultaneously with an applied stimulus. Application of stimulus via the 
recording electrode caused extrusion of biotinamide from the electrode’s capillary barrel. 
Cellular firing entrainment resulted in uptake of this biotinamide label. Subsequent 
immunohistochemistry confirmed the presence of TpOH, an enzyme unique to 5-HT 
synthesis, and thus, a marker of serotonergic neurons, in biotinamide-labeled neurons, 
which confirmed the neurons were serotonergic. Thus, a number of recorded neurons 
were confirmed to be 5-HT neurons, and the remainder were confirmed as 5-HT neurons 
by the algorithm that distinguishes between serotonergic and non-serotonergic cells using 
firing pattern characteristics (Mason, 1997).  
 
Isoflurane inhibits firing of raphé 5-HT neurons at different concentrations. All 
putative 5-HT neurons (n=38) were administered a single dose of isoflurane at 
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concentrations approximating 1.15 MAC (minimum alveolar concentration for 
isoflurane): 1 % (n=18); 1.5 % (n=10); or 2 % (n=10). 36 of the 38 recorded cells were 
inhibited or silenced by isoflurane. For 2 of the 38 recorded cells, baseline firing either 
did not significantly change (7.89 % increase) or significantly increased (48.0 % 
increase) in response to 1 % isoflurane (data not shown). These neurons were positively 
identified as 5-HT by the algorithm (Mason, 1997) and were included in all data analysis. 
The mean firing frequency in the last minute of isoflurane exposure for each isoflurane 
dose (1 % isoflurane: 0.349 ± 0.11 Hz; 1.5 % isoflurane: 0.113 ± 0.04 Hz; or 2 % 
isoflurane: 0.021 ± 0.01 Hz) was significantly different from the mean firing frequency 
under baseline conditions prior to isoflurane exposure (0 % isoflurane: 0.965 ± 0.07 Hz), 
as determined by paired t-test (P < 0.001), which indicated that isoflurane inhibits 
medullary raphé 5-HT neurons at a range of concentrations approximating 1.15 MAC 
(Fig. 2.2). A one-way ANOVA confirmed that mean firing frequencies at baseline for 
each isoflurane treatment group were not significantly different (P = 0.971).  
 
Isoflurane-induced inhibition of raphé 5-HT neurons is dose-dependent. The mean 
percent decrease from baseline during isoflurane exposure was calculated for each 
isoflurane treatment group (1 % isoflurane: -68.96 ± 9.57 %; 1.5 % isoflurane: -89.78 ± 
3.52 %; 2 % isoflurane: -97.76 ± 1.24 %). A comparison of these mean percent changes 
using one-way ANOVA indicated a significant difference between means for neurons 
administered 1 % and 2 % isoflurane (means differed by 28.79 %; P < 0.05), which 
confirmed that isoflurane-induced inhibition of putative raphé 5-HT neurons was dose-
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dependent (Fig. 2.3). The percent changes induced by 1 and 1.5 % isoflurane were not 
significantly different (p=0.147) and neither were the changes induced by 2 and 1.5 % 
isoflurane (p=0.541). 
 
Presence of isoflurane in the perfusate confirmed by gas chromatography – mass 
spectrometry analysis. Aliquots of the perfusate sampled during administration of 
isoflurane were analyzed by gas chromatography – mass spectrometry (GC – MS) to 
confirm that the experimental preparation received the intended concentration of 
isoflurane via the perfusate. A chromatogram of a sample of 1 % isoflurane in 
extracellular solution indicates two distinct peaks (Fig. 2.4a). The peaks at retention times 
2.64 and 3.20 min were identified as CO2 and isoflurane, respectively, by mass spectral 
analysis. As shown in Figure 2.4b, the mass spectra for isoflurane (C3H2ClF5O; 
molecular weight = 184.49 g/mol) showed characteristic molecular and fragment ions: 
m/z 149 (C3H2F5O – Cl) and 116.9 (C2HClF3 – OCHF2). The mass spectra for CO2 
showed the characteristic peak at m/z 44 (Fig. 2.4c).  
 
Standard curve for isoflurane based on GC – MS analysis of perfusate. A standard 
curve for isoflurane was generated from a saturated solution of isoflurane (15 mM; 
Scheller et al., 1997), and dilutions of the saturated solution (1:2, 1:4, 1:8, 1:16, 1:32, and 
1:64) were analyzed by GC – MS. The mean peak area for each dilution, corresponding 
to the number of isoflurane molecules in solution, was used to generate the standard 
curve for isoflurane (Fig. 2.5), which was fit to a linear regression line described by the 
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following equation: y = 6.2*106 x + 6.0*105 (R2 = 0.994).  
 
Isoflurane concentration in perfusate is equivalent to 1 volume percent. Isoflurane is 
poorly soluble in water, but readily soluble in plastic and rubber tubing (Eger, 1981); 
thus, it was imperative that we confirm the concentration of isoflurane received by the 
preparation through the perfusate. GC – MS analysis of perfusate samples taken at each 
minute during a 10-min 1 % isoflurane exposure yielded a value for mean peak area, 
corresponding to the number of isoflurane molecules in solution. The concentration of 
isoflurane in solution at each minute of the drug exposure was calculated from the 
standard curve equation: y = 6.2*106 x + 6.0*105 (R2 = 0.994). At 10 min, the time point 
when all neuronal responses to isoflurane were recorded, the mean equilibrium isoflurane 
concentration was 0.38 mM, which was equivalent to 1 volume percent (0.38 mM = 
mean concentration from 6 to 10 min; 0.37 mM = 1 volume percent; Eilers et al., 1999). 
The 6 to 10 min range was chosen to calculate the mean equilibrium concentration 
because the concentration steadily increased from 3 to 6 min and remained relatively 
constant from 6 to 10 min. Additional samples taken at 11 and 15 min confirmed the 
stability of isoflurane concentrations throughout the period of recording. 
 
2.5   Discussion 
Here we present the first evidence that isoflurane inhibits the baseline firing of caudal 
raphé 5-HT neurons in the descending 5-HT system. Isoflurane routinely inhibited the 
baseline firing of 5-HT neurons, or caused firing to cease completely. These results were 
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consistent for all tested concentrations of isoflurane (1, 1.5, and 2 %), and the degree of 
inhibition increased as the concentration of isoflurane in extracellular solution increased. 
We found a significant difference between neuronal responses to 1 and 2 % isoflurane, 
which indicated dose responsiveness of 5-HT neurons to isoflurane within a clinically 
relevant range. 1 % isoflurane approximated 1.15 MAC, the minimum alveolar 
concentration of isoflurane necessary for surgical anesthesia (Eger, 1981). This 
concentration was confirmed by gas chromatography – mass spectrometry analysis. This 
analysis allowed us to confirm that our results from in situ experiments are relevant to 
evaluating results from in vivo experiments on anesthetized animals, which typically are 
anesthetized within the range of 1 to 2 % inhaled anesthetic. Furthermore, confirming 
that the concentration of isoflurane received by the preparation was equivalent to 1.15 
MAC allowed us to ensure that our results documenting the influence of isoflurane on 5-
HT neurons are clinically relevant. 
 
For 2 of the 38 cells recorded in this study, baseline firing either did not significantly 
change or significantly increased in response to 1 % isoflurane. These cells were 
positively identified as 5-HT neurons by the Mason algorithm (Mason, 1997) and were 
included in all data analysis. The cell that did not respond to 1 % isoflurane may not have 
expressed anesthetic-sensitive channels or the effect of the anesthetic may have been 
masked by other network inputs. The cell that increased firing in response to isoflurane 
may have experienced disinhibition as part of a network that was inhibited by isoflurane. 
Regardless of the mechanism underlying these two unique responses, even when these 
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cells were included in the composite data set, the collective results indicate that isoflurane 
inhibits 5-HT neurons. 
 
The mechanism by which isoflurane inhibits 5-HT neurons remains a pertinent research 
question, but evidence does support a specific binding site for isoflurane on two-pore 
domain potassium channels (Bayliss and Barrett, 2008). These channels mediate 
instantaneous open-rectifier background K+ currents, and volatile anesthetics have been 
shown to potentiate this background current (Sirois et al., 1998; Patel et al., 1999; Sirois 
et al., 2000; Talley et al., 2000). Two subtypes of TASK channels, TASK-1 and TASK-3, 
are highly expressed in the raphé nuclei compared to other brain regions (Talley et al., 
2001). Specific to raphé serotonergic cells, the majority of 5-HT neurons (70-90 %) in 
both dorsal and caudal raphé cell populations have been shown to express TASK-1 and 
TASK-3 channels (Washburn et al., 2002). Based on these prior studies, we postulate that 
potentiation of the TASK channel-mediated background K+ current by isoflurane may 
have hyperpolarized our target population of raphé 5-HT neurons and caused their 
baseline firing frequencies to decrease or cease firing during isoflurane treatment.  
 
Presynaptic binding sites for volatile anesthetics on voltage-gated Na+ channels have also 
been reported (Hemmings, 2009; Herold and Hemmings, 2012) and voltage-gated Ca2+ 
channels (Orestes and Todorovic, 2010). Blockade of Na+ channels by anesthetics has 
been shown to inhibit action potential conductance (Ouyang and Hemmings, 2005; Wu et 
al., 2004), and anesthetic-induced inhibition of Ca2+ currents has been shown to depress 
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membrane excitability and neurotransmitter release (Study, 1994; Nikonorov et al., 1998; 
Kamatchi et al., 1999). The influence of isoflurane on these channels that mediate action 
potential conductance and neuronal excitability could also contribute to the inhibition of 
action potential discharge in 5-HT neurons that we observed in response to isoflurane.  
 
Our data demonstrating that isoflurane inhibits action potential generation in 5-HT 
neurons suggest that anesthetics act on presynaptic sites, a hypothesis that, until recently, 
has been overshadowed by research on postsynaptic anesthetic effects. Many studies on 
the influence of anesthetics on 5-HT neurons have focused on the molecular action of 
anesthetics on postsynaptic 5-HT receptors (Minami et al., 1997; Bardin et al., 2000; 
Mukaida et al., 2007; Nagatani et al., 2011). Importantly, our recordings of 5-HT neuron 
action potentials allow for observation of presynaptic effects during anesthesia, and our 
results demonstrating that isoflurane inhibits 5-HT neuron firing contribute to the 
growing body of literature demonstrating that presynaptic sites are also critical to 
anesthetic action (Griffiths and Norman, 1993; Pocock and Richards, 1993). Although we 
did not directly measure neurotransmitter release from the synaptic terminal, the 
inhibition of 5-HT neuron firing observed during isoflurane treatment is assumed to result 
in decreased action potential dependent release of serotonin. These observations are 
consistent with the generally accepted hypothesis that anesthetic-induced neuronal 
depression results from enhanced inhibitory transmission and decreased excitatory 
transmission (Franks and Lieb, 1994; Campagna et al., 2003; Torri, 2010). Further 
investigations into presynaptic influences of isoflurane on 5-HT neurons may have 
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important implications in our understanding of the neurological mechanisms governing 5-
HT neuron involvement in the state of anesthesia.  
 
The effect of anesthetics on dorsal raphé 5-HT neuron activity in the ascending 5-HT 
system has been previously characterized (McCardle and Gartside, 2012), but anesthetic 
influences on caudal raphé 5-HT neuron activity in the descending 5-HT system had not 
been investigated prior to this study. The caudal raphé population of 5-HT neurons that 
we targeted mediate autonomic output, respiratory control, cardiovascular control, motor 
control, and nociception (Richerson, 2004). Inhibition of this serotonergic system by 
isoflurane may contribute to the immobilization, sedation, insensitivity to pain, and 
cardiorespiratory depression characteristic of isoflurane anesthesia. In fact, several 
reports suggest that the serotonergic system contributes to general anesthetic effects, 
including analgesia, immobility, and hypnosis. 5-HT2A and 5-HT2C receptor blockade 
modulated sevoflurane-induced immobility in response to noxious stimulation in rats in 
vivo, suggesting a role for 5-HT neurons in the immobility effects of anesthesia (Nagatani 
et al., 2011). Volatile anesthetics blocked the response of 5-HT2A receptors to the 
excitatory neurotransmitter serotonin in vitro (Minami et al., 1997), and 5-HT2A receptors 
were shown to mediate 5-HT-induced analgesic effects in rats in vivo (Bardin et al., 
2000), which may indicate 5-HT neuron involvement in pain tolerance during anesthesia. 
In vivo microdialysis measuring extracellular 5-HT indicated that 5-HT release decreased 
in the rat frontal cortex during isoflurane anesthesia to a similar degree as during slow-
wave sleep, suggesting that 5-HT neurons may contribute to hypnosis (Mukaida et al., 
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2007).  Collectively, these data indicate that decreased serotonergic transmission 
contributes to various states of anesthesia. Our data indicating that isoflurane inhibits 5-
HT neuron firing and, therefore, action potential-dependent release of serotonin is 
consistent with this mechanism, in which decreased serotonergic transmission, whether 
by postsynaptic receptor blockade or inhibited presynaptic neuronal firing, gives rise to 
the state of anesthesia.  
 
Defining the molecular mechanisms that give rise to the state of anesthesia holds broad 
interest and impact clinically and, since anesthetics are also abundantly used in scientific 
practice, elucidating how anesthetics affect neuronal activity holds great practical 
significance in interpretation of scientific findings and experimental design. The majority 
of in vivo electrophysiology studies on 5-HT neurons are conducted in animals 
maintained under anesthesia. Given that we observe marked inhibition of 5-HT neurons 
in response to isoflurane, it is plausible that in vivo experiments on 5-HT neuron activity 
using anesthetized rodents unknowingly target only those 5-HT neurons that are 
marginally sensitive or insensitive to isoflurane. These populations may express low 
levels of TASK channels, or isoflurane-insensitivity may be conferred by a different 
unknown mechanism. The effect of isoflurane on 5-HT neurons observed in this study 
may apply to other inhaled anesthetics that are currently used in clinical and research 
practice, including halothane, enflurane, sevoflurane, and desflurane (Campagna et al., 
2003). It would be informative for both clinical and scientific purposes to systematically 
investigate the effects of different types of anesthetics on 5-HT neuron activity. Our 
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results demonstrating that isoflurane causes hyperpolarization of 5-HT neurons in situ are 
critical to consider when interpreting results from in vivo experiments on anesthetized 
rats. Although the research advantages of using anesthesia for in vivo electrophysiology 
are clear, the present data should be taken into account when designing future 
experiments to study 5-HT neuron activity in vivo. 
 
Our study was limited by the difficulty of cellular entrainment for subsequent 
identification by neurotransmitter phenotype. Although it would certainly be ideal to 
conclusively identify all recorded cells, the juxtacellular labeling technique is by nature a 
relatively low-yield process. However, we targeted areas in the medullary raphé that are 
known to contain high concentrations of serotonergic cell bodies, and we selected cells 
that were likely to be serotonergic based on characteristic firing pattern and regularity. 
We identified serotonergic cells for recording by their characteristic slow rhythm without 
pauses or bursts, large spike width, and long after-hyperpolarization. All recorded cells 
are analyzed by an algorithm that distinguishes between serotonergic and non-
serotonergic cells (Mason, 1997). We have previously demonstrated the utility of using 
the juxtacellular labeling method in concert with this algorithm for 5-HT neuron 
identification (Iceman et al., 2013). In this study, all recorded 5-HT neurons were 
positively identified as serotonergic neurons by the algorithm. 
 
Future studies should target the question of how anesthetics affect 5-HT neurons 
presynaptically. We postulate that inhibition of the action potential results in decreased 5-
! 73!
HT release, but this has not been confirmed by direct measurement of 5-HT release from 
synaptic terminals. Although we speculate that isoflurane potentiates the background K+ 
current through TASK channels in 5-HT neurons, the mechanism by which isoflurane 
hyperpolarizes 5-HT neurons is not known. The extent to which inhibition of action 
potential discharge in 5-HT neurons by isoflurane contributes to the state of anesthesia is 
also unclear. Further investigation into the molecular action of isoflurane on 5-HT 
neurons and how this action relates to the behavioral effects of anesthesia is required.  
 
In summary, we demonstrate that isoflurane inhibits baseline firing of 5-HT neurons in a 
concentration-dependent manner. Our work contributes to the growing body of literature 
that investigates presynaptic sites as critical components of mechanisms of anesthetic 
action. Documenting how anesthetics affect serotonergic neurons presynaptically is 
important for interpretation of scientific conclusions from experiments using anesthesia, 
and defining how this molecular action contributes to the state of anesthesia holds broad 
clinical relevance.  
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2.7   Figures 
Continued on the following pages 
 
Figure 2.1. Isoflurane inhibits firing of medullary raphé 5-HT neurons. 
a) Representative extracellular recording of a 5-HT neuron that ceased firing 
during isoflurane treatment. The neuron returned to baseline upon washout. 
Under baseline conditions, firing frequency (1.12 Hz) and pattern was 
characteristic of serotonergic cells (Mason, 1997). Scale bar = 30 s. b) The 
same neuron was entrained to fire simultaneously with an applied stimulus, 
which extruded biotinamide and labeled the recorded neuron. c) Fluorescent 
markers of serotonin synthesis (tryptophan hydroxylase; green) and biotinamide 
(red) colocalize (yellow) to indicate the recorded neuron was a serotonergic 
neuron. Scale bar = 50 µm.
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Figure 2.2. Isoflurane inhibits firing of raphé 5-HT neurons at various 
concentrations. All putative 5-HT neurons (n=38) were administered a single 
dose of isoflurane [1 % (n=18); 1.5 % (n=10); and 2 % (n=10)]. For each dose, 
comparison of mean firing frequency at baseline (0 % isoflurane; 0.965 ± 0.07 
Hz) to mean firing frequency in the last minute of isoflurane exposure (1 % 
isoflurane: 0.349 ± 0.11 Hz; 1.5 % isoflurane: 0.113 ± 0.04 Hz; or 2 % 
isoflurane: 0.021 ± 0.01 Hz) was determined by paired t-test (***P < 0.001). 
Mean firing frequencies at baseline were compared by one-way ANOVA to 
confirm that baseline firing frequencies for the isoflurane treatment groups were 
not significantly different (P = 0.971). 
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Figure 2.3. Isoflurane-induced inhibition of raphé 5-HT neurons is dose 
dependent. Values presented are mean percent decrease from baseline ± 
standard error for each isoflurane dose. Isoflurane doses of 1, 1.5, and 2 % 
inhibited raphé 5-HT neuron firing by 68.96 ± 9.57 (n=18), 89.78 ± 3.52 
(n=10), and 97.76 ± 1.24 % (n=10), respectively. Between groups comparison 
of percent change from baseline during isoflurane exposure, using one-way 
ANOVA, indicated a significant difference between means for 1 and 2 % 
isoflurane (mean difference = 28.79 %; *P < 0.05). This analysis confirms that 
isoflurane-induced inhibition is dose-dependent. Between groups comparison of 
percent change from baseline was not significant comparing 1 and 1.5 % 
isoflurane (P = 0.147) or comparing 1.5 and 2 % isoflurane (P = 0.541).
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Figure 2.4. Presence of isoflurane in the perfusate is confirmed by gas 
chromatography – mass spectrometry analysis. a) Chromatogram of a 
sample of 1 % isoflurane in perfusate solution. The peaks at retention times 
2.64 min and 3.20 min were identified as CO2 and isoflurane, respectively, by 
mass spectral analysis. b) Mass spectra for isoflurane (C3H2ClF5O; molecular 
weight = 184.49 g/mol) showed characteristic molecular and fragment ions: m/z 
149 (C3H2F5O – Cl)  and 116.9 (C2HClF3 – OCHF2). c) Mass spectra for CO2 
showed the characteristic peak at m/z 44 (molecular weight = 44 g/mol). 
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Figure 2.5. Standard curve for isoflurane based on GC-MS analysis of 
perfusate. A standard curve for isoflurane was generated from a saturated 
solution of isoflurane (15 mM; Scheller et al., 1997). Dilutions of the 
saturated solution (1:2, 1:4, 1:8, 1:16, 1:32, and 1:64) were analyzed by gas-
chromatography-mass spectrometry. Mean peak area corresponds to the 
number of isoflurane molecules in solution. The standard curve follows a 
linear regression line described by the equation: y = 6.2*10^6 x + 6.0*10^5 
(R^2 = 0.994).
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Figure 2.6. Isoflurane concentration in perfusate is equivalent to 1 volume 
percent. Gas chromatography - mass spectrometry analysis was performed on 
perfusate samples taken at each minute during a 10-min 1 % isoflurane 
exposure. The concentration of isoflurane in solution at each minute of the drug 
exposure was calculated from the standard curve equation: y = 6.2*10^6 x + 
6.0*10^5 (R^2 = 0.994). At 10 min, the time point when all neuronal responses 
to isoflurane were recorded, the average equilibrium isoflurane concentration 
was 0.38 mM, which was equivalent to 1 volume percent (0.38 mM = average 
concentration from 6 to 10 min; 0.37 mM = 1 volume percent; Eilers et al., 
1999). Additional samples were taken at 11 and 15 min to confirm that 
isoflurane concentrations were stable throughout neuronal recording periods. 
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Chapter 3 
The response of CO2-inhibited neurons to isoflurane: Evidence for a heterogeneous 
population of medullary raphé GABA neurons2 
 
3.1   Abstract 
Anesthetics are widely used in clinical and scientific practice, but mechanisms of 
anesthetic action remain largely undefined. Specifically, the influence of anesthetics on 
central chemoreceptors, neurons that sense changes in arterial CO2/pH, remains a 
question that is relevant to understanding the depressed hypercapnic ventilatory response 
during anesthesia. Here, we investigated the influence of isoflurane on GABA neurons, 
which are proposed chemoreceptors in the medullary raphé, using the arterially perfused 
in situ brainstem preparation. We tested the hypothesis that 1 % isoflurane, 
approximating 1.15 MAC for isoflurane, enhances action potential discharge in 
medullary raphé GABA neurons and disrupts their chemosensitivity. We documented a 
heterogeneous population of CO2-inhibited putative GABA neurons, represented by at 
least two distinct groups, which differed in their baseline firing frequencies and response 
to isoflurane. Furthermore, we found that isoflurane disrupted the chemosensitivity of 
these CO2-inhibited putative GABA neurons. This study offers insight into the 
contribution of GABA neurons to the depressed ventilatory response that is characteristic 
of general anesthesia. !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
2 Johansen SL, Iceman KE, Richerson GB, and Harris MB. 2014. The response of CO2-
inhibited neurons to isoflurane: Evidence for a heterogeneous population of medullary 
raphé GABA neurons. In preparation for submission in the British Journal of 
Anesthesiology. 
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3.2   Introduction 
The molecular mechanisms that give rise to the state of anesthesia are poorly understood, 
despite the widespread use of anesthetics in clinical and scientific practice. Several 
theories have been historically proposed to answer the critical question of how a wide 
array of anesthetic agents with diverse molecular structures produce the same state of 
anesthesia, characterized by immobility, hypnosis, analgesia, and amnesia. These theories 
of general anesthetic mechanisms of action have evolved from a unitary theory of non-
specific anesthetic action, to a theory that anesthetics act on specific protein targets, and 
now to a multiple mechanism concept. It is now clear that anesthetics act at multiple 
anatomical sites and on multiple molecular targets to produce the state of anesthesia 
(Campagna et al., 2003; Grasshoff et al., 2005; Torri, 2010). The effect of anesthetics on 
a vast array of protein targets, including membrane receptors, ion channels, serum 
proteins, and intracellular signaling molecules (Rudolph and Antkowiak, 2004), is the 
current focus of research that seeks to relate molecular actions of anesthetics to 
behavioral states of anesthesia.  
 
Virtually all areas in the central nervous system experience depressed neuronal responses 
during anesthesia. The current working hypothesis states that system-wide depression 
results from enhanced inhibitory postsynaptic activity through action on GABAA 
[receptor subtype for the inhibitory neurotransmitter γ-aminobutyric acid (GABA)] and 
glycine receptors and decreased excitatory postsynaptic activity through action on 
glutamate, nicotinic acetylcholine, and serotonin receptors (Franks and Lieb, 1994; 
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Campagna et al., 2003; Torri, 2010). The majority of research focuses on postsynaptic 
sites of anesthetic action, particularly GABAA receptors, which are the most abundant 
receptors for inhibitory neurotransmitters in the brain. General anesthetics increase the 
sensitivity of GABAA receptors to GABA at clinically relevant concentrations and 
prolong the GABAA receptor-mediated current in response to a pulse of GABA, thereby 
inhibiting postsynaptic neuronal excitability (Jones and Harrison, 1993). Many classes of 
both inhalational and intravenous anesthetics have been shown to prolong inhibitory post-
synaptic currents (IPSCs) mediated by GABAA receptors (Krasowski and Harrison, 
2000). This potentiation of the GABAA receptor-mediated current in vitro corresponds to 
the anesthetic potency measured by MAC-immobility (minimum alveolar concentration 
that prevents movement in response to noxious stimuli in 50 % of subjects) in vivo 
(Zimmerman et al., 1994). In humans, positron emission tomography scans using a 11C-
labeled benzodiazepine ligand, a GABAA receptor-sensitive probe, indicate that 
isoflurane dose-dependently enhances binding of the ligand to GABAA receptors, which 
may suggest that a conformational change of GABAA receptors occurs during isoflurane 
anesthesia in the human brain (Gyulai et al., 2001). These and many other studies provide 
strong evidence that GABAA receptors play a major role in mechanisms of anesthetic 
action.  
 
The wide body of literature on GABAA receptors suggests that postsynaptic sites 
predominate in anesthetic mechanisms, but evidence is emerging that supports 
presynaptic sites as critical targets for anesthetics (Griffiths and Norman, 1993; Pocock 
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and Richards, 1993). Presynaptic sites of anesthetic action are implied from 
electrophysiological studies that compare the effect of presynaptic stimulation and direct 
application of neurotransmitter on postsynaptic potentials in the presence of anesthetics. 
For example, 1 MAC halothane reduced glutamatergic excitatory postsynaptic currents in 
mouse hippocampal slices by approximately 50 %, but halothane had no effect, even at 
concentrations approximating 5 MAC, on postsynaptic currents induced by glutamatergic 
agonists (Perouansky et al., 1995). Presynaptic sites are also implicated from studies that 
show that anesthetics affect neurotransmitter release. Although molecular mechanisms 
are not yet defined, the volatile anesthetic isoflurane has been shown to inhibit the 
mammalian neurotransmitter release in neurons (Herring et al., 2009), and this inhibition 
is thought to be the result of interaction with vesicle fusion proteins, SNARE and 
SNARE-associated proteins (Xie et al., 2013). Volatile anesthetics have also been shown 
to inhibit voltage-gated Na+ channels (Herold and Hemmings, 2012), two-pore-domain 
background K+ channels (TASK channels; Bayliss and Barrett, 2008), and voltage-gated 
Ca2+ channels (Orestes and Todorovic, 2010), which could affect membrane excitability, 
action potential conductance, and neurotransmitter release.  
 
Given the working hypothesis that central nervous system depression during anesthesia 
involves both inhibition of excitatory transmission and enhancement of inhibitory 
transmission, many studies on presynaptic neurotransmitter release focus on glutamate 
versus GABA release. Isoflurane has been shown to selectively inhibit Na+ channel-
dependent 4-aminopyridine (4AP)-evoked release of glutamate compared to GABA 
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release (Westphalen et al., 2011; Westphalen et al., 2013). Volatile anesthetics were also 
shown to preferentially inhibit Ca2+-dependent 4AP-evoked glutamate versus GABA 
release (Westphalen and Hemmings, 2006). These studies conclude that anesthetics 
inhibit glutamate release more potently than GABA release. The influence of anesthetics 
on GABA release is a subject of some controversy, as both inhibition and enhancement 
of GABA release in response to anesthetics are reported. Some studies report that 
anesthetics act on GABAergic presynaptic nerve terminals to decrease action potential 
dependent GABA release (Ogawa et al., 2011; Kotani and Akaike, 2012), while others 
conclude that anesthetics increase inhibitory postsynaptic current (IPSC) frequency and 
GABA release from presynaptic nerve terminals (Larsen et al., 1998; Murugaiah and 
Hemmings, 1998; Pittson et al., 2004). The current literature supports the conclusion that 
anesthetics act on GABA neurons presynaptically but, clearly, molecular mechanisms 
have yet to be resolved. Additionally, the question of how those molecular actions relate 
to the state of anesthesia has yet to be systematically investigated.  
 
A component of the state of anesthesia that is particularly relevant in clinical settings is 
the influence of anesthetics on control of breathing, since respiratory depression during 
anesthesia is a well-known critical concern (Evers et al., 2006). Volatile halogenated 
anesthetics, such as isoflurane, affect both the chemical control of breathing, which 
responds to changes in the chemical composition of arterial blood (pH, PCO2, PO2), and 
the behavioral control of breathing, which responds to changes in behavioral states, such 
as arousal or stress (Dahan and Teppema, 2003). In humans, the ventilatory response to 
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decreased O2 (hypoxia) and increased CO2 (hypercapnia) are depressed by volatile 
anesthetics, including halothane (Dahan et al., 1994), isoflurane (Sollevi and Lindahl, 
1995; van den Elsen et al., 1998), and sevoflurane (Sarton et al., 1996). The mechanism 
by which this depressed ventilatory response occurs, however, is not fully defined.  
 
Chemoreceptors, cells that function to sense changes in CO2/pH and stimulate respiratory 
network responses necessary to regain homeostasis, are thought to play a primary role in 
mechanisms that give rise to blunted ventilatory responses during anesthesia. The first 
studies on the effect of anesthetics on the ventilatory response in humans showed that 
low-dose anesthetics selectively impaired hypoxic and hypercapnic drive in peripheral 
chemoreceptors, but not in central chemoreceptors (Knill and Gelb, 1978; Knill and 
Clement, 1985). This conclusion has been corroborated by a number of more recent 
studies (Dahan et al., 1994; van den Elsen, 1995). These studies used subanesthetic 
concentrations (0.5 to 0.1 MAC) to select for the peripheral rather than central response. 
In a later study, van den Elsen et al. (1998) considered level of sedation of human 
subjects in addition to the anesthetic concentration, and suggested that at levels of 
sedation comparable with sleep volatile anesthetics (isoflurane, desflurane, and 
sevoflurane) depressed central and peripheral chemoreflexes. It is now understood that 
volatile anesthetics affect both peripheral and central chemoreflexes at clinical 
concentrations. For example, halothane has been shown to depress ventilatory drive by 
abolishing peripheral drive from peripheral chemoreceptors in the carotid bodies (Dahan 
et al., 1994) and by inhibiting central drive from major respiratory control networks, such 
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as the pre-Bötzinger complex (Koizumi et al., 2010). These prior studies indicate that 
central mechanisms of anesthetic action contribute to the blunted ventilatory response 
under anesthesia, but the direct influence of anesthetics on central chemoreceptors 
remains an important question. 
 
The medullary raphé region in the brainstem is associated with homeostatic regulation 
and central respiratory control in vivo. Intrinsically chemosensitive neurons of two 
distinct phenotypes, including CO2-stimulated serotonin (5-HT) and CO2-inhibited γ-
aminobutyric acid (GABA) synthesizing cells, have been identified in the medullary 
raphé in vitro (Richerson et al., 2001), and both serotonergic and GABAergic systems 
have been implicated in facilitation of the homeostatic response to hypercapnia/acidosis. 
Research using unanesthetized rat in situ perfused decerebrate brainstem preparations 
suggests these raphé neurons also function as central chemosensors in intact animals 
(Iceman et al., 2010; Iceman et al., 2013). As these cell types are known to be involved in 
central chemoreception, they may contribute to the depressed central chemoreflex that 
results in a blunted ventilatory response during anesthesia.  
 
We have previously described the influence of isoflurane on 5-HT neurons, which are 
proposed to provide excitatory input in central respiratory control (Johansen et al., 2012; 
Massey et al., 2013). Here, we investigated the proposed inhibitory input in central 
respiratory control by documenting the effect of isoflurane on action potential discharge 
and chemosensitivity of GABA neurons. We tested the hypothesis that isoflurane 
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enhances action potential discharge of medullary raphé GABA neurons and disrupts their 
chemosensitivity using the arterially perfused in situ brainstem preparation. We 
demonstrated the influence of 1 % isoflurane on medullary raphé GABA neurons, a 
concentration that approximates 1.15 MAC (isoflurane concentration required for 
surgical anesthesia; Eger, 1981). Our present aim was to investigate the presynaptic 
influence of anesthetics on GABA neuron action potential discharge, which will add to 
the growing body of literature describing presynaptic mechanisms of anesthetic action. 
We also aimed to assess the effect of isoflurane on GABA neuron chemosensitivity, 
which may offer insight into the central mechanisms that contribute to the blunted 
ventilatory response to hypercapnia during anesthesia.  
 
3.3   Methods 
Experimental preparations: Animal care and experimental procedures followed 
guidelines set by the National Institutes of Health Office of Laboratory Animal Welfare 
and the United States Department of Agriculture Animal Welfare Act. All protocols were 
in accordance with the University of Alaska Fairbanks Institutional Animal Care and Use 
Committee guidelines. Juvenile male rats (50 – 150 g; Sprague-Dawley strain; Simonson 
Laboratories) were used to generate the perfused in situ brainstem preparation as 
previously described (Paton, 1996; Corcoran et al., 2013, Iceman et al., 2013). Briefly, 
animals were administered an intraperitoneal heparin sodium injection (0.5 mL, 1000 
USP; Sagent Pharmaceuticals) to prevent formation of blood clots during surgery. Deep 
anesthesia was induced using isoflurane and assessed by cessation of spontaneous 
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breathing and absence of a withdrawal response to firm toe pinch. Anesthesia was 
discontinued as preparations were bisected sub-diaphragmatically and decerebrated 
rostral to the superior colliculi, and subsequent procedures were conducted in the absence 
of anesthesia. Preparations were immersed in chilled artificial cerebral spinal fluid 
(aCSF) for the remainder of the dissection, which was conducted to isolate the 
descending aorta.  
 
Each preparation was placed in the recording chamber in a prone position. The 
descending aorta was cannulated retrogradely with a double-lumen catheter, and 
preparations were perfused with a solution at a temperature of 31 °C. The perfusate 
solution contained the following (in mM): 1.0 MgSO4, 125 NaH2PO4, 4.0 KCl, 24 
NaHCO3, 115 NaCl, 10 D-Glucose, 2.0 CaCl2, and 0.18 Ficoll. Baseline conditions, when 
the perfusate was equilibrated with 95 % O2 – 5 % CO2 (PCO2 33 mmHg; pH=7.4), 
approximated normocapnic plasma in vivo. Levels of O2 and CO2 in the perfusate were 
controlled by equilibrating a perfusate reservoir with gas mixtures produced by a 
precision gas mixer (CWE GSM-3) and verified by a CO2 analyzer (Applied 
Electrochemistry CD-3A). Following cannulation, perfusion pressure was gradually 
increased to 40-60 mmHg by regulating the speed of a peristaltic perfusion pump. The 
first 50 mL of perfusate that passed through the preparation was discarded to eliminate 
blood, and the remaining 450 mL of perfusate was recirculated. The neuro-muscular 
blocker gallamine triethidodide (60 mg/L, Sigma-Aldrich) was added to the perfusate to 
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eliminate movement. The occipital bone, surrounding musculature, and cerebellum were 
removed to expose the dorsal surface of the brainstem.  
 
Extracellular recording and experimental treatments: Extracellular recordings of 
medullary raphé (r. magnus, r. obscurus, r. pallidus) neurons were made using pulled-
glass capillary electrodes (15–20 MΩ) filled with biotinamide hydrobromide (5 % in 0.5 
M sodium acetate, Life Technologies). The electrode was positioned along the brainstem 
midline (≤ 0.1 mm lateral) 0 to 3 mm rostral of obex and advanced through the brain 
tissue in 2 µm increments using a fine stepping motor (Burleigh Instruments Inchworm). 
Extracellular recordings were made with an intracellular amplifier (Axon Instruments 
Multiclamp 700B) in current clamp mode, with a high pass filter at 300 Hz and low pass 
filter at 1 kHz bessel with an high impedance headstage (Axon CV7B, Molecular 
Devices). Action potentials were digitized using Spike 2 (Cambridge Electronic Design 
Power 1401) and LabChart (AD Instruments) software and stored as computer data files. 
 
Neuronal recordings were initiated under baseline conditions (95 % O2 – 5 % CO2; PCO2 
33 mmHg; pH=7.4). As stated above, these conditions approximate normocapnic plasma 
in vivo; however, due to the lack of hemoglobin, the solution hyperoxia (PO2 ~ 600 
mmHg) was necessary to maintain O2 content sufficient to meet tissue metabolic 
demands, and this unavoidable hyperoxia was constant under all conditions. The 
normocapnic condition was followed by a hypercapnic challenge (91% O2 – 9% CO2; 
PCO2 60 mmHg; pH 7.2; 5 min) to approximate conditions similar to those in plasma 
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during a 4 % increase in inspired CO2. The preparation was then returned to normocapnic 
conditions for an additional 5 min. The 5-min exposure was demonstrated to be sufficient 
for brain tissue equilibration with the 91 % O2 – 9 % CO2 gas levels in the perfusate 
(Wilson et al., 2001).   
 
Spontaneously active neurons were identified electrophysiologically and classified 
according to changes in firing frequency elicited by elevation of arterial CO2 
concentrations during hypercapnic challenges (increase, decrease, and no change in 
baseline firing frequency). We have previously shown that CO2-inhibited medullary 
raphé neurons may be considered putative GABA neurons (Iceman et al., 2010). All CO2-
inhibited neurons were considered putative GABA neurons and were selected for further 
recording. CO2-inhibited putative GABA neurons were administered isoflurane bubbled 
into the perfusate for 10 min (1, 1.5, or 2 % isoflurane in 95 % O2 – 5 % CO2; percent 
isoflurane refers to volume percent). For neurons that did not cease under isoflurane, the 
5-min hypercapnic challenge was repeated in the presence of isoflurane (1, 1.5, or 2 % 
isoflurane; 91 % O2 – 9 % CO2). Hypercapnic responses under isoflurane could not be 
assessed for neurons that ceased firing in response to 1% isoflurane. Upon return to 
baseline conditions (0 % isoflurane; 95 % O2 – 5 % CO2), neurons were allowed to 
recover toward baseline firing frequency. Recovery times ranged from 10-30 min, 
depending on the individual neuronal characteristics and assays performed.   
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Juxtacellular labeling: Subsets of recorded neurons were individually filled with 
biotinamide using the juxtacellular labeling method (Pinault, 1996; Winkler et al., 2006). 
Extracellular recordings were conducted in current clamp mode (Axon Multiclamp 700B) 
to allow current to be injected through the electrode while action potentials were 
monitored. Positive current pulses were applied through the electrode (400-ms duration) 
and gradually increased from 0-15 mV (0.5 mV steps; Grass Stimulator S44B) until the 
cell was entrained to fire simultaneously with the applied stimulus.  Injected current, 
ejection of biotinamide, and cellular firing entrainment caused uptake of the biotinamide 
marker by the recorded cell. Entrainment was maintained for at least 30 s. After 
termination of entrainment, the biotinamide was allowed to disperse for 30 min. Rats 
were then perfused through the descending aorta with fixative [4 % paraformaldehyde 
(PFA) in 0.1 M phosphate buffer saline (PBS); pH 7.4; Sigma-Aldrich]. Brainstems were 
then removed and stored in fixative prior to sectioning. Coronal sections (60 µm) were 
cut through the medulla (Vibratome 1000Plus), and sections were processed free-floating.  
 
Immunohistochemistry: Coronal tissue sections were blocked and permeabilized in 
blocking buffer [Blocking buffer: 5 % normal goat serum (NGS in 0.1 % sodium axide; 
Caltag Spec. No. L10000, Lot: 384935A) and 0.3 % Triton X-100 in 0.1 M PBS] for 1 hr 
at 22 °C. Sections were incubated with a streptavidin-Alexa 546 conjugate (Life 
Technologies #S-11225; 1:500 dilution in PBS with 5 % NGS) for 2 hr at 22 °C to reveal 
biotinamide introduced into single neurons by juxtacellular labeling. To identify 
GABAergic cells, we used an antibody for the GABA-synthesizing enzyme glutamate 
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decarboxylase (GAD-67). Following incubation with mouse monoclonal anti-GAD67 
(Millipore MAB5406), sections were incubated with goat anti-mouse Alexa 488 (Life 
Technologies #A11029) to label GAD67-immunoreactive cells. Sections were air-dried 
for 30 min, mounted with Vectashield (Vector Labs), and coverslipped. Low-
magnification (10x) images were used to determine the location of biotinamide-labeled 
cells in relation to anatomical landmarks. Local biotinamide and GABA fluorescence 
identified colocalization of GABAergic markers in biotinamide-labeled neurons. 
Fluorophores were individually excited and emission spectra were collected separately to 
minimize interference using a Zeiss LSM510 confocal microscope: biotinamide-labeled 
neuron, Alexa 546, 543 nm laser, filter BP 560-615; anti-GAD67, Alexa 488, 488 nm 
laser, filter BP505-530. Images were constructed as 40x projections of z-stacks.  
 
Data analysis: We discriminated extracellularly recorded individual unit activity using 
computer spike sorting software (Spike Histogram, AD Instruments). Stable 1-2 min 
periods of individual unit firing were analyzed before and during hypercapnic challenge 
to provide a mean value for unit firing frequency (spikes/s) and interspike interval (ms). 
Subset analysis was used to classify neurons as chemo-stimulated or chemo-inhibited 
where relative frequencies changed by greater than 20 %, and chemo-insensitive where 
relative frequencies changed by less than 20 % (Wang et al., 2001). For cells identified as 
CO2-inhibited putative GABA neurons based on a minimum 20 % decrease in firing 
frequency during hypercapnic challenge, between groups comparison of the change in 
absolute firing frequency from normocapnia (5 % CO2) to hypercapnia (9 % CO2) and 
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recovery (5 % CO2) was determined using one-way repeated-measures ANOVA. Post-
hoc tests used Holm-Sidak pairwise comparison (SigmaPlot).  
 
Considering all CO2-inhibited neurons as a single group (n=19), between groups 
comparison of baseline firing frequency with firing frequency during 1 % isoflurane 
treatment was determined using a paired t-test. However, this analysis of the entire 
population of CO2-inhibited putative GABA neurons did not reflect the occurrence of 
neurons that increased firing in response to 1 % isoflurane. Neurons were subsequently 
analyzed by percent change from baseline during isoflurane, to reveal a bimodal 
distribution represented by two groups: 1) “slow firing” cells that increased firing during 
isoflurane and 2) “fast firing” cells that decreased or ceased firing during isoflurane. 
Between groups comparison of the mean percent change from baseline of "slow firing" 
and "fast firing" CO2-inhibited neurons was determined by t-test. Between groups 
comparison of mean baseline firing frequencies of "slow firing" and "fast firing" CO2-
inhibited neurons was determined by one-tailed t-test. The one-tailed t-test was used 
because the distribution of firing frequencies was truncated at zero, corresponding to a 
neuron that is not firing (0 Hz) and, therefore, the distribution was not normal and a two-
tailed t-test was not appropriate for analysis. The between groups comparison of mean 
baseline firing frequencies was also determined by a t-test on ranks by the same 
justification of a distribution that is truncated at zero. Throughout the text, values are 
expressed as means ± standard error of the mean. The criteria for statistical significance 
was P < 0.05, and instances of P < 0.01 and P < 0.001 are also noted. 
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3.4   Results 
CO2-inhibited medullary raphé neurons are GABA-synthesizing neurons. Medullary 
raphé neurons that decreased in firing frequency by at least 20 % from baseline during 
hypercapnic challenge (9 % CO2; pH 7.2; 5 min) were categorized as “CO2-inhibited” 
neurons, and these CO2-inhibited neurons were identified as GABA-synthesizing 
neurons. Two representative cells are shown in Figure 3.1. Both neurons were inhibited 
during hypercapnic challenge and returned toward baseline firing rates upon return to 
normocapnia. The difference in baseline firing frequencies (0.27 Hz compared to 8.95 
Hz) and patterns (tonic compared to bursting) between these two cells demonstrates the 
heterogeneity of baseline firing characteristics that we observe in medullary raphé CO2-
inhibited cells (Fig. 3.1a and 3.1c). Both cells were confirmed GABAergic by 
colocalization of markers of GABA-synthesis in biotinamide-labeled neurons (Fig. 3.1b 
and 3.1d).  
 
CO2-inhibited medullary raphé putative GABA neurons display heterogeneous 
responses to isoflurane. CO2-inhibited putative GABA neurons exhibited two different 
responses to 1 % isoflurane. Isoflurane stimulated action potential discharge in a subset 
of CO2-inhibited neurons and inhibited action potential discharge in a different subset of 
CO2-inhibited neurons. A representative cell for the subset of isoflurane-stimulated CO2-
inhibited neurons is shown in Figure 3.2a-b. In this case, isoflurane stimulated action 
potential discharge by 1,622 %. A different cell representing the response of the subset of 
isoflurane-inhibited CO2-inhibted neurons is shown in Figure 3.2c-d. In this case, 
!104!
isoflurane caused action potential discharge to cease. In both cases, the cells recovered 
toward baseline firing upon washout of isoflurane.  
 
Consideration of the total population of medullary raphé CO2-inhibited putative 
GABA neurons indicates inhibition by isoflurane, but this response to isoflurane is 
not reflective of all neuron responses. Considering all CO2-inhibited neurons as a single 
group (n=19), it appears that on average, 1 % isoflurane inhibited action potential 
discharge in the population as a whole. The mean firing frequency at baseline (2.14 ± 
0.57 Hz) was significantly different from the mean firing frequency during 1 % isoflurane 
treatment (0.65 ± 0.26 Hz), as shown in Figure 3.3 (*P < 0.05). However, this analysis of 
the entire population of CO2-inhibited putative GABA neurons did not reflect the 
occurrence of neurons that increased firing in response to 1 % isoflurane (see Fig. 3.2a-
b). Consideration of the change in baseline firing frequency in response to 1 % isoflurane 
for each individual cell (n=19) indicated a significant degree of variability between 
neurons, both in terms of their absolute firing frequencies at baseline and responses to 1 
% isoflurane (Fig. 3.4). The majority of neurons decreased or ceased firing during 
isoflurane treatment (n=14), but a subset of neurons increased firing in response to 
isoflurane (n=5).  
 
Individual responses of medullary raphé CO2-inhibited putative GABA neurons to 1 
% isoflurane treatment are characterized by a bimodal distribution. The percent 
increase from baseline during 1 % isoflurane treatment revealed a bimodal distribution 
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represented by two groups: CO2-inhibited neurons that increased firing in response to 
isoflurane and CO2-inhibited neurons that decreased or ceased firing during isoflurane 
treatment (Fig. 3.5). Neurons that had a percent change from baseline greater than zero 
(n=5) increased firing in response to isoflurane. Neurons that had a percent change from 
baseline less than zero (n=14) decreased firing in response to isoflurane. Not all lines are 
apparent because neurons that ceased firing have overlapping lines and data points (n=10; 
0 to -100 % on the y-axis). 
 
The medullary raphé population of CO2-inhibited putative GABA neurons is 
heterogeneous. The population of CO2-inhibited putative GABA neurons is 
heterogeneous and represented by at least two distinct groups, which differ in their mean 
baseline firing frequencies and responses to isoflurane. The CO2-inhibited neurons that 
increased firing in response to isoflurane were characterized as “slow firing” neurons 
with a mean baseline firing frequency of 0.50 ± 0.38 Hz, and the CO2-inhibited neurons 
that decreased or ceased firing in response to isoflurane were characterized as “fast-
firing” neurons with a mean baseline firing frequency of 2.72 ± 0.70 Hz (Fig. 3.6).  
Comparison of baseline firing frequencies of "slow firing" and "fast firing" CO2-inhibited 
neurons indicated a significant difference between means (*one-tailed P < 0.05). 
Comparison of the percent change from baseline of "slow firing" (mean percent increase 
= 1043.86 ± 668.70 %) and "fast firing" CO2-inhibited neurons (mean percent decrease = 
-85.82 ± 7.07 %) indicated a significant difference between means (**P < 0.01). In 
summary, the two groups of CO2-inhibited putative GABA neurons observed in the 
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medullary raphé region are significantly different in terms of their mean baseline firing 
frequency and mean percent change from baseline in response to 1 % isoflurane.  
 
A subset of medullary raphé neurons are CO2-inhibited. All cells identified as CO2-
inhibited demonstrated a minimum 20 % decrease from baseline firing frequency during 
hypercapnic challenge (n=19; Fig. 3.7). Between groups comparison of the change in 
absolute firing frequency from normocapnia (5 % CO2; pH 7.4) to hypercapnia (9 % 
CO2; pH 7.2) and recovery (5 % CO2; pH 7.4) indicated a significant difference between 
normocapnia and hypercapnia (***P < 0.001) and between hypercapnia and recovery (*P 
< 0.05). There was not a significant difference between firing frequencies during 
normocapnia and recovery periods (P = 0.095).   
 
Isoflurane disrupts the chemosensitivity of medullary raphé CO2-inhibited putative 
GABA neurons. CO2-inhibited neurons that were stimulated by 1 % isoflurane did not 
respond to the hypercapnic challenge given during isoflurane treatment (9 % CO2 in 
solution with 1 % isoflurane; pH 7.2; 5 min). A representative cell is shown in Figure 3.8. 
Considering all “slow-firing” isoflurane-stimulated neurons that received a hypercapnic 
challenge during isoflurane (n=5), there was not a significant difference in absolute firing 
frequency between normocapnia and hypercapnia during 1 % isoflurane treatment (Fig. 
3.9; P = 0.510). Only those neurons that increased firing in response to isoflurane were 
included in analysis of chemosensitivity under isoflurane because hypercapnic responses 
could not be assessed in “fast-firing” neurons that ceased firing with isoflurane.  
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3.5   Discussion 
Here, we present the first evidence of heterogeneity in the presynaptic response to 
isoflurane of medullary raphé CO2-inhibited putative GABA neurons. We found that 
CO2-inhibited cells responded to isoflurane in one of two distinct ways: action potential 
discharge of these cells either dramatically increased or significantly decreased, to the 
point of ceasing in the majority of cases, in response to 1 % isoflurane. Comparing the 
baseline firing characteristics of cells that were stimulated to cells that were inhibited, we 
found a significant difference in baseline firing rates. Isoflurane-stimulated neurons fired 
slowly at baseline (0.50 ± 0.38 Hz) compared to isoflurane-inhibited neurons (2.72 ± 0.70 
Hz). Our results indicate a heterogeneous population of medullary raphé CO2-inhibited 
putative GABA neurons represented by at least two distinct groups, which differ in their 
response to isoflurane and baseline firing frequency: 1) “slow-firing” CO2-inhibited 
putative GABA neurons that are stimulated by isoflurane; and 2) “fast-firing” CO2-
inhibited putative GABA neurons that are inhibited by isoflurane. 
 
It is now widely accepted that central depression during anesthesia occurs as a result of 
enhanced inhibitory neurotransmission and decreased excitatory neurotransmission 
(Franks and Lieb, 1994; Campagna et al., 2003; Torri, 2010). The majority of studies 
suggest that the enhanced inhibitory neurotransmission during anesthesia is due to 
potentiation of inhibitory currents through postsynaptic anesthetic action, notably on 
GABAA receptors, but a growing number of studies suggest that presynaptic sites are also 
critical components of anesthetic mechanisms (Griffiths and Norman, 1993; Pocock and 
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Richards, 1993). Here, we document a presynaptic response to anesthetic by recording 
action potentials before and after isoflurane treatment. Our observation of a population of 
CO2-inhibited putative GABA neurons that are stimulated by isoflurane is consistent with 
the current working hypothesis of enhanced inhibitory neurotransmission during 
anesthesia. We postulate that the population of CO2-inhibited putative GABA neurons 
that increased firing in response to isoflurane may contribute to central inhibition 
characteristic of general anesthesia. We did not directly measure neurotransmitter release, 
so this interpretation is based on the assumption that increased firing frequency results in 
increased action potential dependent release of GABA. The population of CO2-inhibited 
putative GABA neurons that decreased or ceased firing in response to isoflurane, 
however, does not fit with the working hypothesis of enhanced inhibitory 
neurotransmission during anesthesia, as we would expect removal of inhibitory inputs to 
result in increased neural activity. The contribution of this response to the state of 
anesthesia remains a pertinent question.  
 
Our identification of two opposing responses to isoflurane in CO2-inhibited putative 
GABA neurons may be relevant in consideration of the current controversy surrounding 
anesthetic effects on GABA release, wherein some studies conclude that anesthetics 
stimulate release and others report that anesthetics inhibit GABA release. In the CA1 
region of rat hippocampal slices, general anesthetics caused an increase in IPSC 
frequency, which was attributed to a presynaptic mechanism (Pittson et al., 2004). These 
findings corroborated earlier studies showing that both inhalational and intravenous 
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anesthetics increased IPSC frequency and calcium-dependent GABA release from nerve 
terminals in rat cerebral cortex (Larsen et al., 1998; Murugaiah and Hemmings, 1998). 
However, other studies indicate that anesthetics depress GABA release (Kotani and 
Akaike, 2012). Volatile anesthetics, including isoflurane, have been shown to decrease 
action potential dependent GABA release in synaptic boutons isolated from rat 
hippocampal CA1 neurons (Ogawa et al., 2011). Our observations of both isoflurane-
inhibited and isoflurane-stimulated CO2-inhibited putative GABA neurons are consistent 
with the literature that reports both inhibition and enhancement of GABA release. 
Collectively, these data suggest a heterogeneous response of GABA neurons to 
anesthetics. It is likely that whether GABA release is stimulated or inhibited by 
anesthetics is specific to the anesthetic agent, anatomical location, channel composition, 
and network inputs, and that these multiple sites and multiple effects are necessary for 
inducing the complex state of anesthesia.    
 
To interpret the responses of CO2-inhibited putative GABA neurons to isoflurane within 
this multi-site theory, and to begin characterizing the two populations of “slow-firing” 
isoflurane-stimulated neurons and “fast-firing isoflurane-inhibited neurons, we need to 
investigate molecular mechanisms underlying presynaptic enhancement or inhibition of 
action potential discharge in GABA neurons. A number of membrane channels are 
potential anesthetic targets. Convincing evidence exists to suggest that volatile 
anesthetics exert presynaptic effects on voltage-gated Na+ channels (Herold and 
Hemmings, 2012), two-pore-domain background K+ channels (TASK channels; Bayliss 
!110!
and Barrett, 2008), and voltage-gated Ca2+ channels (Orestes and Todorovic, 2010). 
Volatile anesthetics have been shown to inhibit neurotransmission through blockade of 
Na+ channels leading to depression of action potential conductance (Ouyang and 
Hemmings, 2005; Wu et al., 2004), potentiation of background K+ currents leading to 
membrane hyperpolarization (Patel et al., 1999; Sirois et al., 2000), and inhibition of 
voltage-gated Ca2+ currents leading to decreased neurotransmitter release (Study, 1994; 
Nikonorov et al., 1998; Kamatchi et al., 1999). These and other presynaptic interactions 
are important to consider as potential underlying mechanisms for the population of 
putative GABA neurons that ceased firing during isoflurane treatment.  
 
We postulate that the response of neurons that ceased firing during isoflurane may have 
been due to potentiation of the background K+ channels by isoflurane. The two-pore-
domain channel subtypes TASK-1 and TASK-3 are highly expressed in the raphé nuclei 
compared to other brain regions (Talley et al., 2001). Binding of isoflurane to TASK 
channels on GABA neurons would hyperpolarize these neurons and inhibit action 
potential discharge during isoflurane treatment. Inhibition of action potential conductance 
through Na+ channel blockade may also be a contributing factor. Further research should 
explore these and other potential molecular mechanisms that give rise to isoflurane’s 
inhibition of action potential discharge in GABA neurons. 
 
With regards to the CO2-inhibited putative GABA neurons that exhibited an increase in 
action potential discharge during isoflurane treatment, we postulate that the underlying 
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molecular mechanism may be related to the ionic mechanism that was previously 
described for retrotrapezoid nucleus (RTN) neurons that are stimulated by isoflurane 
(Lazarenko et al., 2010). In chemosensitive, Phox2b-expressing RTN neurons, the 
enhanced action potential discharge during isoflurane treatment was attributed to 
inhibition of a background K+ current with properties similar to TWIK-related halothane-
inhibited K+ channels (THIK-1 channels). Although most subfamilies of the two-pore-
domain K+ channels, such as TASK-1 and TASK-3, show an increase in outward 
potassium current when exposed to inhalational anesthetics (Patel et al., 1999), the 
THIK-1 channels are inhibited by inhalational anesthetics (Rajan et al., 2001), and 
inhibition of the outward K+ current leads to membrane depolarization and increased 
neuronal excitability. We postulate that the enhanced action potential discharge in CO2-
inhibited putative GABA neurons may be due to the inhibition of a background K+ 
current through THIK-1 channels or other unidentified channels with similar properties. 
Regardless of specific mechanism or channel type, enhanced action potential discharge in 
CO2-inhibited putative GABA neurons was accompanied by an disrupted response to 
hypercapnia during isoflurane treatment. We found that isoflurane-stimulated cells no 
longer exhibited a hypercapnic response during isoflurane treatment. The action potential 
discharge of these isoflurane-stimulated cells either did not change or continued 
increasing throughout the hypercapnic challenge with isoflurane. Although GABA 
neurons have been shown to be CO2-inhibited in vitro and in situ (Richerson et al., 2001, 
Iceman et al., 2010; Iceman et al., 2013), the mechanism controlling GABA neuron 
chemosensitivity remains to be determined. Also unknown is whether the mechanism that 
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conferred enhanced action potential discharge is also responsible for disruption of the 
chemosensitive response, or if those effects were independent of each other.  
 
The disrupted chemosensitive response that we observed in CO2-inhibited isoflurane-
stimulated putative GABA neurons may contribute to the decreased ventilatory response 
that is characteristic of general anesthesia. While the inhibitory effect of sub-anesthetic 
concentrations of volatile anesthetics has been abundantly documented in peripheral 
chemoreceptors (Knill and Gelb, 1978; Knill and Clement, 1985; Dahan et al., 1994; van 
den Elsen, 1998), the effect of volatile anesthetics on central chemoreceptors has not 
been completely defined. The volatile anesthetic halothane has been shown to depress 
ventilatory drive in part by inhibiting central drive from major respiratory control 
networks, such as the pre-Bötzinger complex (Koizumi et al., 2010). Our results 
documenting that isoflurane inhibits chemosensitivity in CO2-inhibited putative GABA 
neurons add to the literature describing an inhibitory effect of volatile anesthetics on 
neurons involved in the central chemoreflex. This inhibition likely contributes to the 
respiratory depression characteristic of general anesthesia (Evers et al., 2006).  
 
The present study was limited by the inability to conclusively identify all CO2-inhibited 
neurons that were used for electrophysiological recordings as GABAergic. The 
juxtacellular labeling method used to fill neurons with biotinamide for 
immunohistochemical identification is by nature a low-yield process. However, our 
identification of a subset of CO2-inhibited cells as GABA-synthesizing neurons support 
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prior in vitro and in situ studies that document a population of medullary raphé GABA 
neurons that are inhibited during hypercapnia (Corcoran et al., 2008; Iceman et al., 2010). 
We recognize that it is certainly probable that not all GABA neurons in the medullary 
raphé are CO2-inhibited, and due to the inherent difficulty of the juxtacellular labeling 
method, we are not able to label all recorded neurons; however, we have yet to document 
a CO2-inhibited cell that was not identified as a GABA neuron by colocalization of 
markers of GABAergic synthesis in the biotinamide-labeled neuron. 
 
Future studies should focus on fully characterizing the two populations of GABA 
neurons. We found significantly fewer of the “slow-firing” isoflurane-stimulated cells 
(n=5) compared to “fast-firing” isoflurane-inhibited cells (n=14), but the relative 
proportions of these two populations in the medullary raphé is not known. Furthermore, it 
is not clear what properties of isoflurane-stimulated cells cause them to fire significantly 
slower at baseline compared to isoflurane-inhibited cells. We postulate that the 
mechanism underlying the response of “fast-firing” isoflurane-inhibited cells may be 
attributed to potentiation of the background K+ current through TASK channels, and we 
further hypothesize that the mechanism responsible for the response of “slow-firing” 
isoflurane-stimulated cells could be attributed to inhibition of the background K+ current 
through THIK-1 channels, but these hypotheses need to be investigated. Furthermore, the 
contribution of each population of isoflurane-stimulated and isoflurane-inhibited putative 
GABA cells to the state of anesthesia is a remaining question. In terms of the 
chemosensitive response, we postulate that the disrupted chemosensitivity of GABA 
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neurons by isoflurane contributes to the respiratory depression characteristic of general 
anesthesia, but this has not been confirmed. Further investigation of the molecular action 
of isoflurane on GABA neurons, and how this molecular action relates to the state of 
anesthesia and ventilatory depression during anesthesia, is required.  
 
In summary, we demonstrate a heterogeneous population of medullary raphé CO2-
inhibited putative GABA neurons that is represented by at least two distinct groups, 
which differ in their baseline firing frequencies and response to isoflurane. This study 
documents how isoflurane affects action potential discharge and chemosensitivity in 
GABA neurons and contributes to literature that describes a presynaptic site of anesthetic 
action. Elucidating these molecular actions may offer insight into the contribution of 
GABA neurons to the respiratory depression characteristic of general anesthesia.  
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3.7   Figures 
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Figure 3.1. CO2-inhibited medullary raphé neurons are GABAergic. 
a) A neuron firing at 0.27 Hz at baseline decreased firing by 68.8 % during 
hypercapnic challenge (9 % CO2; pH 7.2; 5 min) and recovered toward baseline 
firing upon return to normocapnia. Scale bar = 5 s. b) Fluorescent markers of 
GABA synthesis [glutamate decarboxylase (GAD67); green] and biotinamide 
(red) colocalize (yellow) to indicate the recorded neuron was GABAergic. Scale 
bar = 50 µm. c) A different neuron firing at 8.95 Hz at baseline decreased firing 
by 43.4 % during hypercapnic challenge and recovered toward baseline firing 
upon return to normocapnia. Scale bar = 5 s. d) Fluorescent markers of GABA 
synthesis (GAD67; green) and biotinamide (red) colocalize (yellow) to indicate 
the recorded neuron was GABAergic. Scale bar = 50 µm. Note different time 
scales for panels a and c. 
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Figure 3.2. CO2-inhibited putative GABA neurons display heterogeneous 
responses to isoflurane. a) A neuron firing at 0.13 Hz at baseline was inhibited 
during hypercapnic challenge (9 % CO2; pH 7.2; 5 min) and recovered toward 
baseline firing upon return to normocapnia. b) The same neuron increased firing 
by 1,622 % during treatment with 1 % isoflurane. Firing frequency returned to 
baseline upon washout. Scale bar = 1 min. c) A different neuron firing at 2.92 Hz 
at baseline was inhibited during hypercapnic challenge (9 % CO2; pH 7.2) and 
recovered toward baseline firing upon return to normocapnic conditions. Scale 
bar = 10 sec. d) Continued recording from the same neuron indicated the neuron 
ceased firing during treatment with 1 % isoflurane. Firing frequency returned to 
baseline firing upon washout. Scale bar = 1 min. Note different time scales for 
panels a-d. 
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Figure 3.3. Consideration of the total population of CO2-inhibited putative 
GABA neurons reflects population-wide inhibition by isoflurane. 
Considering all CO2-inhibited neurons as a single group (n=19), the mean 
baseline firing frequency (2.14 ± 0.57 Hz) decreased during treatment with 1 % 
isoflurane (0.65 ± 0.26 Hz). Between groups comparison of baseline firing 
frequency to firing frequency during 1 % isoflurane treatment, determined by 
paired t-test, indicated a significant difference between means (*P < 0.05). This 
analysis of the entire population of CO2-inhibited putative GABA neurons did 
not reflect the occurrence of neurons that increased firing in response to 1 % 
isoflurane (see Fig. 3.2a-b).
*
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Figure 3.4. Individual responses of CO2-inhibited putative GABA neurons 
to 1 % isoflurane treatment. The change in absolute firing frequency from 
baseline in response to 1 % isoflurane for each individual CO2-inhibited 
putative GABA neuron (n=19) indicated a significant degree of variability 
between neurons, both in baseline firing frequency and response to isoflurane. 
The majority of neurons decreased or ceased firing during isoflurane treatment, 
but a subset of neurons increased firing in response to isoflurane. 
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Figure 3.5. Individual responses of CO2-inhibited putative GABA neurons 
to 1 % isoflurane treatment are characterized by a bimodal distribution. 
The percent increase from baseline during 1 % isoflurane treatment revealed a 
bimodal distribution represented by two groups: CO2-inhibited neurons that 
increased firing in response to isoflurane and CO2-inhibited neurons that 
decreased or ceased firing during isoflurane treatment. Neurons that had a 
percent change from baseline greater than zero (n=5, shown in red) increased 
firing in response to isoflurane. Neurons that had a percent change from 
baseline less than zero (n=14, shown in blue) decreased firing in response to 
isoflurane. Not all lines are apparent because neurons that ceased firing have 
overlapping lines and data points (n=10; 0 to -100 % on the y-axis). 
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Figure 3.6. Characterization of two distinct populations of CO2-inhibited 
putative GABA neurons. The population of CO2-inhibited putative GABA 
neurons is heterogenous. The “slow-firing” (0.50 ± 0.38 Hz) CO2-inhibited 
neurons increased firing in response to isoflurane. The "fast-firing" (2.72 ± 0.70 
Hz) CO2-inhibited neurons decreased or ceased firing in response to isoflurane. 
Comparison of baseline firing frequencies of "slow firing" and "fast firing" 
CO2-inhibited neurons indicated a significant difference between means, 
determined by t-test (*one-tailed P < 0.05). Comparison of the percent change 
from baseline of "slow firing" (mean percent increase = 1043.86 ± 668.70 %) 
and "fast firing" CO2-inhibited neurons (mean percent decrease = -85.82 ± 7.07 
%) indicated a significant difference between means, determined by t-test (**P 
< 0.01). 
**
*
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Figure 3.7. A subset of medullary raphé neurons are CO2-inhibited. Cells 
identified as CO2-inhibited (n=19) demonstrated a minimum 20 % decrease from 
baseline firing frequency during hypercapnic challenge. Between groups 
comparison of the change in absolute firing frequency from normocapnia (5 % 
CO2; pH 7.4) to hypercapnia (9 % CO2; pH 7.2) and recovery (5 % CO2), 
determined using one-way repeated-measures ANOVA, indicated a significant 
difference between normocapnia and hypercapnia (***P < 0.001) and between 
hypercapnia and recovery (*P < 0.05). There was not a significant difference 
between firing frequencies during normocapnia and recovery periods (P = 0.095).  
*
***
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Figure 3.8. A CO2-inhibited putative GABA neuron is no longer 
chemosensitive during 1 % isoflurane treatment. a) Extracellular 
recording of a medullary raphé neuron firing at 0.13 Hz at baseline (5 % 
CO2; pH 7.4). Scale bar = 5 s. b) The neuron exhibited a 37.5 % decrease 
in firing frequency during hypercapnic challenge (9 % CO2; pH 7.2). c) 
Firing frequency recovered to 0.15 Hz upon return to baseline conditions. 
d) The same neuron increased firing from 0.15 Hz to 2.58 Hz in response 
to 1 % isoflurane. e) During hypercapnic challenge, the neuron continued 
increasing its firing frequency to 2.68 Hz. f) The cell recovered toward 
baseline firing upon washout of isoflurane and return to normocapnia. 
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Figure 3.9. Isoflurane disrupts the chemosensitivity of CO2-inhibited putative 
GABA neurons. Cells that increased firing frequency in response to isoflurane, 
which prior to isoflurane treatment were identified as CO2-inhibited neurons, did 
not respond to the hypercapnic challenge during 1 % isoflurane treatment. During 
treatment with 1 % isoflurane, absolute firing frequency during normocapnia (5 % 
CO2; pH 7.4) and hypercapnia (9 % CO2; pH 7.2) were not significantly different, 
determined by paired t-test (n=4; P = 0.510). 
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Chapter 4 
Conclusion 
 
4.1   Summary of results 
This graduate thesis presents research on the influence of the volatile anesthetic 
isoflurane on the action potential discharge and chemosensitivity of medullary raphé 5-
HT and GABA neurons. Initially, this project aimed to address a long-standing 
controversy surrounding the identity of 5-HT neurons as central chemoreceptors, in 
which 5-HT neurons were shown to be stimulated by CO2 in vitro (Richerson et al., 
2001), in situ (Iceman et al., 2013), and in vivo studies on awake, freely-moving cats 
(Veasey et al., 1995; Veasey et al., 1997), but in vivo studies on rodents anesthetized with 
the halogenated volatile anesthetics, halothane and isoflurane, did not find 5-HT neurons 
to be chemosensitive (DePuy et al., 2011; Mulkey et al., 2004). We tested the hypothesis 
that isoflurane disrupts the chemosensitivity of medullary raphé 5-HT neurons in situ. In 
collaboration with in vitro and in vivo studies from the Richerson laboratory at the 
University of Iowa, we showed that isoflurane does, in fact, disrupt the chemosensitivity 
of 5-HT neurons (Massey et al., 2013). We suggest that these data offer a potential 
explanation for the contradictory findings surrounding the identity of 5-HT neurons as 
central chemoreceptors in vivo.  
 
Following our study on the influence of isoflurane on the chemosensitivity of medullary 
raphé 5-HT neurons, we investigated how isoflurane affects action potential discharge of 
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5-HT neurons. We tested the hypothesis that isoflurane inhibits the baseline firing of 
medullary raphé 5-HT neurons in situ. We showed that isoflurane inhibited the baseline 
firing of caudal raphé 5-HT neurons in the descending 5-HT system. Isoflurane routinely 
inhibited action potential discharge in 5-HT neurons, or caused firing to cease 
completely. These results were consistent for all tested concentrations of isoflurane (1, 
1.5, and 2 %), and the degree of inhibition increased as the concentration of isoflurane in 
extracellular solution increased. We found a significant difference between neuronal 
responses to 1 and 2 % isoflurane, which indicated dose responsiveness of 5-HT neurons 
to isoflurane within a clinically relevant range.  
 
1 % isoflurane approximated 1.15 MAC, the minimum alveolar concentration for 
isoflurane necessary for surgical anesthesia (Eger, 1981). This concentration was 
confirmed by gas chromatography – mass spectrometry (GC – MS) analysis. At 10 min, 
the time point when all neuronal responses to isoflurane were recorded, the mean 
equilibrium isoflurane concentration was 0.38 mM, which was equivalent to 1 volume 
percent (0.38 mM = mean concentration from 6 to 10 min; 0.37 mM = 1 volume percent; 
Eilers et al., 1999). This GC – MS analysis confirmed that our results from experiments 
in situ are relevant to evaluating results from in vivo experiments on anesthetized 
animals, which typically are anesthetized within the range of 1 to 2 % inhaled anesthetic. 
Furthermore, confirming that the concentration of isoflurane received by the preparation 
was equivalent to 1.15 MAC allowed us to ensure that our results documenting the 
influence of isoflurane on 5-HT neurons are clinically relevant.  
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Having established the effect of isoflurane on the basal activity and chemosensitivity of 
5-HT neurons, the proposed excitatory chemosensors in our “push – pull” model, we then 
focused on defining how isoflurane affects GABA neurons, which are the inhibitory 
chemosensors proposed in our model. We aimed to identify how isoflurane affects the 
basal activity and chemosensitivity of CO2-inhibited putative GABA neurons in the 
medullary raphé. We tested the hypothesis that isoflurane enhances action potential 
discharge of medullary raphé CO2-inhibited GABA neurons and disrupts their 
chemosensitivity in situ. We showed that CO2-inhibited cells respond to isoflurane in one 
of two distinct ways: action potential discharge of these cells either dramatically 
increased, or significantly decreased, to the point of ceasing in the majority of cases, in 
response to 1 % isoflurane. Comparing the baseline firing characteristics of cells that 
were stimulated to cells that were inhibited by isoflurane, we found a significant 
difference in baseline firing rates, in which isoflurane-stimulated neurons fired slowly at 
baseline (mean firing frequency: 0.50 ± 0.38 Hz) compared to isoflurane-inhibited 
neurons (mean firing frequency: 2.72 ± 0.70 Hz). Our results point toward a 
heterogeneous population of medullary raphé CO2-inhibited putative GABA neurons 
represented by at least two distinct groups, which differ in their response to isoflurane 
and baseline firing frequency: 1) “slow-firing” CO2-inhibited putative GABA neurons 
that are stimulated by isoflurane; and 2) “fast-firing” CO2-inhibited putative GABA 
neurons that are inhibited by isoflurane.  
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In terms of the influence of isoflurane on the chemosensitivity of CO2-inhibited putative 
GABA neurons, we found that isoflurane disrupts chemosensitivity in the population of 
“slow-firing” isoflurane-stimulated CO2-inhibited putative GABA neurons. 
Chemosensitive responses could not be resolved in the population of “fast-firing” 
isoflurane-inhibited CO2-inhibited putative GABA neurons because these neurons ceased 
firing with isoflurane. These results indicating that isoflurane disrupts chemosensitivity in 
CO2-inhibited isoflurane-stimulated putative GABA neurons are consistent with our 
previous findings that isoflurane disrupts chemosensitivity in medullary raphé CO2-
stimulated 5-HT neurons (Massey et al., 2013).  
 
4.2   Relevance of this dissertation 
Interpretation of results from in vivo studies using anesthesia: Collectively, these data on 
the influence of isoflurane on medullary raphé 5-HT and GABA neurons indicate that 
these two neuron types are profoundly affected by anesthetics. The fact that isoflurane 
caused significant changes in the action potential discharge of medullary raphé 5-HT and 
GABA neurons is imperative to consider when evaluating results from in vivo studies that 
use anesthesia during neuronal recording. For example, Mulkey et al. (2004) reported 
from in vivo recordings in rats maintained under 0.9 % halothane that 5-HT neurons fired 
within a range of 0.5 to 4.2 Hz at baseline (n=37; 27 cells were filled with biotinamide 
and 24 cells showed tryptophan hydroxylase immunocytochemical reactivity). The 
relatively fast maxima reported in the firing frequency range of 0.5 to 4.2 Hz (we observe 
serotonergic neurons firing within a range of approximately 0.5 to 3 Hz) may reflect a 
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subset of 5-HT neurons that are insensitive to anesthetics, perhaps due to a low 
expression of TASK channels. Alternatively, the relatively fast firing frequencies may 
reflect the fact that these 5-HT neurons were stimulated antidromically for selection of 
bulbospinal neurons, and spinally activating these neurons prior to recording may have 
caused them to have slightly higher baseline firing rates. As we have clearly 
demonstrated here, the halogenated anesthetic isoflurane, which has many properties 
similar to halothane, has a profound effect on 5-HT neurons as baseline. Thus, any 
analysis of the baseline firing frequency of the 5-HT neurons reported in Mulkey et al. 
(2004) is impeded by the fact that the animals were anesthetized with halothane 
throughout neuronal recording. 
 
As a second example, DuPuy et al. (2011) reported the baseline firing rates of 
channelrhodopsin-2 (ChR2)-transfected serotonergic neurons from in vivo recordings in 
rats anesthetized with low concentrations (0.2 to 1 %) of isoflurane. Of the 19 cells, 11 
were tonically active with baseline firing rates ranging from 0.1 to 4.4 Hz. Similar to 
Mulkey et al. (2004), their reported maxima is relatively high, which may either reflect a 
population of 5-HT neurons that are insensitive to isoflurane, or it may be due to the fact 
that these ChR2-transfected 5-HT neurons were identified by photostimulation prior to 
recording, which may have stimulated the firing rates observed at baseline. Importantly, 
of the 19 recorded cells, 8 were silent prior to photostimulation-induced depolarization. 
This population of 5-HT neurons may highly express TASK channels and may be 
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representative of the serotonergic neurons that are silenced by isoflurane, as characterized 
in this study.  
 
Given that we observe marked inhibition of 5-HT neurons in response to isoflurane, it is 
plausible that in vivo experiments on anesthetized rats unknowingly target only those 5-
HT neurons that are marginally sensitive or insensitive to isoflurane. These populations 
may express low levels of TASK channels, or isoflurane-insensitivity may be conferred 
by a different unknown mechanism. It is also plausible that some recordings misrepresent 
normal neuronal activity at baseline due to the artifact introduced by anesthesia. Our 
interpretation of the results from these and other in vivo studies must be viewed in light of 
the fact that we have demonstrated that isoflurane profoundly affects the firing 
characteristics of 5-HT and GABA medullary raphé neurons.   
 
Evidence of a presynaptic site of anesthetic action: Following the transition to the 
hypothesis that anesthetics act on specific protein targets, particularly ion channels, the 
majority of research on molecular mechanisms of anesthetic action has centered on 
investigating how anesthetics affect GABAA receptors. As the most abundant inhibitory 
neurotransmitter receptor in the brain, GABAA receptors are a popular target for research 
targeting the question of how anesthetics produce overall central nervous system 
depression. However, a growing number of researchers recognize the likely contribution 
of presynaptic inhibition of neurotransmitter release to central nervous system depression 
during anesthesia (Griffiths and Norman, 1993; Pocock and Richards, 1993). Thus, a 
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growing body of literature describes anesthetic action on presynaptic sites that are 
involved in neurotransmitter release, including voltage-gated Na+ channels (Herold and 
Hemmings, 2012), two-pore-domain background K+ channels (Bayliss and Barrett, 
2008), and voltage-gated Ca2+ channels (Orestes and Todorovic, 2010).  
 
Anesthetics have been shown to inhibit neurotransmitter release through inhibition of 
voltage-gated Ca2+ currents (Study, 1994; Nikonorov et al., 1998; Kamatchi et al., 1999). 
Studies have also shown that anesthetics can inhibit neurotransmitter release through 
direct interaction with neurotransmitter release machinery (Herring et al., 2009), which is 
thought to involve anesthetics binding to vesicle fusion proteins, SNARE and SNARE-
associated proteins (Xie et al., 2013). Perhaps most germane to the present study is 
evidence suggesting that anesthetics depress neurotransmitter release by inhibiting action 
potential conductance. Convincing evidence suggests that anesthetics inhibit action 
potential conductance through blockade of Na+ channels (Ouyang and Hemmings, 2005; 
Wu et al., 2004). Additionally, anesthetics have been shown to inhibit action potential 
conductance by hyperpolarizing neurons through potentiation of TASK channel-mediated 
background K+ currents (Patel et al., 1999; Sirois et al., 2000). Inhibition of action 
potential conductance through blockade of Na+ channels and/or potentiation of 
background K+ currents would lead to decreased action potential dependent 
neurotransmitter release, which could contribute to overall central nervous system 
depression during general anesthesia.  
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In the present study, we monitored action potential discharge before and during treatment 
with isoflurane. Observing how action potential discharge changes in response to 
isoflurane treatment allowed us to directly observe a presynaptic influence of anesthetics. 
Importantly, our evidence of a presynaptic influence of anesthetics on action potential 
discharge is demonstrated in a partially intact network, whereas the vast majority of prior 
studies on presynaptic anesthetic action are conducted in reduced in vitro or isolated 
synaptic bouton preparations. Our observation that isoflurane inhibits action potential 
discharge in medullary raphé 5-HT neurons may be relevant to mechanisms underlying 
overall central nervous system depression during anesthesia because decreased release of 
excitatory neurotransmitters, such as serotonin, would lead to depressed excitatory 
neurotransmission. Our observation that isoflurane stimulates action potential discharge 
in a subset of medullary raphé CO2- inhibited putative GABA neurons may also lend 
insight into mechanisms describing central nervous system depression during anesthesia, 
as increased neurotransmitter release of inhibitory neurotransmitters, such as GABA, 
would lead to increased inhibitory neurotransmission. This work contributes to the 
growing body of literature that suggests that anesthetics affect action potential 
conductance and, thus, exert a presynaptic influence on neurotransmission. 
 
Central mechanisms contributing to respiratory depression during anesthesia: 
Respiratory depression is a well-known secondary effect of general anesthesia (Evers et 
al., 2006). All potent halogenated anesthetics, such as halothane and isoflurane, depress 
ventilation by reducing tidal volume, which is not compensated for by the concomitant 
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increase in respiratory rate, such that PaCO2 increases (Torri, 2010). Anesthetics inhibit 
the ventilatory response to this increase in CO2, but the mechanisms that give rise to the 
blunted ventilatory hypercapnic response are not completely defined. Convincing 
evidence suggests that low concentrations of anesthetics selectively affect peripheral 
chemoreceptors (Knill and Gelb, 1978; Knill and Clement, 1985; Dahan et al., 1994; van 
den Elsen et al., 1995), but the effect of volatile anesthetics on central chemoreceptors 
remains a pertinent question.  
 
The Phox2b-expressing retrotrapezoid nucleus (RTN) neurons that have been well 
characterized as central chemoreceptors are known to be stimulated by isoflurane 
(Lazarenko et al., 2010). Enhanced action potential discharge in RTN neurons during 
isoflurane treatment is thought to contribute to maintenance of respiration during 
anesthesia since, although the response is blunted, there is some ventilatory response to 
hypercapnia during anesthesia. Previously, ours was the first study to document that 
isoflurane disrupted chemosensitivity in 5-HT neurons, the proposed central 
chemoreceptors in the medullary raphé (Massey et al., 2013). In the present study, we 
show that isoflurane disrupted chemosensitivity in the second population of cells that we 
identify as central chemosensors in the medullary raphé, the CO2-inhibited putative 
GABA neurons. The fact that isoflurane disrupted the chemosensitivity of both 
phenotypes of medullary raphé central chemosensors, CO2-stimulated 5-HT and CO2-
inhibited GABA neurons, may suggest a potential mechanism that contributes to the 
depressed ventilatory hypercapnic response during anesthesia; however, the fact that 
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there is some residual ventilatory response during anesthesia suggests that the central 
chemosensors proposed in our “push – pull” model of central chemosensitivity are not 
the only chemosensors that contribute to central chemosensitivity. Likely, RTN neurons 
stimulated by halogenated anesthetics, and perhaps other central chemoreceptors, play a 
larger role in maintaining the ventiliatory response to increased CO2 during anesthesia. 
Our results suggest that the medullary raphé 5-HT and GABA neurons that we study may 
contribute to the overall blunted ventilatory hypercapnic response that occurs during 
anesthesia.  
 
4.3   Future directions 
Design of in vivo experiments using anesthesia: System CO2 sensitivity is dampened 
under some types of anesthesia, particularly when using halogenated volatile anesthetics 
such as halothane and isoflurane. We studied CO2-stimulated 5-HT and CO2-inhibited 
GABA neurons and showed that chemosensitivity of these neurons is disrupted by 
isoflurane, which may contribute to blunted systemic CO2 sensitivity during anesthesia. 
The fact that halogenated anesthetics significantly affect the chemosensitivity of raphé 
neurons, which may contribute to the blunted systemic ventilatory hypercapnic response, 
makes it difficult to interpret results from in vivo studies on central chemosensitivity that 
use anesthesia during neuronal recording. Although there are significant benefits to using 
anesthesia to maintain preparations for electrophysiological recording in vivo, future 
experimental design should be carefully considered in light of our results that show that 
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in fact, the chemosensitivity and basal activity of raphé neurons are significantly changed 
in the presence of anesthesia.  
 
In contrast to the volatile anesthetics halothane and isoflurane, urethane is known to have 
minimal effects on respiration and systemic chemosensitivity (Hughes et al., 1982; 
Pagliardini et al., 2012). In fact, a single low dose (typically 1.0 to 1.5 g/kg) produces 
immobility for several hours while preserving normal circulation, respiration, and reflex 
responses (Koblin, 2002). Due to its minimal interference with homeostatic conditions, 
urethane is popular for use in animal experiments because data collected in animals 
maintained under urethane anesthesia is considered physiologically relevant. Although 
urethane is not administered to patients due to its mutagenic, carcinogenic, and 
hepatotoxic properties, and thus, studies on this agent are less clinically relevant, it would 
be useful to investigate the effect of urethane on 5-HT and GABA raphé populations for 
the purpose of designing future experiments aimed at investigating central 
chemosensitivity in vivo. Choice of concentration would be a key point in any potential 
future studies involving urethane, as larger doses (≥1.5 g/kg) depress respiratory function 
(Koblin, 2002). If low doses of urethane did not affect neuronal chemosensitivity, then 
those data would support use of urethane-anesthetized preparations in studying central 
chemosensitivity in vivo.  
 
Investigating molecular mechanisms of anesthetic action: This research indicates that 
isoflurane significantly affects baseline activity of both 5-HT and GABA raphé neurons, 
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but the molecular mechanisms underlying these effects remain unknown. The potential 
mechanisms of anesthetic action proposed in this thesis should be explored. We proposed 
that inhibition of action potential discharge in 5-HT neurons in response to isoflurane 
may be due to isoflurane binding to TASK-1 and TASK-3 channels on 5-HT neurons.  
Potentiation of background potassium current through TASK channels would cause 
hyperpolarization and decreased neuronal excitability. An antagonist specific to TASK-1 
and TASK-3 channels should be applied while recording from 5-HT neurons during 
isoflurane administration to test this hypothesis.  
 
We also proposed that enhancement of action potential discharge in a subset of CO2-
inhibited putative GABA neurons may be due to the inhibition of a background K+ 
current through THIK-1 channels. THIK-1 channels are inhibited by inhalational 
anesthetics (Rajan et al., 2001), and inhibition of the outward K+ current through these 
channels leads to membrane depolarization and increased neuronal excitability. Thus, we 
postulate that inhibition of THIK-1 channels by isoflurane may cause the enhanced action 
potential discharge observed in a subset of CO2-inhibited putative GABA neurons during 
isoflurane treatment. Although pharmacological methods have not yet been developed to 
target THIK-1 channels, there are antibodies to target these channels. CO2-inhibited 
putative GABA neurons that are stimulated by isoflurane could be labeled with 
biotinamide by the juxtacellular labeling method, and then immunohistochemical 
methods could assess the presence of THIK-1 channels in these neurons. Collectively, 
these experiments would help define some of the molecular mechanisms of anesthetic 
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action that give rise to the changes in baseline activity observed in medullary raphé 
neurons during isoflurane treatment.  
 
4.4.   Summary 
In conclusion, the research presented here indicates that the anesthetic isoflurane has a 
significant influence on neuronal baseline activity, in terms of action potential discharge, 
and chemosensitivity, in terms of a response to hypercapnic challenge, of medullary 
raphé 5-HT and GABA neurons in situ. We showed that isoflurane inhibited action 
potential discharge in medullary raphé 5-HT neurons, which added to our previous study 
indicating that isoflurane disrupts the chemosensitivity of these neurons (Massey et al., 
submitted, see appendix). We also showed that isoflurane stimulates action potential 
discharge in a subset of medullary raphé CO2-inhibited putative GABA neurons and 
inhibits action potential discharge in a different subset of medullary raphé CO2-inhibited 
putative GABA neurons. In the subset of CO2-inhibited isoflurane-stimulated cells, 
isoflurane disrupted chemosensitivity of these putative GABA neurons.  
 
This research will contribute to our understanding of how anesthetics affect action 
potential discharge in medullary raphé neurons, which may offer insight into mechanisms 
of general anesthesia. Our results indicating that medullary raphé neurons are profoundly 
affected by anesthetics, both in terms of their baseline firing and chemosensitive 
properties, will aid in interpretation of results from in vivo studies on anesthetized rodents 
and may inform future design of experiments that require anesthesia for conducting 
!148!
neuronal recordings. Furthermore, by documenting how action potential discharge in 
medullary raphé 5-HT and GABA neurons is affected by isoflurane, we contribute to the 
growing body of literature describing presynaptic mechanisms of anesthetic action 
Finally, documenting how anesthetics affect the chemosensitivity of medullary raphé 
neurons that are known to be involved in respiratory circuits may help define molecular 
mechanisms underlying the decreased ventilatory response to hypercapnia that is 
characteristic of general anesthesia.  
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Appendix A 
Complete Methods 
 
Experimental animals and preparations: Animal care and experimental procedures 
followed guidelines set by the National Institutes of Health Office of Laboratory Animal 
Welfare and the United States Department of Agriculture Animal Welfare Act. All 
protocols were in accordance with the University of Alaska Fairbanks Institutional 
Animal Care and Use Committee guidelines. Juvenile male rats (50 – 150 g; Sprague-
Dawley strain; Simonson Laboratories) were used to generate the perfused in situ 
brainstem preparation as previously described (Paton, 1996; Corcoran et al., 2013). 
Animals were placed in an enclosed chamber, anesthetized with vaporized isoflurane (5 
% isoflurane – 95 % O2; Isoflurane Vapor 19.1; Butler Schein), and administered an 
intraperitoneal heparin sodium injection (0.5 mL of 1000 iu/ml ip; Baxter, Deerfield, IL) 
to prevent formation of blood clots during surgery. Following a 15-min recovery period, 
deep anesthesia was induced with 5 % isoflurane and assessed by the cessation of 
spontaneous breathing and absence of a withdrawal response to firm toe pinch and 
“retinal tap.” Anesthesia was discontinued as preparations were bisected sub-
diaphragmatically, decerebrated rostral to the superior colliculi, and skinned. The head 
and thorax were immersed in ice-chilled perfusate for the remainder of the dissection. 
The descending aorta was isolated, and the posterior throax and spinal cord were 
removed to mid-thoracic level to expose the heart.   
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Each preparation was placed in the recording chamber in a prone position. The 
descending aorta was cannulated with a double-lumen catheter, and preparations were 
retrogradely perfused with a solution at a temperature of 31 °C. The perfusate solution 
contained the following (in mM): 1.0 MgSO4, 125 NaH2PO4, 4.0 KCl, 24 NaHCO3, 115 
NaCl, 10 D-Glucose, 2.0 CaCl2, and 0.18 Ficoll. Baseline conditions, when the perfusate 
was equilibrated with 95 % O2 – 5 % CO2 (PCO2 33 mmHg; pH=7.4), approximated 
normocapnic plasma in vivo. Levels of O2 and CO2 in the perfusate were controlled by 
equilibrating a perfusate reservoir with gas mixtures produced by a precision gas mixer 
(CWE GSM-3) and verified by a CO2 analyzer (Applied Electrochemistry CD-3A). The 
perfusate passed through a heat exchanger to maintain temperature at 31 °C (Lauda E100 
Water Bath), bubble trap to remove gas bubbles and minimize pulsations from the roller 
pump, and mesh filter to prevent debris from blocking capillary beds. The first 50 mL of 
perfusate that passed through the preparation was discarded to eliminate blood, and the 
remaining 450 mL of perfusate was recirculated. Following cannulation, vasopressin (200 
µm; 5 µM Arg-vasopressin acetate salt in H2O) was administered through the perfusate at 
approximately 3 min post-cannulation to stimulate an initial increase in pressure. 
Perfusion pressure, measured with a blood pressure transducer on the second lumen of 
the catheter, was gradually increased to 40-60 mmHg by regulating the speed of a 
peristaltic perfusion pump (Watson-Marlow 505Du). The pericardium was removed and 
the heart was tied off to prevent interference from heart pulsations during neuronal 
recordings. The preparation was tightly secured in a stereotaxic head frame using ear 
bars, nose bar, and mouthpiece, and once the preparation exhibited spontaneous 
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breathing, the neuromuscular blocker gallamine triethidodide (3 mL; 60 mg/L, Sigma-
Aldrich) was added to the perfusate to eliminate movement. The occipital bone, 
surrounding musculature, and cerebellum were removed to expose the dorsal surface of 
the brainstem.  
 
Extracellular recording and experimental treatments: Extracellular recordings of 
medullary raphé (r. magnus, r. obscurus, r. pallidus) neurons were made using single 
pulled glass capillary electrodes (1.2 mM; 15–30 MΩ; David Kopf Instruments 700 D) 
filled with biotinamide hydrobromide (5 % in 0.5 M sodium acetate, Life Technologies). 
The electrode was secured to the electrode-holder (caudally inclined 1.25 mm; David 
Kopf Instruments), positioned near the brainstem midline (≤ 0.1 mm lateral) 0 to 3 mm 
rostral of obex, and advanced through the brain tissue in 2 µm increments using a fine 
stepping motor (Burleigh Instruments Inchworm). Extracellular recordings were made 
with an intracellular amplifier (Axon Instruments Multiclamp 700B) in current clamp 
mode, with a high pass filter at 300 Hz and low pass filter at 1 kHz bessel with an high 
impedance headstage (Axon CV7B, Molecular Devices). Action potentials were digitized 
using Spike 2 (Cambridge Electronic Design Power 1401) and LabChart (AD 
Instruments) software and stored as computer data files. 
 
Neuronal recordings were initiated under baseline conditions (95 % O2 – 5 % CO2; PCO2 
33 mmHg; pH=7.4). As stated above, these conditions approximate normocapnic plasma 
in vivo; however, due to the lack of hemoglobin, the solution hyperoxia (PO2 ~ 600 
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mmHg) was necessary to maintain O2 content sufficient to meet tissue metabolic 
demands, and this unavoidable hyperoxia was constant under all conditions. The 
normocapnic condition was followed by a hypercapnic challenge (91 % O2 – 9 % CO2; 
PCO2 60 mmHg; pH 7.2; 5 min) to approximate conditions similar to those in plasma 
during a 4 % increase in inspired CO2. The preparation was then returned to normocapnic 
conditions for an additional 5 min. The 5-min exposure was demonstrated to be sufficient 
for brain tissue equilibration with the 91 % O2 – 9 % CO2 gas levels in the perfusate 
(Wilson et al., 2001).   
 
Spontaneously active neurons were identified electrophysiologically and classified 
according to changes in firing frequency elicited by elevation of arterial CO2 
concentrations during hypercapnic challenges (increase, decrease, and no change in 
baseline firing frequency). Following a return to baseline conditions for an additional 5 
min, both chemosensitive and insensitive neurons were administered isoflurane. 
Isoflurane was bubbled into the perfusate for 10 min (1, 1.5, or 2 % isoflurane in 95 % O2 
– 5 % CO2; percent isoflurane refers to volume percent). The volume percent was held 
constant by the isoflurane vaporizer (Isoflurane Vapor 19.1, Butler Schein). For 
chemosensitive neurons, the 5-min hypercapnic challenge was repeated in the presence of 
isoflurane (1, 1.5, or 2 % isoflurane; 91 % O2 – 9 % CO2). For insensitive neurons, 
hypercapnic challenges were not repeated. Upon return to baseline conditions (0 % 
isoflurane; 95 % O2 – 5 % CO2), the neuron was allowed to recover toward its baseline 
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firing frequency. Recovery times ranged from 10-30 min, depending on the individual 
neuronal characteristics and assays performed.   
 
Juxtacellular labeling: Subsets of recorded neurons were individually filled with 
biotinamide using the juxtacellular labeling method (Pinault, 1996; Winkler et al., 2006). 
Extracellular recordings were conducted in current clamp mode (Axon Multiclamp 700B) 
to allow current to be injected through the electrode while action potentials were 
monitored. Positive current pulses were applied through the electrode (400-ms duration) 
and gradually increased from 0-15 mV (0.5 mV steps; Grass Stimulator S44B) until the 
cell was entrained to fire simultaneously with the applied stimulus.  Injected current, 
ejection of biotinamide, and cellular firing entrainment caused uptake of the biotinamide 
marker by the recorded cell. Entrainment was maintained for at least 30 s. After 
termination of entrainment, the biotinamide was allowed to disperse for 30 min. Rats 
were perfused through the descending aorta with fixative [4 % paraformaldehyde (PFA) 
in 0.1 M phosphate buffer saline (PBS); pH 7.4; Sigma-Aldrich]. Brainstems were then 
removed and stored in fixative prior to sectioning. Coronal sections (60 µm) were cut 
through the medulla (Vibratome 1000Plus), and sections were processed free-floating.  
 
Immunohistochemistry: Coronal tissue sections were blocked and permeabilized in 
blocking buffer [Blocking buffer: 5 % normal goat serum (NGS in 0.1 % sodium axide; 
Caltag Spec. No. L10000, Lot: 384935A) and 0.3 % Triton X-100 in 0.1 M PBS] for 1 hr 
at 22 °C. Sections were incubated with a streptavidin-Alexa 546 conjugate (Life 
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Technologies #S-11225; 1:500 dilution in PBS with 5 % NGS) for 2 hrs at 22 °C to 
reveal biotinamide introduced into single neurons by juxtacellular labeling. To identify 
serotonergic cells, we used an antibody for the 5-HT-synthesizing enzyme tryptophan 
hydroxylase (TpOH). Sections were incubated overnight at 4 °C with mouse monoclonal 
anti-TpOH (Sigma-Aldrich #T0678; 1:1000 dilution in blocking buffer), followed by 
incubation for 1 hr at 22 °C. To identify GABAergic cells, we used an antibody for the 
GABA-synthesizing enzyme glutamate decarboxylase (GAD-67). Sections were 
incubated for 48 hrs at 22 °C in mouse monoclonal anti-GAD67 (Millipore MAB5406; 
1:500 dilution in blocking buffer). Sections were incubated for 2 hrs at 22 °C in a 
secondary goat anti-mouse Alexa 488 antibody (Life Technologies #A-11029; 1:500 
dilution in 0.1 M PBS with 5 % NGS) to label TpOH-immunoreactive and GAD67-
immunoreactive cells. Sections were air-dried for 30 min, mounted with Vectashield 
(Vector Labs), and coverslipped. Low-magnification (10x) images were used to 
determine the location of biotinamide-labeled cells in relation to anatomical landmarks. 
Local biotinamide, 5-HT, and GABA fluorescence identified colocalization of 
serotonergic or GABAergic markers in biotinamide-labeled neurons. Fluorophores were 
individually excited and emission spectra were collected separately to minimize 
interference using a Zeiss LSM510 confocal microscope: biotin-labeled neuron, Alexa 
546, 543 nm laser, filter BP 560-615; anti-TpOH, Alexa 488, 488 nm laser, filter BP505-
530; anti-GAD-67, Alexa 647, 633 nm laser, filter LP650. Images are presented as a 40x 
projection of a z-stack.  
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Gas chromatography – mass spectrometry: All gas chromatography – mass spectrometry 
(GC – MS) analyses were performed on an Agilent Technologies 7890A GC System and 
5975C mass selective detector with Triple Axis Detector. Helium carrier gas was used at 
a constant flow rate of 20 mL min−1. A sample of 250 µL was injected into a DB-1 ms 
capillary column (45 m x 0.25 mm, film thickness 0.25 µm) at a split ratio of 50:1. The 
system oven temperature was initially maintained at 30 °C for 6 min, and then increased 
at a rate of 10 °C min−1 from 30 to 120 °C. MS acquisition was performed in full scan 
mode in the 40 to 200 amu mass ranges. Mass conditions were as follows: ionization 
voltage, 69.9 eV; ion source temperature, 230 °C; detector voltage, 1.6 kV.  
 
Isoflurane was continuously bubbled into the perfusate for the duration of isoflurane 
treatment at a volume percent held constant by the isoflurane vaporizer (Butler Schein; 
Isoflurane Vapor 19.1). Isoflurane is poorly soluble in water but highly soluble in plastic 
and rubber tubing (Eger, 1981), so samples of the perfusate were analyzed by GC – MS 
to confirm that the experimental preparation received the intended concentration of 
isoflurane through the perfusate. A saturated solution of isoflurane was prepared by 
adding aliquots of isoflurane to perfusate solution and stirring in an airtight container for 
3 hr (15 mM; Scheller et al., 1997). Different concentrations were prepared by diluting 
the saturated solution in perfusate (1:2, 1:4, 1:8, 1:16, 1:32, and 1:64) and 250 µL of 
headspace gas from each dilution was injected directly onto the GC-MS. The mean peak 
area for each dilution, corresponding to the number of isoflurane molecules in solution, 
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was used to generate a standard curve for isoflurane. The standard curve was fit to a 
linear regression line (SigmaPlot).  
 
Samples of perfusate were taken from the aortic cannula, to best approximate the sample 
received by experimental preparations, at each minute during a 10-min 1 % isoflurane 
exposure. Additional samples were taken at 11 and 15 min to confirm that isoflurane 
concentrations were stable throughout the period of recording. GC – MS analysis of these 
samples yielded a value for mean peak area, corresponding to the number of isoflurane 
molecules in solution. The concentration of isoflurane in solution at each minute of the 
drug exposure was calculated from the standard curve equation. These calculated 
concentrations were used to confirm that at 10 min, the time point when all neuronal 
responses to isoflurane were recorded, the concentration of isoflurane in the perfusate 
was equivalent to 1 volume percent.  
 
Data analysis: We discriminated individual extracellular unit activity using computer 
spike sorting software (Spike 2, CED and LabChart, AD Instruments). Stable 1- to 2-min 
periods of single-unit firing were analyzed before (baseline), during (hypercapnia), and 
after (recovery) hypercapnic challenge to provide a mean value for unit firing frequency 
(spikes/s), mean interspike interval (ms), standard deviation and standard error of mean 
interspike interval, and spike width. Subset analysis was used to classify neurons as 
chemo-stimulated where relative frequencies increased by greater than 20 % during 
hypercapnia and returned toward baseline firing during recovery, chemo-inhibited where 
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relative frequencies decreased by greater than 20 % during hypercapnia and returned 
toward baseline firing during recovery, and chemo-insensitive where relative frequencies 
changed by less than 20 % (Wang et al., 2001). We have previously reported the 
influence of isoflurane on hypercapnic responses in chemo-stimulated 5-HT neurons 
(Johansen et al., 2012; Massey et al., submitted). The present data set includes only 
chemo-insensitive neurons.  
 
Data analysis – CO2-insensitive putative 5-HT neurons: Cells were initially screen for 
being serotonergic by a real-time assessment of firing frequency and regularity. Neurons 
with firing frequencies between approximately 0.5 and 3 Hz that fired regularly, without 
sustained pauses or bursts in firing, were regarded as putative 5-HT neurons during 
experimental recording. Putative 5-HT neurons were confirmed as such with the 
following algorithm, in which the mean interspike interval (!, in ms) and standard 
deviation of the intervals (sd, in ms) are considered independent variables: Y(!,sd) = 146 
– ! + 0.98sd (Mason, 1997). If the value of this function is less than zero [Y(!,sd) < 0], 
then the cell was confirmed serotonergic, and if the value of the function is greater than 
zero [Y(!,sd) > 0], then the cell was considered nonserotonergic. All putative 5-HT 
neurons that were identified by real-time assessment of firing pattern and regularity for 
recording were confirmed serotonergic cells by the algorithm.  
 
All putative 5-HT neurons (n=38) were administered a single dose of isoflurane [1 % 
(n=18); 1.5 % (n=10); and 2 % (n=10)]. For each dose, the mean firing frequency at 
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baseline (0 % isoflurane) and mean firing frequency in the last minute of isoflurane 
exposure (1, 1.5, or 2 % isoflurane) were compared using a paired t-test. Baseline firing 
frequencies for each of the three groups (1, 1.5, and 2 % isoflurane) were compared by 
one-way ANOVA to confirm that mean firing frequencies under baseline conditions were 
not significantly different from each other. To assess the existence of a dose response, 
percent change from baseline during isoflurane exposure was compared between 
isoflurane treatment groups using a one-way ANOVA. Post-hoc tests used Holm-Sidak 
pairwise comparison (SigmaPlot). Throughout the text, values are expressed as means ± 
standard error of the mean. The criteria for statistical significance was P < 0.05, and 
instances of P < 0.01 and P < 0.001 are also noted. 
 
Data analysis – CO2-inhibited putative GABA neurons: For cells identified as CO2-
inhibited based on a minimum 20 % decrease in firing frequency during hypercapnic 
challenge, between groups comparison of the change in absolute firing frequency from 
normocapnia (5 % CO2) to hypercapnia (9 % CO2) and recovery (5 % CO2) was 
determined using one-way repeated-measures ANOVA. Post-hoc tests used Holm-Sidak 
pairwise comparison (SigmaPlot).  
 
Considering all CO2-inhibited neurons as a single group (n=19), between groups 
comparison of baseline firing frequency to firing frequency during 1 % isoflurane 
treatment was determined using a paired t-test. However, this analysis of the entire 
population of CO2-inhibited putative GABA neurons did not reflect the occurrence of 
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neurons that increase firing in response to 1 % isoflurane. Neurons were subsequently 
analyzed by percent change from baseline firing during isoflurane, to reveal a bimodal 
distribution represented by two groups: 1) “slow firing” cells that increase firing during 
isoflurane and 2) “fast firing” cells that decrease or cease firing during isoflurane. 
Between groups comparison of the mean percent change from baseline of "slow firing" 
and "fast firing" CO2-inhibited neurons was determined by t-test. Between groups 
comparison of mean baseline firing frequencies of "slow firing" and "fast firing" CO2-
inhibited neurons was determined by one-tailed t-test. The one-tailed t-test was used 
because the distribution of firing frequencies was truncated at zero, corresponding to a 
neuron that is not firing (0 Hz), and therefore, the distribution was not normal and a two-
tailed t-test was not appropriate for analysis. The between groups comparison of mean 
baseline firing frequencies was also determined by a t-test on ranks by the same 
justification of a distribution that is truncated at zero. Throughout the text, values are 
expressed as means ± standard error of the mean. The criteria for statistical significance 
was P < 0.05, and instances of P < 0.01 and P < 0.001 are also noted. 
  
 
 
 
 !!!
!
! 167 
Appendix B 
Co-authored manuscript: Isoflurane abolishes the response of serotonin neurons to 
CO2/pH 
 
The full submitted manuscript is attached on the following pages 
 
 
 
!
!!
169!
!
Isoflurane!abolishes!the!response!of!!
serotonin!neurons!to!CO2/pH!!Cory!A.!Massey1,2,!Kimberly!E.!Iceman3,!Sara!L.!Johansen3,!Yuanming!Wu,!M.D.2,!Michael!B.!Harris,!Ph.D.3,4,!and!George!B.!Richerson,!M.D.,!Ph.D.2,5,6!Interdisciplinary!Graduate!Program!in!Neuroscience1,!Departments!of!Neurology2!and!Molecular!Physiology!and!Biophysics5,!!University!of!Iowa!Hospitals!and!Clinics!200!Hawkins!Drive,!Iowa!City,!Iowa,!52242!VAMC6,!Iowa!City,!IA!!52242;!Department!of!Biology!and!Wildlife3,!Institute!of!Arctic!Biology4!University!of!Alaska!Fairbanks,!902!N.!Koyukuk!Dr.!Fairbanks,!AK!99775!!!
Corresponding!Author:!Cory!A.!Massey!Interdisciplinary!Graduate!Program!in!Neuroscience!Department!of!Neurology!University!of!Iowa!Hospitals!and!Clinics!200!Hawkins!Drive!Iowa!City,!IA!52242!Phone:!!319Z353Z4456!Fax:!!319Z356Z1616!EZmail:!!coryZmassey@uiowa.edu!!
Running!Title:!Isoflurane!blocks!5?HT!neuron!chemosensitivity!
Key!Words:!TASK,&Patch&clamp,&Breathing,&Chemosensitivity,&Raphe&!
!
!
!!
170!
Central!CO2!chemoreceptors!are!critically!important!elements!of!the!respiratory!
control!system,!but!the!identity!of!these!cells!is!unknown!and!highly!
controversial.!!Serotonin!(5?HT)!neurons!have!properties!expected!of!
chemoreceptors,!except!that!they!are!insensitive!to!CO2/pH!in#vivo!in!animals!
anesthetized!with!halothane!or!isoflurane.!!Here!we!found!that!isoflurane!
markedly!impaired!the!hypercapnic#ventilatory!response!in#vivo.!!5?HT!neurons!
in!culture!and!in!an!in#situ!perfused!brainstem!were!stimulated!by!hypercapnia.!
Isoflurane!completely!abolished!5?HT!neuronal!chemosensitivity!in!both!
preparations,!and!hyperpolarized!5?HT!neurons!consistent!with!activation!of!leak!
K+!channels.!However,!these!channels!were!not!involved!in!the!underlying!
mechanism!of!chemosensitivity.!!These!data!resolve!a!major!controversy!about!
respiratory!chemoreception,!and!provide!missing!evidence!supporting!the!
hypothesis!that!5?HT!neurons!are!central!chemoreceptors.!We!conclude!that!
halogenated!anesthetics!can!introduce!a!serious!artifact!into!in#vivo#studies!of!
control!of!breathing.!!!!!!!!!!!!!!!
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INTRODUCTION!Breathing!is!controlled!by!a!network!of!neurons!within!the!brainstem!that!generate!rhythmic!motor!output!to!respiratory!muscles.!!One!of!the!most!important!sources!of!feedback!for!regulation!of!tidal!volume!(VT)!and!respiratory!frequency!(FR)!comes!from!central!respiratory!chemoreceptors!(CRCs)!that!monitor!arterial!PCO2!indirectly!via!brain!tissue!pH1Z3.!!The!location!and!identity!of!the!CRCs!has!been!the!subject!of!considerable!controversy,!with!multiple!sites!proposed!to!contain!putative!pH/CO2!sensors1Z6,!but!there!is!significant!disagreement!about!whether!all!of!these!neurons!are!chemoreceptors!or!the!relative!importance!of!each.!!!There!is!strong!evidence!from!in&vivo!and!in&vitro!approaches!that!serotonin!(5ZHT)!neurons!in!the!medulla!are!CRCs1Z4,!6Z22.!The!hypothesis!that!5ZHT!neurons!are!CRCs!has!generated!considerable!support,!and!would!be!widely!adopted!except!for!the!observation!that!hypercapnia!does!not!consistently!stimulate!5ZHT!neurons!
in&vivo5,!23!.!!For!example,!recordings!from!the!raphé!obscurus18!and!dorsal!raphé19!in!unanesthetized,!behaving!cats!demonstrate!that!a!subset!of!neurons!presumed!to!be!serotonergic!increase!their!firing!frequency!in!response!to!as!little!as!3%!inhaled!CO2.!!In!contrast,!extracellular!recordings!from!the!raphé!obscurus!and!ventrolateral!medulla!(VLM)!of!anesthetized!rats!in&vivo!indicate!that!5ZHT!neurons!do!not!increase!their!firing!frequency!in!response!to!inhalation!of!up!to!10%!CO25,!23.!It!is!important!to!determine!why!such!different!results!were!obtained!in!two!relatively!similar!preparations.!Single!unit!recordings&in&vivo!are!the!gold!standard!for!defining!normal!neuronal!activity,!and!these!four!studies5,!18,!19,!23!are!the!only!ones!to!use!this!
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approach!to!study!chemosensitivity!of!5ZHT!neurons.!!A!potential!confounding!variable!is!that!in!the!two!studies!failing!to!show!5ZHT!neuron!chemosensitivity,!animals!were!anesthetized!with!halothane!or!isoflurane5,!23.!These!anesthetics!potentiate!TASK!channel!currents24!and!these!channels!are!highly!expressed!on!5ZHT!neurons25.!!TASK!channels!mediate!a!leak!K+!current,!which!causes!hyperpolarization!of!membrane!potential!(Em).!Thus,!these!anesthetics!would!inhibit!respiratory!output!at!multiple!sites,!including!5ZHT!neurons!in!particular.!Consistent!with!this,!the!hypercapnic!ventilatory!response!(HCVR)!reported!by!DePuy!et&al.23!in!isoflurane$anesthetized$rats$was$limited$to$an$increase$in$ventilation)(V, E)!of!only!35%!with!inhalation!of!10%!CO2.""In"contrast,"it"is"characteristic)for)V- E!to!increase!by!more!than!250%!in!unanesthetized!mice!and!rats!exposed!to!only!7%!CO210,!17,!26.!!This!reduced!responsiveness!to!CO2!is!disconcerting!and!suggests!a!defect!in!the!HCVR!in!the!two!studies!that!used!halogenated!anesthetics5,!23.!!Resolving!this!controversy!is!critical!to!evaluate!the!veracity!of!the!hypothesis!that!5ZHT!neurons!are!CRCs.!!Here!we!found!that!isoflurane!strongly!depressed!the!HCVR!in&vivo.!!We!also!found!that!isoflurane!profoundly!inhibited!firing!of!5ZHT!neurons!in!cell!culture!and!in!an!isolated!perfused!brainstem!preparation,!and!abolished!chemosensitivity!of!5ZHT!neurons!in!both!preparations.!!These!data!demonstrate!that!halogenated!anesthetics!introduce!a!severe!artifact!in!studies!of!respiratory!chemoreception!or!5ZHT!neuron!chemosensitivity.!Accurate!conclusions!cannot!be!made!about!CRCs!or!neural!control!of!breathing!on!the!basis!of!experiments!using!these!anesthetics.!!
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RESULTS!
Isoflurane!severely!impaired!the!hypercapnic!ventilatory!response!in#vivo!! To!quantify!the!effect!of!isoflurane!on!chemoreception,!we!measured!the!HCVR!in!awake!(unanesthetized)!animals!(Fig.!1a)!and!again!following!at!least!15!minutes!of!exposure!to!1%!isoflurane!(Fig.!1b).!Increases!in!inspired!CO2!from!0%!to!3%,!5%!and!7%!were!each!performed!with!50%!O2!(balance!N2)!to!reduce!the!contribution!from!peripheral!chemoreceptors10."V$ E!increased!by!338%!in!unanesthetized!mice!in!response!to!7%!CO2!!(from!2.52!±!0.86!μl!gZ1!minZ1!to!11.03!±!2.95!μl!gZ1!minZ1;!p<0.0001;!Fig.!1c).!Isoflurane!(1%),!which!is!the!approximate!concentration!needed!to!reach!1!MAC!(mean!alveolar!concentration!required!for!surgical!anesthesia)27,!had!no!effect!on!baseline!breathing!(p=0.63).!However,!the!anesthetic!severely!blunted!the!HCVR.!!In!response!to!7%!CO2,"V$ E!increased!by!only!83%!(from!2.23!±!.61!μl!gZ1!minZ1!to!4.08!±!1.31!μl!gZ1!minZ1;!a!75%!reduction!in!the!HCVR!with!isoflurane,!Fig.!1c);"V$ E!in!7%!CO2!was!significantly!reduced!in!the!presence!of!isoflurane!(p<0.0001)!as!compared!to!7%!CO2!in!the!absence!of!isoflurane.!Isoflurane!had!a!particularly!profound!effect!on!the!FR!component!of!the!HCVR!(Fig.!1d).!In!awake!mice,!when!CO2!was!increased!to!7%,!FR!increased!by!85%!(from!150.85!±!22.67!breaths!minZ1!to!279.71!±!38.95!breaths!minZ1;!p<0.0001).!In!1%!isoflurane,!FR!no!longer!changed!with!hypercapnia!(p=0.92).!Isoflurane!also!blunted!the!effect!of!CO2!on!VT,!albeit!less!than!on!FR!(Fig.!1e).!In!awake!mice,!VT!increased!139%!(from!16.43!±!3.80!μl!gZ1!to!39.32!±!7.67!μl!gZ1)!while!in!1%!isoflurane,!VT!only!increased!89%!(14.75!±!3.19!μl!gZ1!to!27.85!±!8.40!μl!gZ1).!VT!in!
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7%!CO2!was!significantly!reduced!in!the!presence!of!isoflurane!as!compared!to!7%!CO2!in!the!absence!of!isoflurane!(p<0.0001).!!
Isoflurane!inhibited!firing!of!5?HT!neurons!in#vitro!and!abolished!their!
response!to!CO2!
! To!examine!the!effect!of!isoflurane!on!5ZHT!neuron!chemosensitivity,!we!performed!perforated!patch!recordings!from!medullary!raphé!5ZHT!neurons!cultured!from!ePetZEYFP!mice28!(Fig.!2a).!For!the!5ZHT!neuron!shown!in!Figure!2b,!acidic!artificial!cerebrospinal!fluid!(aCSF)!(pH!7.15)!dramatically!increased!firing!frequency.!This!effect!quickly!reversed!with!a!return!to!aCSF!(pH!7.4).!!Isoflurane!(1%)!in!aCSF!eliminated!5ZHT!neuron!firing,!and!acidosis!no!longer!caused!increase!in!firing.!!Firing!was!restored!in!aCSF!upon!washout!of!isoflurane!and!acidosis!again!caused!an!increase!in!firing!frequency.!!! The!effect!of!isoflurane!was!highly!consistent!across!all!recorded!neurons!(n=15;!Fig.!2c).!In!the!absence!of!isoflurane,!acidosis!consistently!increased!firing!frequency!in!all!5ZHT!neurons!tested!(from!0.43!±!0.25!Hz!in!aCSF!to!1.90!±!1.30!Hz!in!acidic!aCSF,!mean!increase!of!342%;!p<0.0001;!n=15),!consistent!with!the!degree!of!5ZHT!neuron!chemosensitivity!previously!reported6,!8,!20Z22.!When!neurons!were!exposed!to!1%!isoflurane!in!aCSF,!the!firing!frequency!decreased!from!0.43!±!0.25!Hz!to!0.00!±!0.01!Hz!(n=15).!Furthermore,!isoflurane!abolished!chemosensitivity!of!5ZHT!neurons;!in!isoflurane,!there!was!no!change!in!firing!rate!in!response!to!acidosis!(from!0.00!±!0.01!Hz!to!0.12!±!0.22!Hz;!p=0.66;!n=15)!(Fig.!2c).!The!
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inhibition!of!5ZHT!neurons!was!reversible!upon!washout!of!isoflurane!(n=12).!!!
!
Isoflurane!did!not!affect!the!underlying!mechanism!of!chemosensitivity!in!5?
HT!neurons!! This!protocol!(Fig.!2b)!did!not!distinguish!whether!isoflurane!interfered!with!an!underlying!chemosensory!mechanism,!or!hyperpolarized!5ZHT!neurons!and!prevented!acidosis!from!reaching!threshold!for!action!potential!generation.!!To!differentiate!between!these!possibilities,!we!examined!changes!in!membrane!potential!(Em)!in!response!to!isoflurane.!!In!aCSF,!isoflurane!(1%)!hyperpolarized!5ZHT!neurons!by!Z6.52!±!3.94!mV!(Fig.!2d,!left!bar;!n=15)!relative!to!aCSF!without!isoflurane.!!Isoflurane!in!acidic!aCSF!hyperpolarized!Em!by!Z2.45!±!4.07!mV!(Fig.!2d,!right!bar!n=15)!relative!to!aCSF!without!isoflurane.!Differences!in!these!Em!values!indicate!that!acidosis!could!not!overcome!the!hyperpolarization!induced!by!isoflurane.!!Thus,!5ZHT!neurons!retain!sensitivity!to!acidosis,!but!isoflurane!prevents!their!responsiveness.!!Chemosensitivity!of!5ZHT!neurons!was!then!studied!after!the!hyperpolarization!induced!by!isoflurane!was!reversed!by!inducing!an!equal!and!opposite!depolarization!with!current!injection.!5ZHT!neurons!were!first!exposed!to!acidic!aCSF!to!quantify!their!chemosensitivity!(Fig.!2e).!Bath!solution!was!then!switched!to!aCSF!with!1%!isoflurane!which!hyperpolarized!neurons!and!ceased!their!firing.!!Sufficient!current!was!then!injected!to!return!firing!frequency!back!to!baseline..!!When!so!treated,!despite!continued!exposure!to!isoflurane!neurons!
!!
176!
increased!firing!when!exposed!to!acidic!aCSF,!and!did!so!to!a!degree!equal!to!that!in!the!absence!of!isoflurane!(Fig.!2f).!Thus,!when!hyperpolarization!induced!by!isoflurane!was!overcome!by!current!injection,!the!underlying!chemosensitivity!was!neither!exaggerated!nor!blunted,!suggesting!that!chemosensory!mechanisms!were!unaltered.!!
5?HT!neurons!were!chemosensitive!in!a!perfused!brainstem!preparation!! It!has!been!suggested!that!chemosensitivity!of!5ZHT!neurons!is!an!artifact!of!culture,!and!that!it!does!not!occur!to!a!significant!degree!in!an!intact!nervous!system23.!The!abnormal!cytoarchitecture!in!cell!culture!has!been!proposed!to!result!in!a!decrease!in!glial!buffering23,!causing!neurons!to!be!exposed!to!larger!changes!in!pH!during!hypercapnia.!!In!contrast,!it!has!been!proposed!that!the!normal!glial!microenvironment!in!the!intact!brain!would!prevent!large!changes!in!pH!in!most!regions29!(including!the!raphé),!while!allowing!larger!changes!in!pH!in!a!few!specialized!regions!(such!as!the!retrotrapezoid!nucleus;!RTN)!where!uniquely!important!chemoreceptors!are!located.!To!address!the!possibility!that!5ZHT!neurons!lack!a!robust!chemoresponse!when!the!glial!microenvironment!is!intact,!we!conducted!experiments!in!an!unanesthetized!acutely!perfused!in&situ!rat!brainstem!preparation.!This!preparation!maintains!an!intact!and!functional!respiratory!control!network,!a!normal!glial!microenvironment!and!cardiorespiratory!reflexes!similar!to!those!in&vivo30,!31.!To!determine!whether!5ZHT!neurons!are!chemosensitive!in!an!intact!respiratory!network,!recordings!were!made!from!5ZHT!neurons!in&situ!(Fig.!
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3a).!These!neurons!were!identified!as!presumably!serotonergic!using!electrophysiological!criteria!described!by!Veasey!et&al.18,!19,!32.!Mason32!and!Mulkey!
et&al.5!confirmed!the!validity!of!these!criteria!by!labeling!recorded!neurons,!and!demonstrated!that!electrophysiological!characteristics!correctly!identify!5ZHT!neurons!with!approximately!90%!accuracy.!!When!the!preparation!was!supplied!with!hypercapnic!perfusate!(pH!7.2)!(Fig.!3b),!the!5ZHT!neuron!increased!its!firing!frequency!by!33%!(from!0.9!Hz!to!1.2!Hz)!compared!to!control!perfusate!(pH!7.4).!This!effect!reversed!when!the!perfusate!was!switched!back!to!control!(Fig.!3c).!An!overlay!of!triggered!spikes!verified!that!this!was!a!single!unit!recording!(Fig.!3d).!Juxtacellular!labeling!and!subsequent!immunohistochemistry!demonstrated!that!the!recorded!neuron!was!tryptophan!hydroxylase!(TpOH)!immunoreactive!(Fig.!3e).!!These!results!refute!the!argument!that!chemosensitivity!of!5ZHT!neurons!is!an!artifact!of!culture.!5ZHT!neurons!are!chemosensitive!in!this!in&situ!preparation!in!which!the!glial!microenvironment!is!intact.!!These!results!agree!with!those!of!Veasey!
et&al.18,!19!who!demonstrated!chemosensitivity!of!5ZHT!neurons!in!unanesthetized!cats!in&vivo,!and!our!own!observations!of!5ZHT!neuron!chemosensitivity!in!acute!rat!and!mouse!brain!slices6,!8,!21.!!These!results!provide!the!major!piece!of!support!that!had!been!missing!for!the!5ZHT!neuron!chemoreceptor!hypothesis!–!documentation!in!an!intact!mammalian!nervous!system!of!chemosensitivity!in!neurons!verified!to!be!serotonergic!by!anatomical!methods.!!!!!
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Isoflurane!abolished!chemosensitivity!of!5?HT!neurons!in!the!perfused!
brainstem!!! We!next!determined!whether!isoflurane!affected!firing!frequency!of!5ZHT!neurons!in!a!perfused!brainstem.!!In!control!perfusate!(pH!7.4),!isoflurane!(1%)!reduced!(Fig.!4a)!or!completely!eliminated!(Fig.!4bZc)!spontaneous!firing!in!64%!(n=14/22)!or!36%!(n=8/22)!of!5ZHT!neurons,!respectively.!!This!effect!was!reversible!(Fig.!4a!and!d).!Illustrated!neurons!were!verified!to!be!serotonergic!using!juxtacellular!labeling!followed!by!TpOH!immunohistochemistry!(Fig.!4e!and!4f).!!! Isoflurane!(1%)!also!eliminated!chemosensitivity!of!5ZHT!neurons!in!the!in&
situ!perfused!brainstem!preparation.!!As!with!our!previously!described!experiment,!extracellular!recordings!from!neurons!(n=9)!meeting!the!electrophysiological!criteria!for!5ZHT!neurons!in!the!rostral!medullary!raphé!(r.!magnus!and!r.!pallidus)!revealed!that!these!cells!increased!their!firing!frequency!when!control!perfusate!was!changed!to!hypercapnic!perfusate!(Fig.!5!aZc),!confirming!that!5ZHT!neurons!were!chemosensitive!in&situ.!!The!response!was!sizable!(71%!±!56%!increase!from!control),!and!consistent!with!the!sensitivity!of!5ZHT!neurons!documented!in!cats!in&
vivo!18,!19!and!the!response!of!the!respiratory!system!as!a!whole!in!this!preparation31.!As!above,!exposure!to!1%!isoflurane!in!control!perfusate!eliminated!(n=3/9)!or!markedly!decreased!(n=6/9)!firing!frequency!and!completely!eliminated!the!response!to!hypercapnic!perfusate!(Fig.!5!dZe).!!This!effect!of!isoflurane!was!reversible!(n=8/9;!Fig.!5c).!!Juxtacellular!labeling!and!TpOH!immunostaining!confirmed!that!this!was!a!5ZHT!neuron!(Fig.!5f).!!These!results!provide!an!
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explanation!for!why!5ZHT!neurons!have!been!found!unresponsive!to!CO2/pH!during!two!of!the!previous!four!published!studies!that!used!single!unit!recordings!in&vivo!to!address!this!question5,!23.!In!both!cases!halogenated!anesthetics!were!used,!and!such!anesthetics!abolished!5ZHT!neuron!chemosensitivity.!
!
DISCUSSION!
5?HT!neurons!have!properties!consistent!with!CO2!chemoreceptors#There!are!certain!properties!that!are!essential!for!neurons!or!glia!to!be!CRCs1.!These!include!that!they!are!intrinsically!chemosensitive!to!small!physiologically!relevant!changes!in!CO21,!3,!4,!6,!8,!15,!20,!22,!and!the!change!in!firing!frequency!induced!by!hypercapnia!would!stimulate!respiratory!output23.!There!are!other!properties!that!5ZHT!neurons!have!that!make!them!well!suited!to!be!CRCs.!5ZHT!neurons!are!closely!associated!with!the!basilar!artery!and!its!largest!branches8,!where!they!can!accurately!monitor!arterial!blood!PCO2.!There!is!a!dense!concentration!of!5ZHT!immunoreactive!nerve!terminals33!and!5ZHT!receptor!expression34!in!respiratory!nuclei.!In!support!of!the!hypothesis!that!5ZHT!neurons!are!CRCs,!focal!acidosis!in!the!raphé!nuclei!causes!increased!respiratory!output!in&vivo!and!in&vitro!2,!7,!9,!14,!35.!Disruption!of!5ZHT!neurons!by!neurotoxins13,!36!or!nonselective!agents!such!as!muscimol12!depresses!the!HCVR.!Mice!with!genetic!deletion10,!11!or!acute!silencing15!of!5ZHT!neurons!have!a!blunted!HCVR.!The!HCVR!of!rodents!also!develops!with!age!in!parallel!with!chemosensitivity!of!5ZHT!neurons21,!
26.!!
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Until!recently!it!was!unclear!whether!5ZHT!neurons!stimulate!or!inhibit!breathing,!only!have!a!modulatory!effect!on!respiratory!output,!or!are!required!for!plasticity37,!38.!It!has!now!been!unequivocally!demonstrated!that!5ZHT!neurons!stimulate!the!respiratory!network!at!multiple!sites.!For!example,!5ZHT2A!receptor!activation!is!required!for!generation!of!respiratory!output!from!brain!slices!containing!the!preZBötzinger!complex!(PBC)14,!39.!!This!is!due!in!part!to!a!requirement!for!5ZHT!in!expression!of!bursting!pacemaker!activity!in!a!subset!of!neurons!of!the!mouse!PBC14.!ThyrotropinZreleasing!hormone!(TRH),!which!is!coZlocalized!in!some!5ZHT!neurons,!also!induces!bursting!pacemaker!activity!in!the!dorsal!respiratory!group!of!guinea!pigs40.!Genetic!deletion!of!5ZHT!neurons!leads!to!decreased!respiratory!output!and!periods!of!apnea!in!Lmx1bf/f/p!neonates11.!Exogenous!application!of!1Z[2,3ZdimethoxyZ4Ziodophenyl]Z2Z!aminopropane!(DOI),!a!5ZHT2A/1C!agonist,!increases!V" E!in!neonatal!Lmx1bf/f/p!mice11!and!rats!in&vivo&41.!Selective!stimulation!of!5ZHT!neurons!in!the!medullary!raphé!in&vivo&using!optogenetics,!increases!phrenic!nerve!activity23.!Thus,!it!is!now!well!established!that!medullary!5ZHT!neurons!stimulate!respiratory!output.!!!
Hypercapnia!stimulates!5?HT!neurons!in#vivo#There!exists!a!longZstanding!controversy!regarding!chemosensitivity!of!5ZHT!neurons!in&vivo.!!Mulkey!et&al.5!reported!that!5ZHT!neurons!in!the!VLM!do!not!respond!to!inhalation!of!10%!CO2!in!halothane!anesthetized!rats!in&vivo.!!More!recently!DePuy!et&al.23!found!that!5ZHT!neurons!in!the!raphé!obscurus!also!do!not!
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respond!to!10%!CO2!in!isoflurane!anesthetized!rats!in&vivo.!From!these!data!it!was!concluded!that!acid!sensitivity!of!5ZHT!neurons!“is!only!notable!in!culture.!It!is!inconsistent!in!slices,!and!these!cells!do!not!respond!to!hypercapnia!in&vivo.”23!The!explanation!for!why!5ZHT!neurons!are!chemosensitive!in!culture!and!slices,!but!are!unresponsive!to!hypercapnia!in&vivo!was!proposed!to!be!due!to!stronger!buffering!of!extracellular!pH!by!glia!in!an!intact!brain,!and!this!was!said!to!be!more!effective!in!the!raphé!than!other!brain!regions23.!It!is!true!that!glial!buffering!can!have!a!powerful!effect!on!brain!pH!and!within!brain!slices29.!This!could!explain!in!part!the!larger!responses!of!5ZHT!neurons!in!culture!than!in!slices,!in!situ!or!in&vivo.!!However,!hypercapnia!in&vivo&actually!induces!a!larger!change!in!pH!in!the!medullary!raphé!than!in!other!regions!of!the!brain42,!and!pH!responses!in!slices!are!smaller!than!in!culture!primarily!because!most!recordings!made!in!slices!have!been!from!young!neurons!(<P18)!when!chemosensitivity!is!not!fully!mature21.!A!greater!degree!of!glial!buffering!also!does!not!explain!why!Veasey!et&al.18,!19!found!that!a!subset!of!5ZHT!neurons!in!both!the!medulla!and!midbrain!of!unanesthetized!cats!respond!to!inhalation!of!as!little!as!3%!CO2,!and!some!nearly!double!their!firing!frequency!in!response!to!8%!CO2.!!The!experiments!of!Veasey!et&
al.!18,!19!identified!neurons!as!serotonergic!using!electrophysiological!criteria!instead!of!the!juxtacellular!labeling!used!by!Mulkey!et&al.5,!but!using!even!a!subset!of!these!electrophysiological!criteria!is!approximately!90%!accurate5,!32.!Medullary!raphé!neurons!have!also!repeatedly!been!shown!to!be!CO2!sensitive!in!unanesthetized!animals!in&vivo&using!cZfos!staining4,!16.!!!
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Our!data!confirm!that!5ZHT!neurons!are!chemosensitive!in!cell!culture.!!They!also!show!that!they!are!chemosensitive!in!a&preparation!in!which!the!lower!brainstem,!the!entire!respiratory!network!and!its!glial!environment,!are!intact.!Thus,!chemosensitivity!of!5ZHT!neurons!is!not!restricted!to!in&vitro!preparations,!but!has!now!been!reported!from!culture,!slices,!in&situ&and!in&vivo.&!These!data!show!that!the!properties!of!5ZHT!neurons!make!them!exceptionally!well!suited!to!be!CRCs.!It!remains!possible!that!only!a!subset!are!CRCs,!whereas!others!are!involved!in!other!functions!such!as!thermoregulation10.!!!!
Isoflurane!inhibits!5?HT!neuron!chemosensitivity!!Our!data!provide!a!clear!explanation!for!why!5ZHT!neurons!were!not!recognized!as!chemosensitive!in!the!in&vivo!studies!of!Mulkey!et&al.5!and!DePuy!et&
al.23,!since!they!used!halogenated!anesthetics.!In!the!current!studies!isoflurane!had!a!profound!effect!on!5ZHT!neurons!in!culture;!it!eliminated!baseline!firing!and!caused!a!6.5!mV!hyperpolarization.!!As!a!result,!the!firing!frequency!in!aCSF!and!increases!in!firing!in!response!to!acidosis!were!completely!abolished.!Similar!results!were!obtained!in&situ,!with!isoflurane!decreasing!baseline!firing!frequency!and!abolishing!the!firing!frequency!increase!in!response!to!pH!in!5ZHT!neurons.!We!conclude!that!halogenated!anesthetics!that!potentiate!TASK!currents!prevented!5ZHT!neurons!from!increasing!their!firing!frequency!in!response!to!CO2/pH.!Isoflurane!did!not!alter!the!underlying!mechanisms!of!chemosensitivity!in!5ZHT!neurons.!When!current!injection!was!used!to!counter!the!isofluraneZinduced!
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hyperpolarization,!the!response!to!acidosis!was!equal!to!that!seen!before!isoflurane!exposure.!This!indicates!that!intrinsic!chemosensitivity!of!these!neurons!is!independent!of!TASK!channels,!in!contrast!to!previous!conclusions43.!!TASK!channels!are!pH!sensitive,!and!5ZHT!neurons!express!high!levels!of!TASK!channels25,!but!the!change!in!conductance!of!TASK!channels!is!very!small!over!the!range!of!pH!studied!(7.4!to!7.2)44.!!That!is!why!it!was!necessary!to!use!a!change!in!pH!from!7.5!to!6.9!to!evaluate!the!role!of!TASK!channels!in!5ZHT!neurons43.!This!magnitude!of!pH!change!is!not!relevant!to!normal!physiology.!TASK!channels!may!also!have!been!disproportionately!important!in!that!study!because!mice!were!P7ZP12,43!an!age!at!which!chemosensitivity!of!5ZHT!neurons!has!not!matured21.!!Due!to!the!high!level!of!expression!of!TASK!channels!on!5ZHT!neurons!compared!to!other!neurons25,!it!would!be!predicted!that!depression!of!chemosensitivity!would!be!greater!in!5ZHT!neurons!than!other!putative!CRCs.!!!
Halogenated!anesthetics!severely!impair!respiratory!chemoreception!in#vivo!Isoflurane,!halothane,!and!other!halogenated!anesthetics!are!frequently!used!in!both!research!and!clinical!settings27.!Our!data!indicate!that!these!agents!should!not!be!used!for!any!experiments!on!chemoreception!or!control!of!breathing.!We!found!that!isoflurane!at!1%,!a!dose!used!for!surgical!anesthesia,!greatly!attenuated!the!HCVR.!!Previous!studies!in!unanesthetized!mice10!and!rats17,!26!reported'increases(in(V* E!of!250%!with!an!increase!in!inspired!CO2!from!0%!to!7%.!In!contrast,!DePuy!et&al.23!reported'only'a'35%'increase'in'V3 E!when!inspired!CO2!increased!from!
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0%!to!10%!in!anesthetized!rats.!In!the!current!study,!unanesthetized!mice%had%a%338%$increase$in$V- E!in!response!to!7%!CO2,!but!mice!anesthetized!with!1%!isoflurane!responded!to!the!same!stimulus!with!only!an!83%!increase.!Thus,!anesthetics!can!severely!blunt!the!HCVR,!as!was!seen!during!in&vivo!recordings!from!rats5,!23.!!In!the!current!experiments,! isoflurane!strongly! inhibited!the!HCVR,!but!had!no! effect! on! baseline! breathing.! ! This! is! reminiscent! of! what! is! seen! when! 5ZHT!neurons!are!genetically!deleted! in!adult!Lmx1bf/f/p!mice10!or!selectively!silenced! in!adult! 5ZHT! neuron! selective! DREADD! mice15.! Isoflurane! and! several! other!halogenated!anesthetics!have!previously!been! shown! to! reduce! the!HCVR!and! the!hypoxic! ventilatory! response27,!45.! These! effects! should! raise! caution! in! the! use! of!this! class! of! anesthetics! when! studying! respiratory! chemoreception,! and! may!retrospectively!alter!conclusions!made!from!experiments!using!these!anesthetics.!A!wide! range! of! anesthetics! can! affect! both! the! baseline! firing! frequency! of! 5ZHT!neurons!and!their!responses!to!receptor!agonists46.!Therefore,!when!studying!5ZHT!chemosensitivity! and! respiratory! chemoreception! it! is! better! to! avoid! anesthetics!completely.!!The!gold!standard!for!defining!normal!neuronal!activity!is!widely!considered!to!be!extracellular!recordings!of!neurons!in!an!intact!brain!in&vivo.!!However,!this!approach!often!requires!the!use!of!anesthesia,!and!two!of!the!most!common!and!convenient!agents!used!are!halothane!and!isoflurane.!!We!have!shown!here!that!halogenated!anesthetics!alter!normal!physiology!so!severely!that!in&vivo&
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preparations!using!these!agents!can!no!longer!be!considered!the!gold!standard.!!!Here!we!have!provided!missing!evidence!that!clearly!defines!5ZHT!neurons!as!CO2/pH!chemoreceptors,!and!explains!why!establishing!this!has!been!so!controversial.!!Defects!in!the!5ZHT!system!have!been!proposed!to!contribute!to!the!pathophysiology!of!sudden!infant!death!syndrome!(SIDS)47!and!sudden,!unexpected!death!in!epilepsy!(SUDEP)48."Both"of"these"disorders"are"thought"to"involve"a"deficit"in#the#arousal#and#increased#V0 E!that!occurs!in&vivo&in!response!to!hypercapnia47,!48.!!These!two!deficits!are!precisely!what!would!be!expected!if!some!5ZHT!neurons!are!chemoreceptors15,!49.!Defining!the!mechanisms!of!5ZHT!neuron!chemosensitivity!could!lead!to!a!better!understanding!of!these!disorders,!and!help!to!develop!therapeutic!interventions.!!
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FIGURE!LEGENDS!
Figure!1.!Isoflurane!severely!impaired!the!HCVR!in#vivo.!a)!Whole!animal!plethysmography!recordings!in!0%!CO2!(above)!and!7%!CO2!(below)!in!50%!O2.!b)!Identical!recordings!from!the!same!mouse!as!in!(a)!except!for!the!addition!of!1%!isoflurane!to!the!50%!O2.!c)!Isoflurane!caused!a!large!reduction!in!the!slope!of!V" E!vs.!inspired!CO2!(%)!(F3,90=52.33,!p<0.001,!n=16).!d)!Isoflurane!ablated!the!increase!in!FR!as!inspired!CO2!(%)!increased!(F3,90=78.70,!p<0.001,!n=16).!e)!Increases!in!VT!were!reduced!in!isoflurane!as!inspired!CO2!(%)!increased!to!5%!and!above!(F3,!
90=12.62,!p<0.001,!n=16).!*!Z!p<0.05,!***!Z!p<0.001.!
!
Figure!2.!Isoflurane!inhibited!firing!of!5?HT!neurons!in#vitro!and!abolished!
their!response!to!CO2.#a)!Confocal!microscopy!image!of!cultured!medullary!ePetZEYFP!neuron.!YFP!–!green.!DAPI!nuclear!stain!–!blue.!Scale!bar!Z!25!μm.!b)!Firing!rate!and!pH!of!a!recording!from!a!cultured!medullary!5ZHT!neuron!held!at!a!constant!current!level.!!Firing!increased!during!acidosis!in!aCSF.!1%!isoflurane!eliminated!firing!in!aCSF!and!abolished!the!response!to!acidosis.!c)!Summary!of!current!clamp!recordings.!Isoflurane!eliminated!firing!and!markedly!decreased!the!response!to!acidosis!(F2,39=8.592,!p=0.0008,!n=15).!These!effects!were!reversible!(n=12).!!d)!Summary!of!differences!in!Em!between!aCSF!(left!bar)!and!acidic!aCSF!(right!bar)!aCSF!with!isoflurane,!in!both!cases!compared!to!aCSF!without!isoflurane!(n=15).!e)!Recording!from!a!5ZHT!neuron!whose!firing!and!chemosensitivity!were!both!abolished!by!isoflurane.!Current!injection!was!increased!from!77.7!pA!to!159.8!
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pA!to!reverse!the!hyperpolarization!induced!by!isoflurane.!!The!response!to!acidosis!was!then!as!large!as!control!despite!the!continued!presence!of!isoflurane.!f)!Summary!of!the!effect!of!acidosis!while!giving!current!injection!to!reverse!the!hyperpolarization!induced!by!isoflurane.!Shown!are!firing!rates!in!aCSF!(pH!7.4)!and!acidic!aCSF!(pH!7.15)!under!control!conditions,!in!isoflurane!while!giving!extra!depolarizing!current,!and!during!washout!of!isoflurane.!Chemosensitivity!remained!intact!in!isoflurane!(F2,28=.122,!p=0.8254,!n=12).!*!Z!p<0.05,!***!Z!p<0.001.!!
Figure!3.!5?HT!neurons!were!chemosensitive!in!the!perfused!brainstem!
preparation.!a)!Extracellular!recording!of!action!potentials!from!a!putative!5ZHT!neuron!during!perfusion!with!control!perfusate!(pH!7.4)!(firing!frequency!Z!0.9!Hz).!
b)!Firing!frequency!increased!in!response!to!hypercapnic!perfusate!(pH!7.2)!by!33%!to!1.2Hz.!c)!Firing!frequency!returned!to!baseline!levels!with!washout!of!hypercapnic!perfusate.!d)!Spike!overlay!of!action!potentials!during!a!60!second!continuous!recording!verified!that!this!was!a!single!cell.!e)!Juxtacellular!labeling!verified!this!was!a!5ZHT!neuron.!!Biotinamide!(red);!TpOH!immunohistochemistry!(green);!CoZlocalization!(yellow).!Scale!bar!Z!50!µm.!
!
Figure!4.!Isoflurane!inhibited!baseline!firing!of!5?HT!neurons!in!the!perfused!
brainstem!preparation.!a)!A!putative!5ZHT!neuron!in!the!perfused!brainstem!preparation!decreased!its!firing!frequency!in!response!to!1%!isoflurane,!with!recovery!upon!washout.!b)!Spontaneous!firing!of!a!putative!5ZHT!neuron!(different!
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than!in!(a))!exposed!to!control!perfusate.!c)!Isoflurane!(1%)!abolished!firing!of!neuron!in!(b).!d)!Spontaneous!firing!of!neuron!in!(b)!returned!after!washout!of!isoflurane.!e?f)!Photomicrographs!of!juxtacellularly!labeled!cells!in!(a!&!bZd,!respectively)!confirmed!they!were!5ZHT!neurons.!Biotinamide!(red);!TpOH!immunohistochemistry!(green);!CoZlocalization!(yellow).!Scale!bar!Z!50!µm.!!
Figure!5.!Isoflurane!abolished!5?HT!neuron!chemosensitivity!in#situ.#a)!Spontaneous!firing!of!a!putative!5ZHT!neuron!during!control!perfusate!(pH!7.4)!in&
situ.!b)!Firing!frequency!increased!in!response!to!hypercapnic!perfusate!(pH!7.2).!c)!Summary!of!all!recordings!testing!5ZHT!neuron!chemosensitivity!in&situ!(n=9).!5ZHT!neurons!were!chemosensitive!under!control!conditions!(p=0.03).!Isoflurane!significantly!reduced!firing!frequency!(p=0.02)!and!caused!loss!of!the!response!to!hypercapnic!perfusate.!Firing!frequency!returned!to!baseline!levels!after!isoflurane!was!washed!out.!d)!Isoflurane!(1%)!caused!a!decrease!in!firing!frequency!of!the!neuron!in!(a).!e)!In!isoflurane,!the!neuron!no!longer!responded!to!hypercapnic!perfusate!with!an!increase!in!firing!frequency.!f)!Juxtacellular!labeling!confirmed!this!was!a!5ZHT!neuron.!Biotinamide!(red);!TpOH!immunostaining!(green);!CoZlocalization!(yellow).!Scale!bar!Z!50!µm.!*!Z!p<0.05,!***!Z!p<0.001.!! !
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METHODS!
Plethysmography.!V" E!was!measured!using!standard!openZflow!(700!ml/min),!wholeZbody!plethysmography!(Buxco,!Wilmington,!North!Carolina)!as!previously!used!in!our!laboratory10.!The!protocol!consisted!of!>20!minutes!of!baseline!in!0%!CO2,!50%!O2!and!balance!N2!followed!by!approximately!7!minute!exposures!to!3%,!5%,!and!7%!CO2,!50%!O2,!balance!N2;!no!other!gas!combinations!were!used.!The!same!sequence!of!increased!CO2!from!0%!to!7%!was!then!performed!with!1%!isoflurane!added!to!each!gas!mixture.!Mice!were!exposed!to!1%!isoflurane!mixed!with!50%!O2!for!at!least!15!minutes!prior!to!starting!the!sequence!of!CO2!in!order!to!ensure!mice!were!fully!inducted;!1%!isoflurane!was!the!only!concentration!used!for!all!plethysmography!recordings.!All!data!were!acquired!using!customZwritten!Matlab!software.!All!analyzed!data!were!obtained!after!2Z3!minutes!of!gas!exposure!to!ensure!equilibrium!in!the!chamber.!All!data!segments!>10!seconds!in!duration!that!did!not!contain!sighs,!coughs,!sniffing,!or!movement!artifacts!were!selected!for!analysis.!At!least!60!seconds!of!data!were!analyzed!in!each!gas.!!!
Animal&Model&for&in!vitro&studies.!For!patch!clamp!recording!experiments,!ePetZEYFP!mice28!were!used!to!allow!identification!of!5ZHT!neurons!prior!to!recordings.!In!these!mice,!which!have!been!described!previously,!the!enhancer!region!of!the!PetE1!ETS!gene!drives!expression!of!enhanced!YFP.!!!!
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Cell&culture.&Neonatal!ePetZEYFP!pups!were!sacrificed!on!postnatal!day!0Z2!(P0ZP2)!and!a!wedge!of!tissue!from!the!ventromedial!portion!of!the!rostral!half!of!the!medulla!(including!the!raphé!pallidus,!r.!magnus,!and!r.!obscurus)!was!removed.!This!tissue!was!digested,!triturated,!and!plated!on!polyZLZornithineZ!and!lamininZcoated!coverslips.!Cells!were!fed!with!10%!FBS/54%!MEM/36%!Neurobasal!medium!with!B27!supplement.!Cultures!were!maintained!in!an!incubator!at!37°C!and!5%!CO2!as!previously!described!by!our!laboratory20.!Recordings!were!not!performed!on!any!culture!before!P21!(19Z21!days!after!culturing)!to!allow!maturation!of!chemosensitivity21!and!were!made!only!from!YFPZpositive!cells.!!!
Bath&solutions.!aCSF!(pH!7.4)!contained!(in!mM)!124!NaCl,!3!KCl,!2!MgCl2,!2!CaCl2,!1.3!NaH2PO4,!26!NaHCO3,!and!10!dextrose.!!Acidic!aCSF!(pH!7.15)!was!used!to!decrease!pH.!!This!solution!contained!(in!mM)!136!NaCl,!3!KCl,!2!MgCl2,!2!CaCl2,!1.3!NaH2PO4,!13!NaHCO3,!10!dextrose.!Both!solutions!had!an!osmolarity!of!305!±!5!mOsm!and!were!maintained!isocapnic!by!equilibration!with!5%!CO2Z95%!O2!for!the!duration!of!the!experiments.!Fast!glutamatergic!and!GABAergic!synaptic!transmission!was!blocked!by!100!μM!picrotoxin!(PTX)!(SigmaZAldrich,!St.!Louis,!Missouri),!50!μM!(±)Z2ZaminoZ5Zphosphonopentanoic!acid!(APZ5)!(Tocris,!Ellisville,!Missouri),!and!10!μM!6ZcyanoZ7ZnitroquinoxalineZ2,3Zdione!(CNQX)!(Tocris,!Ellisville,!Missouri)!in!both!solutions.!Two!reservoirs!contained!aCSF!and!two!had!acidic!aCSF.!Gas!to!two!reservoirs!(pH!7.4!&!7.15)!was!also!equilibrated!with!1%!isoflurane!using!a!precision!vaporizer!(Summit!Anesthesia!Solutions,!Bend,!Oregon).!
!!
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aCSF!or!acidic!aCSF,!with!or!without!isoflurane,!could!be!administered!by!selecting!the!appropriate!aCSF!reservoir.!There!was!only!one!concentration!of!isoflurane!(1%)!used!in!all!patch!clamp!recordings.!!
PatchEclamp&recordings.!The!gramicidin!perforatedZpatch!technique!was!used!for!all!recordings.!Electrodes!(6Z14!MΩ;!borosilicate!glass)!were!pulled!on!a!micropipette!puller!(Sutter!Instrument!Co.,!Novato,!California)!and!filled!with!intracellular!solution!containing!(in!mM):!135!KOH,!135!methanesulfonic!acid,!10!KCl,!5!HEPES,!and!1!EGTA;!pH!7.2;!osmolarity!275!±!5!mOsm.!Gramicidin!(0.01g;!SigmaZAldrich,!St.!Louis,!Missouri)!was!dissolved!in!1ml!of!sterile!DMSO!(SigmaZAldrich,!St.!Louis,!Missouri).!Gramicidin!solution!(15!μl)!was!added!to!1!ml!of!intracellular!solution.!Coverslips!plated!with!dissociated!neurons!from!the!midline!medulla!of!ePetZEYFP!mice!were!transferred!to!a!recording!chamber!on!a!stage!of!an!Axiovert!200!inverted!microscope!(Carl!Zeiss!USA,!Thornwood,!NY)!and!continuously!superfused!with!aCSF!at!a!rate!of!2!ml/min!at!room!temperature.!5ZHT!neurons!were!identified!using!epifluorescense!microscopy.!Gramicidin!perforated!patch!recordings!were!used!to!record!Em!in!current!clamp!mode.!Recordings!were!performed!with!a!Multiclamp!700B!microelectrode!amplifier!(Molecular!Devices,!Sunnyvale,!California)!and!data!were!collected!using!a!Digidata!1440A!acquisition!system!(Molecular!Devices,!Sunnyvale,!California).!!!!
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In!vitro&protocol.&!Cultured!5ZHT!neurons!were!exposed!to!a!series!of!alternating!episodes!of!aCSF!followed!by!acidic!aCSF!for!5!minutes!each!to!test!for!chemosensitivity.!Neurons!were!then!exposed!to!aCSF!equilibrated!with!1%!isoflurane!and!exposed!to!the!same!cycle!of!aCSF!and!acidic!aCSF.!Isoflurane!was!then!washed!out,!and!recovery!of!chemosensitivity!was!examined.!For!15!neurons,!current!injection!was!given!throughout!the!recording!at!a!constant!level!throughout!the!entire!recording.!!This!current!was!usually!sufficient!to!maintain!firing!frequency!at!or!above!0.5!Hz!in!aCSF!without!isoflurane.!In!10!additional!neurons,!one!level!of!current!was!used!in!solutions!without!isoflurane,!and!the!current!was!increased!during!isoflurane!exposure!to!overcome!the!hyperpolarization!induced!by!isoflurane.!!!In!situ&brainstem&recordings.&All!in&situ&experiments!were!conducted!using!juvenile!(P20Z30;!60Z120!g)!male!SpragueZDawley!derived!rats!(Simonsen!Laboratories,!Gilroy,!California).!Experiments!were!conducted!in&situ!using!the!perfused!decerebrate!juvenile!rat!brainstem!preparation31.!Rats!were!heparinized!(0.3!ml!of!1,000!i.u./ml;!i.p.)!and!briefly!anesthetized!with!isoflurane!until!spontaneous!respirations!ceased.!The!portion!of!the!body!caudal!to!the!diaphragm!was!removed,!and!the!temperature!of!the!rostral!portion!reduced!by!placing!it!in!chilled!perfusate!containing:!(in!mM)!NaCl!125,!KCl!3.75,!CaCl2!2.5,!MgSO4!1.25,!KH2PO4!1.25,!NaHCO3!25,!glucose!10,!ficollZ70!0.18.!Preparations!were!decerebrated!at!a!precollicular!level!and!the!forebrain!removed!by!aspiration.!A!catheter!with!a!double!lumen!was!inserted!
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retrogradely!into!the!descending!aorta,!and!perfusate!was!pumped!into!the!aorta!via!a!peristaltic!pump.!Perfusion!pressure!(measured!with!a!pressure!transducer!attached!to!the!second!lumen)!was!increased!gradually!to!50Z75!mmHg!and!then!held!constant.!The!neuromuscular!blocker!gallamine!triethiodide!was!added!to!the!perfusate!to!eliminate!motor!movements.!!Perfusate!passed!through!a!heat!exchanger,!filter!(25!µm),!“bubble!trap”!and!the!cannula!in!the!aorta.!The!temperature!of!the!perfusate!as!it!entered!the!aorta!was!maintained!at!30Z310C.!Although!hypothermic,!this!temperature!greatly!enhances!the!viability!of!the!preparation,!which!exhibits!phrenic!burst!pattern!and!FR!similar!to!that!of!isothermic!rats!in&vivo.!Venous!outflow!of!perfusate!was!collected!and!recirculated.!
&In!situ&protocol.##The!levels!of!O2!and!CO2!in!the!perfusate!were!maintained!by!equilibrating!a!perfusate!reservoir!with!gas!mixtures!produced!with!a!precision!GSMZ2!gas!mixer!(CWE,!Inc.,!Ardmore,!Pennsylvania)!and!verified!with!a!CDZ3A!CO2!analyzer!(AEI!Technologies,!Pittsburgh,!Pennsylvania).!Control!conditions!approximated!normocapnic!plasma!in&vivo:!perfusate!equilibrated!with!95%!O2!Z!5%!CO2!entered!the!aorta!with!a!PCO2!and!pH!of!33!mmHg!and!7.4,!respectively.!Lacking!hemoglobin,!solution!hyperoxia!(PO2!≈!600!mmHg)!was!necessary!to!maintain!O2!content!sufficient!to!meet!tissue!metabolic!demands.!!This!unavoidable!hyperoxia!was!constant!under!all!conditions.!Neuronal!recordings!were!always!initiated!under!control!gas!conditions,!followed!by!brief!mild!hypercapnic!challenges!(perfusate!equilibrated!with!91%!O2!Z!9%!CO2;!Pco2!60!mmHg;!pH!7.2).!Hypercapnic!conditions!
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were!held!for!5!min!before!return!to!control.!!Preparations!were!then!perfused!with!isoflurane!(1%)!added!to!the!perfusate!using!an!anesthetic!vaporizer!(Draeger!Medical,!Inc.,!Telford,!Pennsylvania).!There!was!only!one!concentration!of!isoflurane!(1%)!used!for!all!in&situ!recordings.!Extracellular!recordings&were!made!using!pulled!glass!capillary!electrodes!fabricated!to!produce!a!tip!resistance!of!15Z20!MΩ,!and!filled!with!biotinamide!hydrobromide!(Life!Technologies,!Grand!Island,!New!York)!dissolved!at!5%!in!0.5!M!sodium!acetate.!Using!a!dorsal!approach,!electrodes!were!placed!in!the!rostral!medullary!raphé!(r.!magnus!and!r.!pallidus)!under!stereotactic!guidance!using!surface!landmarks!(bregma,!midline!and!obex).!Raphé!regions!were!targeted!along!the!midline!(+!0.1!mm!lateral),!!0!–!1.5!mm!caudal!to!the!interaural!line,!10!–!12!mm!below!the!dorsal!surface.!Electrodes!were!placed!using!a!fine!stepping!motor!(2!µm!steps;!Burleigh!Inchworm)!held!in!a!stereotaxic!5Zaxis!micropositioner!integrated!with!a!Benchmark!Angle!Two!digital!brain!atlas!(MyNeuroLab,!St.!Louis,!Missouri).!Electrodes!were!connected!to!an!Axon!Multiclamp!700B!intracellular!amplifier!(Molecular!Devices,!Sunnyvale,!California)!with!high!pass!filter!at!300!Hz!and!low!pass!filter!at!1!kHz!Bessel!via!an!Axon!CV7B!high!impedance!headstage!(Molecular!Devices,!Sunnyvale,!California).!Signals!were!digitized!using!Spike!2!(CED,!Cambridge,!England),!sampled!(>10!kHz)!and!stored!as!computer!data!files!for!subsequent!analysis.!!
&
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Spike&sorting&and&analysis.#Stable!1Z!to!3Zmin!periods!of!singleZunit!firing!frequency!were!analyzed!using!Spike!2!spikeZsorting!and!analysis!software!(CED,!Cambridge,!England).!Mean!singleZunit!firing!frequencies!were!analyzed!before!(baseline),!during!the!last!minute!of!the!5Zminute!hypercapnic!challenge!and!following!a!5Zminute!return!to!control!conditions.!Control!recordings!and!hypercapnic!challenges!were!repeated!after!at!least!a!10Zminute!exposure!to!1%!isoflurane.!If!a!neuron!responded!to!hypercapnic!perfusate!with!an!increase!in!firing!frequency!greater!than!20%!relative!to!baseline!the!neuron!was!considered!chemosensitive!and!the!recording!continued.!
&
Regularity&analysis.&The!regularity!and!frequency!of!neuronal!spikes!were!assessed!over!the!1Z3!min!of!observation!using!a!modification!of!a!method!developed!for!identification!of!5ZHT!neurons!during!extracellular!recordings!from!anesthetized!rats32.!A!modification!of!these!along!with!other!criteria!for!unanesthetized!cats18!can!identify!5ZHT!neurons!purely!based!on!electrophysiological!characteristics!with!approximately!90%!accuracy!in&vivo5.!
&In!situ&juxtacellular&labeling.!Extracellular!recordings!of!action!potentials!were!made!with!an!intracellular!amplifier!(Axon!Multiclamp!700B,!Molecular!Devices,!Sunnyvale,!California)!in!current!clamp!mode!while!field!potentials!were!monitored.!Recorded!neurons!were!filled!with!biotinamide!by!applying!positiveZcurrent!pulses!(400Zms!duration,!50%!duty!cycle)!of!gradually!increasing!intensity!(0!Z!10!nAmp!
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max!in!0.2!nAmp!steps)!to!each!cell!through!the!bridge!circuit!of!the!recording!amplifier!until!entrainment!of!cell!discharge!to!the!current!pulse!was!achieved.!Cell!entrainment!was!maintained!for!at!least!30!s.!!Current!pulses!triggered!the!iontophoretic!ejection!of!biotinamide!and!entrainment!facilitates!uptake!of!this!marker!by!the!recorded!and!entrained!cell.!Entrainment!was!never!initiated!when!multiple!units!were!visible,!and!double!neuron!or!ectopic!labeling!was!not!observed.!Spike!height,!width!and!shape!were!monitored!before,!during!and!after!juxtacellular!entrainment!to!ensure!that!only!one!cell!was!recorded!and!labeled.!
&
Immunohistochemistry.!After!juxtacellular!labeling,!preparations!were!perfused!retrogradely!through!the!descending!aorta!with!4%!paraformaldehyde!in!PBS.!!Brainstems!were!removed!and!submerged!in!fixative!overnight!prior!to!sectioning!(Vibratome;!60Zµm!coronal!sections)!and!processing!as!freeZfloating!slices.!Biotinamide!introduced!into!single!neurons!by!juxtacellular!labeling!was!revealed!with!a!streptavidinZAlexa!546!conjugate!(2μg/ml;!Life!Technologies,!Grand!Island,!New!York).!Sections!were!then!blocked!with!1%!bovine!serum!albumin,!3%!normal!goat!serum,!and!0.3%!Triton!XZ100,!then!incubated!at!4°C!overnight!in!a!mouse!antiZTpOH!monoclonal!antibody!diluted!1:1000!in!blocking!buffer!(#T0678;!SigmaZAldrich,!St.!Louis,!Missouri)!followed!by!a!secondary!goat!antiZmouse!Alexa!488!antibody!(1:500;!Life!Technologies,!Grand!Island,!New!York).!Immunohistochemical!controls!included!incubation!without!primary!antibodies,!and!incubation!without!secondary!antibodies.!Immunoreactivity!was!absent!in!areas!known!not!to!express!
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target!and!was!confirmed!to!be!specifically!localized!in!the!raphé!nuclei.!BiotinamideZlabeled!cells!were!mapped!onto!the!brain!atlas.!Local!biotinamide!label!and!TpOH!immunoreactivity!were!visualized!using!a!Zeiss!LSM510!confocal!microscope.!!!
Statistical&analysis.!All!statistical!differences!were!calculated!using!a!twoZway!repeated!measures!ANOVA!and!HolmZSidak!Pairwise!multiple!comparison!procedures!with!an!overall!significance!level!set!to!p=0.05,!unless!otherwise!indicated!(GraphPad!Prism!V6.01!&!SigmaPlot!V12).!When!data!is!presented!as!X!±!Y,!X!is!the!group!mean!and!Y!is!the!standard!deviation;!all!error!bars!represent!the!standard!error!of!the!mean.!For!wholeZanimal!experiments!with!mice,!each!animal!was!exposed!to!increased!CO2!levels!both!in!the!absence!and!presence!of!isoflurane!to!act!as!inZsubject!controls.!! !
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Figure B-1. Isoflurane severely impaired the hypercapnic ventilatory 
response in vivo. See figure description in text,  "Figure 1" page 187. 
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Figure B-2. Isoflurane inhibited firing of 5-HT neurons in vitro and abolished 
their response to CO2. See figure description in text, "Figure 2" page 187. 
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Massey et al.Figure 3
Figure B-3. 5-HT neurons were chemosensitive in the perfused brainstem 
preparation. See figure description in text, "Figure 3" page 188. 
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Massey et al.Figure 4
Figure B-4. Isoflurane inhibited baseline firing of 5-HT neurons in the 
perfused brainstem preparation. See figure description in text, "Figure 4" 
page 188. 
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Figure B-5. Isoflurane abolished 5-HT neuron chemosensitivity in situ. 
See figure description in text, "Figure 5" page 189. 
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